Home› India› Ministry of Chemicals and Fertilizers› In exercise of the powers, conferred by paragraph 4, 6, 10, ...
Date: 2020-03-25 Category: Extra Ordinary State: Union Government Country: India

In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Executive Summary: This document from the National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers, fixes and revises the ceiling prices of various scheduled drug formulations, effective April 1, 2020. It supersedes previous pricing orders and sets maximum prices, excluding GST, for manufacturers. Manufacturers and retailers must comply with these price limits. Key Points / Main Content: Pricing Fixation and Revision: * Ceiling prices are fixed for scheduled formulations as specified in column 5 of the table, excluding goods and services tax (GST). * Prices are revised based on an annual Wholesale Price Index (WPI) increase of 1.88468. * The revised prices are effective from April 1, 2020. * Supersedes previous orders from the National Pharmaceutical Pricing Authority (NPPA). Manufacturer Responsibilities: * For pack sizes different from those listed, manufacturers must contact NPPA for specific price approval as per paragraph 11(3) of DPCO 2013. * Manufacturers must approach NPPA with relevant information for price approval of any other scheduled formulation not listed. * Manufacturers of branded or generic versions of scheduled formulations must revise prices to align with the ceiling prices specified in column 5, plus applicable GST. * Existing manufacturers can revise the maximum retail price (MRP) based on the WPI for 2019 as per paragraph 16(2) of DPCO 2013, read with paragraph 13(2). * Manufacturers can add GST to the ceiling price if it has been paid or is payable to the government. * Manufacturers must determine the ceiling price for packages of scheduled formulations based on the prices in column 5, as per paragraph 11 of DPCO 2013. * Manufacturers must issue a price list to NPPA, State Drug Controllers, and distributors in Form V, as per paragraph 24 of DPCO 2013. * Manufacturers must submit quarterly reports on production, import, and sales of scheduled formulations to NPPA in Form III. * Manufacturers intending to discontinue production/import of scheduled formulations must notify NPPA six months prior in Form IV. Retailer and Distributor Responsibilities: * Every retailer and distributor must display the price list and supplementary list (if any) in a prominent part of the premises, as provided by the manufacturer, as per paragraph 24(4) of DPCO 2013. New Drug Launches: * Existing manufacturers launching a new drug with different specifications must apply to NPPA for price fixation in Form I, as per paragraph 2(u) of DPCO 2013. Compliance and Penalties: * Manufacturers or marketing companies not complying with the ceiling prices are liable to deposit the overcharged amount with interest under the provisions of DPCO 2013, read with the Essential Commodities Act, 1955. Impact Analysis: Manufacturers of Scheduled Formulations: * Impact: Required to adhere to the newly fixed and revised ceiling prices, potentially affecting profit margins. * Action Required: Revise prices, submit necessary forms to NPPA, and comply with reporting requirements. Retailers and Distributors: * Impact: Must sell scheduled formulations at or below the specified ceiling prices. * Action Required: Display updated price lists prominently and ensure compliance with pricing regulations. National Pharmaceutical Pricing Authority (NPPA): * Impact: Responsible for monitoring and enforcing the new pricing regulations. * Action Required: Process manufacturer applications, monitor compliance, and take action against non-compliant entities. Consumers: * Impact: Benefit from regulated prices, ensuring affordability of essential medicines. * Action Required: Be aware of the ceiling prices and report any instances of overcharging.

Key Entities Referenced

National Pharmaceutical Pricing Authority: A government regulatory agency in India that fixes prices of pharmaceutical products. referred to as NPPA in the document New Delhi: The capital city of India, where the order was issued. Ministry of Chemicals and Fertilizers: The government ministry responsible for issuing the order through the NPPA. Drugs Prices Control Order, 2013: A legal instrument that empowers the NPPA to control prices of drugs. Wholesale Price Index: The index (WPI) used to revise prices, with a specified increase of 1.88468. Acetylsalicylic acid: Medication whose price has been revised in the order Abacavir: Medication whose price has been revised in the order 5aminosalicylic Acid: Medication whose price has been revised in the order
Official Source Record View Original Source →
See Full Document Text
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. NO. D. L.-33004/99 xxxGIDHxxx सी.जी.-डी.एल.-अ.-25032020-218919 xxxGIDExxx CG-DL-E-25032020-218919 असाधारण EXTRAORDINARY भाग II—खण् ड 3—उप-खण्ड (ii) PART II—Section 3—Sub-section (ii) प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 1081] नई दिल्ली, बधु वार, मार् च25, 2020/र्ैत्र 5, 1942 No. 1081] NEW DELHI, WEDNESDAY, MARCH 25, 2020/CHAITRA 5, 1942 jlk;u vkSj moZjd ea=ky; ¼vkS"k/k foHkkx½ ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ubZ fnYyh] 25 ekpZ] 2020 dk-vk- 1213¼v½-—jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼ewY; fu;a=.k½ vkn's k] 2013 ds iSjk 4] 6] 10] 11] 14] 16] 17 vkSj 18 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k dk- vk- la[;k vkSj fnukad fofufnZ"V uhp s LraHk 6¼aaaaa½ vkSj 6¼b½ dk s vf/kØe.k djr s gq,] uhp s dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ eas dh Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ e sa dh rRLFkkuh izfof"V es a fofufnZ"V vulq wfpr fofufeZfr;ks a eas ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i eas fu;r djrh gSA lkj.kh okf"kZd Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij la'kksf/kr ewY;@¼1-88468%½ c<+kdj Ø- vuqlwfpr fofufeZfr [kqjkd :i ,oa izcyrk bdkbZ vf/kdre orZeku dk- vk- la[;k vkSj la- dk uke dher fnukad ¼ 1.884668% dh nj ls 01-04-2020 ls MCY;wihvkbZ ds lkFk izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 6(a 6(b) 1 5&,feukslsyhflfyd lIqiksftVªh 500 fexzk- 1 lIqiksftVªh 16.86 1485(अ) 29.03.2019 ,flM fjVsu'ku ,fuek 1602 GI/2020 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 2 5&,feukslsyhflfyd xksyh 400 fexzk- 1 xksyh 7.45 1485(अ) 29.03.2019 ,flM 3 5&¶ywjksjkfly batSD'ku 250 fexzk-@5 fefy- 1 fefy- 2.33 1485(अ) 29.03.2019 4 6&esdsiZ VkWI;fwju xksyh 50 fexkz- 1 xksyh 6.44 1485(अ) 29.03.2019 5 ,cdkohj xksyh 300 fexzk- 1 xksyh 47.02 1485(अ) 29.03.2019 6 ,cdkohj ¼,½ $ xksyh 60 fexkz- ¼,½ $ 30 1 xksyh 20.02 1485(अ) 29.03.2019 ysfeoqMhu ¼ch½ fexkz- ¼ch½ 7 ,cdkohj ¼,½ $ xksyh 600 fexzk-¼,½$300 1 xksyh 90.86 1485(अ) 29.03.2019 ysfeoqMhu ¼ch½ fexkz- ¼ch½ 8 ,flVktksykekbM dSIlwy 250 fexzk- 1 dSIlwy 4.51 1485(अ) 29.03.2019 9 ,flVktksykekbM xksyh 250 fexzk- 1 xksyh 3.65 1485(अ) 29.03.2019 10 ,lhVkbylSyhflfyd bQsjoslsVa @fMLijflcy@,afVª 1 xksyh 0.18 1485(अ) 29.03.2019 ,flM d dksfVM xksyh 100 fexzk- 11 ,lhVkbylSyhflfyd bQsjoslsVa @fMLijflcy@,afVª 1 xksyh 1.20 1485(अ) 29.03.2019 ,flM d dksfVM xksyh 150 fexzk- 12 ,lhVkbylSyhflfyd bQsjoslsVa @fMLijflcy@,afVª 1 xksyh 1.22 1485(अ) 29.03.2019 ,flM d dksfVM xksyh 75 fexzk- 13 ,lhVkbylSyhflfyd xksyh 100 fexzk- 1 xksyh 0.17 1485(अ) 29.03.2019 ,flM 14 ,lhVkbylSyhflfyd xksyh 150 fexzk- 1 xksyh 0.41 1485(अ) 29.03.2019 ,flM 15 ,lhVkbylSyhflfyd xksyh 325 fexzk- 1 xksyh 0.55 1485(अ) 29.03.2019 ,flM 16 ,lhVkbylSyhflfyd xksyh 350 fexzk- 1 xksyh 0.31 1485(अ) 29.03.2019 ,flM 17 ,lhVkbylSyhflfyd xksyh 75 fexkz- 1 xksyh 0.31 1485(अ) 29.03.2019 ,flM 18 ,fDVuksekbflu Mh batSD'ku ds fy, ikmMj 0-5 izfr iSd 316.20 1485(अ) 29.03.2019 fexkz- 19 ,flDyksohj vksbaVesVa 3% 1 xkze 10.38 1485(अ) 29.03.2019 20 ,flDyksohj vksjy fyD;bw ZM 400 fexzk@5 1 fefy- 1.26 1485(अ) 29.03.2019 fefy- 21 ,flDyksohj xksyh 200 fexzk- 1 xksyh 6.75 1485(अ) 29.03.2019 22 ,flDyksohj xksyh 400 fexzk- 1 xksyh 12.27 1485(अ) 29.03.2019 23 ,flDyksohj batSD'ku ds fy, ikmMj 250 izfr iSd 354.27 1485(अ) 29.03.2019 fexkz- 24 ,flDyksohj batSD'ku ds fy, ikmMj 500 izfr iSd 457.58 1485(अ) 29.03.2019 fexkz- 25 ,Msukslkbu batSD'ku 3 fexzk-@fefy- 1 fefy- 98.17 1485(अ) 29.03.2019 26 ,Mªus kykbu batSD'ku 1 fexzk-@fefy- 1 fefy- 15.61 1485(अ) 29.03.2019 27 ,ycsMa ktksy vksjy fyD;bw ZM 200 fexzk@5 1 fefy- 1.59 1485(अ) 29.03.2019 fefy- 28 ,ycsMa ktksy xksyh 400 fexzk- 1 xksyh 7.68 1485(अ) 29.03.2019 29 ,yksI;fwjuksy xksyh 100 fexzk- 1 xksyh 1.90 1485(अ) 29.03.2019 30 ,yksI;fwjuksy xksyh 300 fexzk- 1 xksyh 7.46 1485(अ) 29.03.2019 31 vkWy&Vªkal jVs hukWbd dSIlwy 10 fexzk- 1 dSIlwy 81.56 958(अ) 03.03.2020 ,flM 32 ,yizksLVkfMy batSD'ku 0-5 fexzk-@fefy- 1 fefy- 5646.64 1485(अ) 29.03.2019 33 ,YVIsyl batSD'ku ds fy, ikmMj 20 izfr iSd 18938.45 1485(अ) 29.03.2019 fexkz- 34 ,YVIsyl batSD'ku ds fy, ikmMj 50 izfr iSd 39541.63 1485(अ) 29.03.2019 fexkz- 35 ,fe;ksMsjksu batSD'ku 50 fexkz-@fefy- 1 fefy- 22.24 1485(अ) 29.03.2019 36 ,fe;ksMsjksu xksyh 100 fexzk- 1 xksyh 5.70 1485(अ) 29.03.2019[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 3 37 ,fe;ksMsjksu xksyh 200 fexzk- 1 xksyh 11.29 1485(अ) 29.03.2019 38 ,fefVªfIVykbu xksyh 10 fexkz- 1 xksyh 2.28 1485(अ) 29.03.2019 39 ,fefVªfIVykbu xksyh 25 fexkz- 1 xksyh 2.25 1485(अ) 29.03.2019 40 ,fefVªfIVykbu xksyh 50 fexkz- 1 xksyh 5.79 1485(अ) 29.03.2019 41 ,fefVªfIVykbu xksyh 75 fexkz- 1 xksyh 5.59 1485(अ) 29.03.2019 42 ,EyksfMikbu xksyh 10 fexkz- 1 xksyh 5.05 1485(अ) 29.03.2019 43 ,EyksfMikbu xksyh 2-5 fexkz- 1 xksyh 1.65 1485(अ) 29.03.2019 44 ,EyksfMikbu xksyh 5 fexzk- 1 xksyh 2.60 1485(अ) 29.03.2019 45 ,eksDlhflfyu dSIlwy 250 fexzk- 1 dSIlwy 2.20 1485(अ) 29.03.2019 46 ,eksDlhflfyu vksjy fyD;bw ZM 250 fexzk@5 1 fefy- 1.34 1485(अ) 29.03.2019 fefy- 47 ,eksDlhflfyu dSIlwy 500 fexzk- 1 dSIlwy 6.44 1485(अ) 29.03.2019 48 ,eksDlhflfyu ¼,½ MªkbZ flji 125 fexkz- ¼,½ $ 1 fefy- 2.16 1485(अ) 29.03.2019 $ Dykoqykfud 31-25 fexzk-¼ch½@5 fefy- ,flM ¼ch½ 49 ,eksDlhflfyu ¼,½ vksjy fyD;bw ZM 200 fexzzk-¼,½ 1 fefy- 1.80 1485(अ) 29.03.2019 $ Dykoqykfud $ 28-5 fexkz-¼ch½@5 fefy- ,flM ¼ch½ 50 ,eksDlhflfyu ¼,½ batSD'ku ds fy, ikmMj 500 izfr iSd 89.76 1485(अ) 29.03.2019 $ Dykoqykfud fexkz- ¼,½ $ 100 fexkz- ¼ch½ ,flM ¼ch½ 51 ,eksDlhflfyu ¼,½ xksyh 500 fexzk- ¼,½ $ 125 1 xksyh 17.91 1485(अ) 29.03.2019 $ Dykoqykfud fexkz- ¼ch½ ,flM ¼ch½ 52 ,eksDlhflfyu ¼,½ batSD'ku ds fy, ikmMj 1 izfr iSd 125.22 1485(अ) 29.03.2019 $ Dykoqykfud xkze ¼,½ $ 200 fexzk- ¼ch½ ,flM ¼ch½ 53 ,EQksVsfjflu ch batSD'ku ds fy, ikmMj 50 izfr iSd 3195.93 2943(अ) 14.08.2019 ¼fyfiM½ fexkz- 54 ,EQksVsfjflu batSD'ku ds fy, ikmMj 50 izfr iSd 7444.31 2943(अ) 14.08.2019 ch&fyikslksey fexkz- 55 ,EQksVsfjflu batSD'ku ds fy, ikmMj 50 izfr iSd 308.82 1485(अ) 29.03.2019 ch&dkWuous 'kuy fexkz- 56 ,Eihflfyu batSD'ku ds fy, ikmMj 1 izfr iSd 21.28 1485(अ) 29.03.2019 xkze 57 ,Eihflfyu batSD'ku ds fy, ikmMj 500 izfr iSd 13.11 1485(अ) 29.03.2019 fexkz- 58 ,aVh&Mh batSD'ku 300 ,elhth izfr iSd 2128.25 1485(अ) 29.03.2019 bEequksXykscqfyu 59 ,aVh&Mh batSD'ku 150 ,elhth izfr ok;y 1658.90 1485(अ) 29.03.2019 bEequksXykscqfyu 60 ,aVh&jcs ht batSD'ku 150 vkbZ;w@fefy- 1 fefy- 2766.21 1485(अ) 29.03.2019 bEequksXykscqfyu 61 ,aVh&jcs ht batSD'ku 300 vkbZ;w@fefy- 1 fefy- 97.52 1485(अ) 29.03.2019 bEequksXykscqfyu 62 ,aVh&VVs ul 250 vkbZ;w izfr iSd 1108.05 1485(अ) 29.03.2019 bEequksXykscqfyu 63 vlZfsud VªhvkWDlkbM batSD'ku 1 fexzk-@fefy- 1 fefy- 54.14 1485(अ) 29.03.2019 64 vVZes sFkj ¼,½ vksjy fyD;bw ZM 80 fexzkz-¼,½ 1 fefy- 4.02 1485(अ) 29.03.2019 $yeq sQkVªhu ¼ch½ $ 480 fexkz-¼ch½@5 fefy- 65 vVZes sFkj ¼,½ xksyh 20 fexkz- ¼,½ $ 120 1 xksyh 12.48 1485(अ) 29.03.2019 $yeq sQkVªhu ¼ch½ fexkz- ¼ch½ 66 vVZes sFkj ¼,½ xksyh 40 fexkz- ¼,½ $ 240 1 xksyh 16.09 1485(अ) 29.03.2019 $yeq sQkVªhu ¼ch½ fexkz- ¼ch½ 67 vVZes sFkj ¼,½ xksyh 80 fexkz- ¼,½ $ 480 1 xksyh 23.10 1485(अ) 29.03.2019 $yeq sQkVªhu ¼ch½ fexkz- ¼ch½4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 68 vVZls uq Vs batSD'ku ds fy, ikmMj 120 izfr iSd 414.90 1485(अ) 29.03.2019 fexkz- 69 vVZls uq Vs batSD'ku ds fy, ikmMj 60 izfr iSd 217.93 1485(अ) 29.03.2019 fexkz- 70 vVZls uq Vs ¼,½ $ xksyh 100 fexzk- ¼,½ $ 1 dksEch iSd 29.41 1485(अ) 29.03.2019 lYQkMkWDlhu & xksyh ¼750 fexzk- $ 37-5 fifjesFkkekbu ¼ch½ fexkz-½ ¼ch½ 71 vVZls uq Vs ¼,½ $ xksyh 150 fexzk- ¼,½ $ 2 dksEch iSd 39.93 1485(अ) 29.03.2019 lYQkMkWDlhu & xksyh ¼500 fexzk- $ 25fexkz-½ fifjesFkkekbu ¼ch½ ¼ch½ 72 vVZls uq Vs ¼,½ $ xksyh 200 fexzk- ¼,½ $ 2 dksEch iSd 36.40 1485(अ) 29.03.2019 lYQkMkWDlhu & xksyh ¼750 fexzk- $ 37-5 fifjesFkkekbu ¼ch½ fexkz-½ ¼ch½ 73 vVZls uq Vs ¼,½ $ xksyh 25 fexkz- ¼,½ $ 1 dksEch iSd 19.60 1485(अ) 29.03.2019 lYQkMkWDlhu & xksyh ¼250 fexzk- $ 12-5 fifjesFkkekbu ¼ch½ fexkz-½ ¼ch½ 74 vVZls uq Vs ¼,½ $ 1 xksyh 50 fexzk- ¼,½ $ 1 dksEch iSd 21.16 1485(अ) 29.03.2019 lYQkMkWDlhu & xksyh ¼500 fexzk $ 25 fexzk-½ fifjesFkkekbu ¼ch½ ¼ch½ 75 ,LdksfZcd ,flM xksyh 100 fexzk- 1 xksyh 0.19 1485(अ) 29.03.2019 ¼foVkfeu lh½ 76 ,LdksfZcd ,flM xksyh 500 fexzk- 1 xksyh 1.37 4461(अ) 13.12.2019 ¼foVkfeu lh½ 77 ,Vktsukohj xksyh 300 fexzk- ¼,½ $ 100 1 xksyh 98.43 1485(अ) 29.03.2019 ¼,½$fjVksusohj ¼ch½ fexkz- ¼ch½ 78 ,Vus ksyksy xksyh 100 fexzk- 1 xksyh 3.47 1485(अ) 29.03.2019 79 ,Vus ksyksy xksyh 50 fexkz- 1 xksyh 1.78 1485(अ) 29.03.2019 80 ,VksjokLVkfVu xksyh 10 fexkz- 1 xksyh 5.47 1485(अ) 29.03.2019 81 ,VksjokLVkfVu xksyh 20 fexkz- 1 xksyh 13.25 1485(अ) 29.03.2019 82 ,VksjokLVkfVu xksyh 40 fexkz- 1 xksyh 19.24 1485(अ) 29.03.2019 83 ,VªkD;wfj;e batSD'ku 10 fexkz-@fefy- izfr iSd 52.27 1485(अ) 29.03.2019 84 ,Vªksikbu vksbaVesVa 1% 1 xkze 3.77 1485(अ) 29.03.2019 85 ,Vªksikbu batSD'ku 0-6 fexzk-@fefy- 1 fefy- 4.18 1485(अ) 29.03.2019 86 ,Vªksikbu MªksIl 1% 1 fefy- 3.42 1485(अ) 29.03.2019 87 ,tkfFk;ksihzu xksyh 50 fexkz- 1 xksyh 10.12 1485(अ) 29.03.2019 88 ,ftFkzksekblhu dSIlwy 250 fexzk- 1 dSIlwy 10.47 1485(अ) 29.03.2019 89 ,ftFkzksekblhu dSIlwy 500 fexzk- 1 dSIlwy 16.53 1485(अ) 29.03.2019 90 ,ftFkzksekblhu vksjy fyD;bw ZM 200 fexzk@5 1 fefy- 3.07 1485(अ) 29.03.2019 fefy- 91 ,ftFkzksekblhu xksyh 250 fexzk- 1 xksyh 10.52 1485(अ) 29.03.2019 92 ,ftFkzksekblhu xksyh 500 fexzk- 1 xksyh 21.23 1485(अ) 29.03.2019 93 ,ftFkzksekblhu batSD'ku ds fy, ikmMj 500 izfr iSd 191.70 1485(अ) 29.03.2019 fexkz- 94 cSDyksQsu xksyh 10 fexkz- 1 xksyh 10.72 1485(अ) 29.03.2019 95 cSDyksQsu xksyh 20 fexkz- 1 xksyh 14.75 1485(अ) 29.03.2019 96 cSDyksQsu xksyh 5 fexzk- 1 xksyh 5.52 1485(अ) 29.03.2019 97 chlhth oSDlhu izfr Mkst 8.91 4461(अ) 13.12.2019 98 cSatkfFku batSD'ku ds fy, ikmMj 12 izfr iSd 18.18 4461(अ) 13.12.2019 cSutkbZyisfuflfyu yk[k ;fwuV 99 cSatkfFku batSD'ku ds fy, ikmMj 6 izfr iSd 12.03 4461(अ) 13.12.2019 cSutkbZyisfuflfyu yk[k ;fwuV 100 csutks,y isjkDlkbM Øhe 2-5% 1 xkze 2.33 1485(अ) 29.03.2019 101 csutks,y isjkDlkbM tSy 2-5% 1 xkze 3.74 1485(अ) 29.03.2019[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 5 102 csutkby isfuflfyu batSD'ku ds fy, ikmMj 10 ifzr iSd 7.78 4461(अ) 13.12.2019 yk[k ;fwuV 103 chVkesFklksu Øhe 0-05% 1 xkze 0.58 1485(अ) 29.03.2019 104 chVkesFklksu Øhe 0-1% 1 xkze 0.84 1485(अ) 29.03.2019 105 chVkesFklksu tSy 0-05% 1 xkze 0.53 1485(अ) 29.03.2019 106 chVkesFklksu yks'ku 0-1% 1 fefy- 0.82 1485(अ) 29.03.2019 107 chVkesFklksu yks'ku 0-5% 1 fefy- 0.53 1485(अ) 29.03.2019 108 chVkesFklksu batSD'ku 4 fexzk-@fefy- 1 fefy- 4.19 1485(अ) 29.03.2019 109 fcdkyqVkekbM xksyh 50 fexkz- 1 xksyh 68.41 1485(अ) 29.03.2019 110 fclkdkWfMy lIqiksftVªh 5 fexkz- 1 lIqiksftVªh 8.41 1485(अ) 29.03.2019 111 fclkdkWfMy xksyh 5 fexzk- 1 xksyh 1.00 1485(अ) 29.03.2019 112 cys;ksekbflu batSD'ku ds fy, ikmMj 15 izfr iSd 618.94 1485(अ) 29.03.2019 ;wfuV 113 cksVstZ kfec batSD'ku ds fy, ikmMj 2 izfr iSd 12263.10 1485(अ) 29.03.2019 fexkz- 114 cqMslksukbM uts y Lizs 100 1 Mkst 0.91 1485(अ) 29.03.2019 ,elhth@Mkst 115 cqMslksukbM uts y Lizs 50 ,elhth@Mkst 1 Mkst 1.01 1485(अ) 29.03.2019 116 cqMslksukbM jls fijVs kWjh lksyq'ku QkWj ;wt 1 fefy- 10.68 1485(अ) 29.03.2019 bu uscyq kbtj 0-5 fexkz @ fefy- 117 cqMslksukbM jls fijVs kWjh lksyq'ku QkWj ;wt 1 fefy- 12.88 1485(अ) 29.03.2019 bu uscyq kbtj 1 fexkz-@fefy- 118 cqMslksukbM bugys s”ku ¼,eMhvkbZ½ 100 izfr ehVj 1.26 1485(अ) 29.03.2019 ,elhth@Mkst Mkst 119 cqMslksukbM bugys s”ku ¼,eMhvkbZ½ 200 izfr ehVj 1.57 1485(अ) 29.03.2019 ,elhth@Mkst Mkst 120 cqMslksukbM bugys s”ku ¼MhihvkbZ½ 100 izfr Mkst 1.99 1485(अ) 29.03.2019 ,elhth@Mkst 121 cqMslksukbM bugys s”ku ¼MhihvkbZ½ 200 izfr Mkst 2.88 1485(अ) 29.03.2019 ,elhth@Mkst 122 cqMslksukbM ¼,½ $ bugys s”ku ¼,eMhvkbZ½ 100 izfr ehVj 1.88 1485(अ) 29.03.2019 QkseksVZ js ksy ¼ch½ ,elhth ¼,½ $ 6 ,elhth Mkst ¼ch½ 123 cqMslksukbM ¼,½ $ bugys s”ku ¼,eMhvkbZ½ 200 izfr ehVj 2.67 1485(अ) 29.03.2019 QkseksVZ js ksy ¼ch½ ,elhth ¼,½ $ 6 ,elhth Mkst ¼ch½ 124 cqMslksukbM ¼,½ $ bugys s”ku ¼,eMhvkbZ½ 400 izfr ehVj 3.04 1485(अ) 29.03.2019 QkseksVZ js ksy ¼ch½ ,elhth ¼,½ $ 6 ,elhth Mkst ¼ch½ 125 cqMslksukbM ¼,½ $ bugys s”ku ¼MhihvkbZ½ 100 izfr Mkst 3.78 1485(अ) 29.03.2019 QkseksVZ js ksy ¼ch½ ,elhth ¼,½ $ 6 ,elhth ¼ch½ 126 cqMslksukbM ¼,½ $ bugys s”ku ¼MhihvkbZ½ 200 izfr Mkst 5.02 1485(अ) 29.03.2019 QkseksVZ js ksy ¼ch½ ,elhth ¼,½ $ 6 ,elhth ¼ch½ 127 cqMslksukbM ¼,½ $ bugys s”ku ¼MhihvkbZ½ 400 izfr Mkst 6.42 1485(अ) 29.03.2019 QkseksVZ js ksy ¼ch½ ,elhth ¼,½ $ 6 ,elhth ¼ch½ 128 cqfiokdsu batSD'ku 0-25% 1 fefy- 2.45 1485(अ) 29.03.2019 129 cqfiokdsu batSD'ku 0-5%ds lkFk 7-5% 1 fefy- 6.19 1485(अ) 29.03.2019 Xywdkst 130 cqfiokdsu batSD'ku 0-50% 1 fefy- 3.91 1485(अ) 29.03.2019 131 dSQhu batSD'ku 20 fexkz-@fefy- 1 fefy- 250.27 1485(अ) 29.03.2019 132 dSQhu vksjy fyD;bw ZM 20 fexkz-@ 1 fefy- 212.56 1485(अ) 29.03.2019 fefy-6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 133 dSykekbu yks'ku ¼vkbZih ds vuqlkj½ 1 fefy- 0.85 1485(अ) 29.03.2019 134 dSfY”k;e dkWcksuZ Vs Xksyh 500 fexkz- 1 xksyh 1.72 959(अ) 03.03.2020 135 dSfY'k;e QkWyhusV xksyh 15 fexkz- 1 xksyh 40.67 1485(अ) 29.03.2019 136 dSfY'k;e XyqdksusV batSD'ku 100 fexzk-@fefy- 1 fefy- 0.55 1485(अ) 29.03.2019 137 dSisflVkckbu xksyh 500 fexzk- 1 xksyh 126.01 1485(अ) 29.03.2019 138 dSizs;ksekbflu batSD'ku ds fy, ikmMj 1 izfr iSd 345.37 1485(अ) 29.03.2019 xkze 139 dkckZektkikbu vksjy fyD;bw ZM 100 fexzk-@5 1 fefy- 0.19 1485(अ) 29.03.2019 fefy- 140 dkckZektkikbu lhvkj xksyh 200 fexzk- 1 xksyh 1.55 1485(अ) 29.03.2019 141 dkckZektkikbu lhvkj xksyh 400 fexzk- 1 xksyh 3.05 1485(अ) 29.03.2019 142 dkckZektkikbu xksyh 100 fexzk- 1 xksyh 0.68 1485(अ) 29.03.2019 143 dkckZektkikbu xksyh 200 fexzk- 1 xksyh 1.39 1485(अ) 29.03.2019 144 dkckZektkikbu xksyh 400 fexzk- 1 xksyh 3.29 1485(अ) 29.03.2019 145 dkfcZektksy xksyh 10 fexkz- 1 xksyh 3.69 1485(अ) 29.03.2019 146 dkfcZektksy xksyh 5 fexzk- 1 xksyh 1.9 1485(अ) 29.03.2019 147 dkcksIZykfVu batSD'ku 10 fexkz-@fefy- 1 fefy- 53.06 1485(अ) 29.03.2019 148 dkcksDZ lhesFkhylys kykst MªksIl 0-5% 1 fefy- 12.74 1485(अ) 29.03.2019 149 dkcksDZ lheFs khylys kykst MªksIl 1% 1 fefy- 17.66 1485(अ) 29.03.2019 150 lQs kMªksDlhy dSIlwy 500 fexzk- 1 dSIlwy 7.13 1485(अ) 29.03.2019 151 lQs kMªksDlhy vksjy fyD;bw ZM 125 fexzk@5 1 fefy- 0.63 1485(अ) 29.03.2019 fefy- 152 lQs kMªksDlhy xksyh 1 xzke 1 xksyh 6.27 1485(अ) 29.03.2019 153 lQs kMªksDlhy xksyh 500 fexzk- 1 xksyh 4.02 1485(अ) 29.03.2019 154 lQs ktksfyu batSD'ku ds fy, ikmMj 1 izfr iSd 24.48 1485(अ) 29.03.2019 xkze 155 lQs ktksfyu batSD'ku ds fy, ikmMj 500 izfr iSd 15.52 1485(अ) 29.03.2019 fexkz- 156 lfsQDlhe dSIlwy 200 fexzk- 1 dSIlwy 14.39 1485(अ) 29.03.2019 157 lfsQDlhe dSIlwy 400 fexzk- 1 dSIlwy 29.15 1485(अ) 29.03.2019 158 lfsQDlhe vksjy fyD;bw ZM 100 fexzk@5 1 fefy- 2.15 1485(अ) 29.03.2019 fefy- 159 lfsQDlhe vksjy fyD;bw ZM 50 fexkz-@5 1 fefy- 1.45 1485(अ) 29.03.2019 fefy- 160 lfsQDlhe xksyh 400 fexzk- 1 xksyh 22.00 1485(अ) 29.03.2019 161 lfsQDlhe xksyh 200 fexzk- 1 xksyh 9.57 1485(अ) 29.03.2019 162 lQs ksVsDlkbe batSD'ku ds fy, ikmMj 1 izfr iSd 34.22 1485(अ) 29.03.2019 xkze 163 lQs ksVsDlkbe batSD'ku ds fy, ikmMj 250 izfr iSd 15.56 1485(अ) 29.03.2019 fexkz- 164 lQs ksVsDlkbe batSD'ku ds fy, ikmMj 500 izfr iSd 20.46 1485(अ) 29.03.2019 fexkz- 165 lQs VkftMkbe batSD'ku ds fy, ikmMj 1 izfr iSd 208.68 1485(अ) 29.03.2019 xkze 166 lQs VkftMkbe batSD'ku ds fy, ikmMj 250 izfr iSd 64.90 1485(अ) 29.03.2019 fexkz- 167 lQs Vªh;kDlksu batSD'ku ds fy, ikmMj 1 izfr iSd 53.75 1485(अ) 29.03.2019 xkze 168 lQs Vªh;kDlksu batSD'ku ds fy, ikmMj 2 izfr iSd 127.77 1485(अ) 29.03.2019 xkze 169 lQs Vªh;kDlksu bta SD'ku d s fy, ikmMj 250 izfr iSd 24.61 1485(अ) 29.03.2019 fexzk-[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 7 170 lQs Vªh;kDlksu batSD'ku ds fy, ikmMj 500 izfr iSd 44.95 1485(अ) 29.03.2019 fexkz- 171 lfsVªftu dSIlwy 10 fexzk- 1 dSIlwy 2.37 1485(अ) 29.03.2019 172 lfsVªftu vksjy fyD;bw ZM 5 fexzk-@5 1 fefy- 0.59 1485(अ) 29.03.2019 fefy- 173 lfsVªftu xksyh 10 fexkz- 1 xksyh 1.65 1485(अ) 29.03.2019 174 lfsVªekbM lksyq'ku 20% ¼da'kuVªVs 1 fefy- 0.32 1485(अ) 29.03.2019 QkWj fMyq'ku½ 175 Dyksjkecfqly xksyh 2 fexzk- 1 xksyh 36.80 1485(अ) 29.03.2019 176 Dyksjkecfqly xksyh 5 fexzk- 1 xksyh 82.70 1485(अ) 29.03.2019 177 DyksjgsDlkMhu lksyq'ku 5% ¼da'kuVªVs QkWj 1 fefy- 0.15 1485(अ) 29.03.2019 fMyq'ku½ 178 DyksjksDohu vksjy fyD;bw ZM 50 fexkz-@5 1 fefy- 0.3 1485(अ) 29.03.2019 fefy- 179 DyksjksDohu xksyh 150 fexzk- 1 xksyh 1.18 4461(अ) 13.12.2019 180 DyksjQsuhjkekbu xksyh 4 fexzk- 1 xksyh 0.09 1485(अ) 29.03.2019 181 dkWyds sfYlQsjksy dSIlwy 1000 vkbZ;w 1 dSIlwy 4.76 1485(अ) 29.03.2019 182 dkWyds sfYlQsjksy dSIlwy 60000 vkbZ;w 1 dSIlwy 29.44 1485(अ) 29.03.2019 183 dkWyds sfYlQsjksy vksjy fyD;bw ZM 400 1 fefy- 2.34 1485(अ) 29.03.2019 vkbZ;w@fefy- 184 dkWyds sfYlQsjksy xksyh 1000 vkbZ;w 1 xksyh 3.74 1485(अ) 29.03.2019 185 dkWyds sfYlQsjksy xksyh 60000 vkbZ;w 1 xksyh 24.18 1485(अ) 29.03.2019 186 flizks¶yksDlkflu vksbaVesVa 0-3% 1 xkze 1.13 1485(अ) 29.03.2019 187 flizks¶yksDlkflu MªksIl 0-30% 1 fefy- 1.52 1485(अ) 29.03.2019 188 flizks¶yksDlkflu batSD'ku 200 fexzk-@100 1 fefy- 0.17 1485(अ) 29.03.2019 fefy- 189 flizks¶yksDlkflu vksjy fyD;bw ZM 250 fexzk@5 1 fefy- 0.63 1485(अ) 29.03.2019 fefy- 190 flizks¶yksDlkflu xksyh 250 fexzk- 1 xksyh 2.07 1485(अ) 29.03.2019 191 flizks¶yksDlkflu xksyh 500 fexzk- 1 xksyh 3.64 1485(अ) 29.03.2019 192 fllIyfsVu batSD'ku 1 fexzk-@fefy- 1 fefy- 6.87 1485(अ) 29.03.2019 193 DysjhFkzksekblhu vksjy fyD;bw ZM 125 fexzk@5 1 fefy- 4.30 1485(अ) 29.03.2019 fefy- 194 DysjhFkzksekblhu xksyh 250 fexzk- 1 xksyh 27.92 1485(अ) 29.03.2019 195 DysjhFkzksekblhu xksyh 500 fexzk- 1 xksyh 49.21 1485(अ) 29.03.2019 196 DyhuMkekblhu dSIlwy 150 fexzk- 1 dSIlwy 14.43 1485(अ) 29.03.2019 197 DyhuMkekblhu dSIlwy 300 fexzk- 1 dSIlwy 23.56 1485(अ) 29.03.2019 198 DyhuMkekblhu xksyh 300 fexzk- 1 xksyh 15.20 1485(अ) 29.03.2019 199 Dykscktse xksyh 10 fexkz- 1 xksyh 9.01 1485(अ) 29.03.2019 200 Dykscktse xksyh 5 fexzk- 1 xksyh 5.12 1485(अ) 29.03.2019 201 DyksQkftekbu dSIlwy 100 fexzk- 1 dSIlwy 3.70 4461(अ) 13.12.2019 202 DyksQkftekbu dSIlwy 50 fexzk- 1 dSIlwy 2.17 4461(अ) 13.12.2019 203 DyksfeQsu dSIlwy 100 fexzk- 1 dSIlwy 55.50 1485(अ) 29.03.2019 204 DyksfeQsu dSIlwy 50 fexzk- 1 dSIlwy 30.53 1485(अ) 29.03.2019 205 DyksfeQsu xksyh 100 fexzk- 1 xksyh 12.18 1485(अ) 29.03.2019 206 DyksfeQsu xksyh 50 fexkz- 1 xksyh 8.30 1485(अ) 29.03.2019 207 Dyksehizkekbu xksyh 10 fexkz- 1 xksyh 2.51 1485(अ) 29.03.2019 208 Dyksehizkekbu xksyh 25 fexkz- 1 xksyh 5.53 1485(अ) 29.03.20198 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 209 Dyksehizkekbu xksyh 75 fexkz- 1 xksyh 14.30 1485(अ) 29.03.2019 210 Dyksuktsike xksyh 0-25 fexkz- 1 xksyh 1.82 1485(अ) 29.03.2019 211 Dyksuktsike xksyh 0-5 fexkz- 1 xksyh 3.10 1485(अ) 29.03.2019 212 Dyksuktsike xksyh 1 fexzk- 1 xksyh 4.22 1485(अ) 29.03.2019 213 DyksfiMksxszy xksyh 75 fexkz- 1 xksyh 6.93 1485(अ) 29.03.2019 214 DyksfVªektksy Øhe 1% 1 xkze 2.90 1485(अ) 29.03.2019 215 DyksfVªektksy MªksIl 1% 1 fefy- 3.02 1485(अ) 29.03.2019 216 DyksfVªektksy yks'ku 1% 1 fefy- 3.57 1485(अ) 29.03.2019 217 DyksfVªektksy isljh 100 fexzk- 1 isljh 8.66 1485(अ) 29.03.2019 218 DyksDlkflfyu dSIlwy 250 fexzk- 1 dSIlwy 1.13 1485(अ) 29.03.2019 219 DyksDlkflfyu dSIlwy 500 fexzk- 1 dSIlwy 1.90 1485(अ) 29.03.2019 220 DyksDlkflfyu xksyh 250 fexzk- 1 xksyh 1.72 1485(अ) 29.03.2019 221 DyksDlkflfyu batSD'ku ds fy, ikmMj 250 izfr iSd 4.43 1485(अ) 29.03.2019 fexkz- 222 Dykstkikbu xksyh 100 fexzk- 1 xksyh 7.72 1485(अ) 29.03.2019 223 Dykstkikbu xksyh 25 fexkz- 1 xksyh 2.51 1485(अ) 29.03.2019 224 Dykstkikbu xksyh 50 fexkz- 1 xksyh 4.79 1485(अ) 29.03.2019 225 dksxqys'ku QSDVj IX batSD'ku ds fy, ikmMj 600 izfr iSd 12284.99 1485(अ) 29.03.2019 vkbZ;w 226 dksxs yq s'ku QSDVj batSD'ku ds fy, ikmMj 250 izfr iSd 3724.11 1485(अ) 29.03.2019 VIII vkbZ;w 227 dksxqys'ku QSDVj batSD'ku ds fy, ikmMj 500 izfr iSd 9138.70 1485(अ) 29.03.2019 VIII vkbZ;w 228 dksyphflu xksyh 0-5 fexkz- 1 xksyh 3.10 1485(अ) 29.03.2019 229 dks&Vªk;eksDlktksy vksjy fyD;wbMZ 200 fexzzk-¼,½ 1 fefy- 0.33 4461(अ) 13.12.2019 [lYQkeFs kkWDlklsy $ 40 fexkz- ¼ch½@5 fefy- ¼,½$VªhesFkksizhe ¼ch½]] 230 dks&Vªk;eksDlktksy xksyh 400 fexzk- ¼,½ $ 80 1 xksyh 0.78 4461(अ) 13.12.2019 [lYQkeFs kkWDlklsy fexkz- ¼ch½ ¼,½$VªhesFkksizhe ¼ch½]] 231 dks&Vªk;eksDlktksy xksyh 800 fexzk- ¼,½ $ 160 1 xksyh 2.02 4461(अ) 13.12.2019 [lYQkeFs kkWDlklsy fexkz- ¼ch½ ¼,½$VªhesFkksizhe ¼ch½]] 232 lkbDyksQkslQkekbM xksyh 50 fexkz- 1 xksyh 4.04 1485(अ) 29.03.2019 233 lkbDyksQkslQkekbM batSD'ku ds fy, ikmMj 500 izfr iSd 79.58 1485(अ) 29.03.2019 fexkz- 234 lkbDykslsfju dSIlwy 250 fexzk- 1 dSIlwy 54.13 1485(अ) 29.03.2019 235 lkbDykslsfju xksyh 250 fexzk- 1 xksyh 46.54 1485(अ) 29.03.2019 236 lkbDyksLiksfju dSIlwy 100 fexzk- 1 dSIlwy 102.20 1485(अ) 29.03.2019 237 lkbDyksLiksfju dSIlwy 25 fexzk- 1 dSIlyw 27.43 1485(अ) 29.03.2019 238 lkbDyksLiksfju dSIlwy 50 fexzk- 1 dSIlwy 52.49 1485(अ) 29.03.2019 239 lkbDyksLiksfju batSD'ku 50 fexkz-@fefy- 1 fefy- 268.93 1485(अ) 29.03.2019 240 lkbDyksLiksfju vksjy fyD;bw ZM 100 1 fefy- 94.24 1485(अ) 29.03.2019 fexkz@fefy- 241 lkbVksflu batSD'ku 100 fexzk-@fefy- izfr iSd 198.09 1485(अ) 29.03.2019 vfcZukslkbM 242 lkbVksflu batSD'ku ds fy, ikmMj izfr iSd 1068.41 1485(अ) 29.03.2019 vfcZukslkbM 1000 fexzk- 243 lkbVksflu batSD'ku ds fy, ikmMj 500 izfr iSd 510.65 1485(अ) 29.03.2019 vfcZukslkbM fexkz-[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 9 244 MkdkckZftu batSD'ku ds fy, ikmMj 200 izfr iSd 438.03 1485(अ) 29.03.2019 fexkz- 245 MkdkckZftu batSD'ku ds fy, ikmMj 500 izfr iSd 988.15 1485(अ) 29.03.2019 fexkz- 246 Msilksu xksyh 100 fexzk- 1 xksyh 0.36 4461(अ) 13.12.2019 247 Mk:ukohj xksyh 600 fexzk- 1 xksyh 166.43 1485(अ) 29.03.2019 248 MkSuk:fclhu I.V. batSD'ku ds fy, ikmMj izfr iSd 242.47 959(अ) 03.03.2020 20 fexzk- ¼5 fexzk-@fefy-½ 249 MslQsjhvksDlkekbu batSD'ku ds fy, ikmMj 500 izfr iSd 160.34 1485(अ) 29.03.2019 fexkz- 250 MsDlkeFs kklksu xksyh 0-5 fexkz- 1 xksyh 0.19 1485(अ) 29.03.2019 251 MsDlkeFs kklksu batSD'ku 4 fexzk-@fefy- izfr iSd ¼10 13.73 1485(अ) 29.03.2019 fefy-½ 252 MsDlkeFs kklksu batSD'ku 4 fexzk-@fefy- izfr iSd ¼2 9.29 1485(अ) 29.03.2019 fefy-½ 253 MsDlkeFs kklksu batSD'ku 4 fexzk-@fefy- izfr iSd ¼20 26.32 1485(अ) 29.03.2019 fefy-½ 254 MsDlkeFs kklksu batSD'ku 4 fexzk-@fefy- izfr iSd ¼30 35.17 1485(अ) 29.03.2019 fefy-½ 255 MsDlkVªku&40 batSD'ku 10% 1 fefy- 0.85 1485(अ) 29.03.2019 256 Mk;tsike batSD'ku 5 fexzk-@fefy- 1 fefy- 6.04 1485(अ) 29.03.2019 257 Mk;tsike vksjy fyD;bw ZM 2 fexzk-@5 1 fefy- 2.73 1485(अ) 29.03.2019 fefy- 258 Mk;tsike lIqiksftVªh 5 fexkz- 1 lIqiksftVªh 5.96 1485(अ) 29.03.2019 259 Mk;tsike xksyh 2 fexzk- 1 xksyh 1.50 1485(अ) 29.03.2019 260 Mk;tsike xksyh 5 fexzk- 1 xksyh 1.42 1485(अ) 29.03.2019 261 fMDyksQsud dSIlwy 50 fexzk- 1 dSIlwy 0.61 1485(अ) 29.03.2019 262 fMDyksQsud batSD'ku 25 fexkz-@fefy- 1 fefy- 1.46 1485(अ) 29.03.2019 263 fMDyksQsud xksyh 50 fexkz- 1 xksyh 1.91 1485(अ) 29.03.2019 264 fMlkbDyksekbu batSD'ku 10 fexkz-@fefy-¼10 1 fefy- 2.05 1485(अ) 29.03.2019 fefy- ,aM 30 fefy- iSd½ 265 fMlkbDyksekbu batSD'ku 10 fexkz-@fefy- 1 fefy- 3.18 1485(अ) 29.03.2019 ¼1fefy- ,aM 2 fefy- iSd½ 266 fMlkbDyksekbu vksjy lksyq'ku 10 fexzk-@5 1 fefy- 0.16 1485(अ) 29.03.2019 fefy- 267 fMlkbDyksekbu xksyh 10 fexkz- 1 xksyh 0.11 1485(अ) 29.03.2019 268 MkbZbFkk;ydkckZestk vksjy fyD;bw ZM 120 fexzk@5 1 fefy- 0.49 1485(अ) 29.03.2019 bu fefy- 269 MkbZbFkk;ydkckZestk xksyh 100 fexzk- 1 xksyh 1.41 1485(अ) 29.03.2019 bu 270 MkbZbFkk;ydkckZestk xksyh 50 fexkz- 1 xksyh 0.56 1485(अ) 29.03.2019 bu 271 MkbxksfDlu batSD'ku 0-25 fexkz-@fefy- 1 fefy- 3.32 1485(अ) 29.03.2019 272 MkbxksfDlu vksjy fyD;bw ZM 0-05 fexzk-@ 1 fefy- 1.26 1485(अ) 29.03.2019 fefy- 273 MkbxksfDlu xksyh 0-25 fexkz- 1 xksyh 1.19 1485(अ) 29.03.2019 274 MkbyksDlkukbM xksyh 500 fexzk- 1 xksyh 1.05 1485(अ) 29.03.2019 Qwjks,V 275 MkbyfV;ktse dSIlwy 90 fexzk- 1 dSIlwy 9.58 1485(अ) 29.03.2019 276 MkbyfV;ktse batSD'ku 5 fexzk-@fefy- 1 fefy- 3.15 1485(अ) 29.03.2019 277 MkbyfV;ktse ,lvkj xksyh 90 fexkz- 1 xksyh 9.30 1485(अ) 29.03.2019 278 MkbyfV;ktse xksyh 30 fexkz- 1 xksyh 2.39 1485(अ) 29.03.2019 279 MkbyfV;ktse xksyh 60 fexkz- 1 xksyh 4.87 1485(अ) 29.03.201910 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 280 fMesjdkizksy batSD'ku 50 fexkz-@fefy- 1 fefy- 199.55 1485(अ) 29.03.2019 281 MkbuksizksLVksu tSy 0-5 fexzk- 1 xkze 80.83 1485(अ) 29.03.2019 282 MkbuksizksLVksu xksyh 0-5 fexkz- 1 xksyh 49.90 1485(अ) 29.03.2019 283 MkbQFksfj;k 10000 vkbZ;w izfr iSd 1306.76 1485(अ) 29.03.2019 ,VhaVksDlhu 284 MkscqVkekbu batSD'ku 50 fexkz-@fefy- izfr iSd 37.39 1485(अ) 29.03.2019 285 MkslVs kDlys batSD'ku ds fy, ikmMj 20 izfr iSd 2984.59 1485(अ) 29.03.2019 fexkz- 286 MkslVs kDlys batSD'ku ds fy, ikmMj 80 izfr iSd 11347.62 1485(अ) 29.03.2019 fexkz- 287 MkseisfjMksu vksjy fyD;bw ZM 1 fexzk @ 1 fefy- 1.07 1485(अ) 29.03.2019 fefy- 288 MkseisfjMksu xksyh 10 fexkz- 1 xksyh 2.41 1485(अ) 29.03.2019 289 Mksusits kby xksyh 10 fexkz- 1 xksyh 16.00 1485(अ) 29.03.2019 290 Mksusits kby xksyh 5 fexzk- 1 xksyh 11.21 1485(अ) 29.03.2019 291 Mksikekbu batSD'ku 40 fexkz-@fefy- 1 fefy- 5.63 1485(अ) 29.03.2019 292 MksDlks:fclhu batSD'ku 2 fexzk-@fefy- 1 fefy- 35.80 1485(अ) 29.03.2019 293 MksDlhlkblyhu dSIlwy 100 fexzk- 1 dSIlwy 2.50 1485(अ) 29.03.2019 294 MksDlhlkblyhu xksyh 100 fexzk- 1 xksyh 0.97 1485(अ) 29.03.2019 295 MhihVh$fgc$gsi ch izfr 0-1 80.08 1485(अ) 29.03.2019 oSDlhu fefy- 296 MhihVh oSDlhu izfr 0-5 14.12 1485(अ) 29.03.2019 fefy- 297 bQkohjsat dSIlwy 200 fexzk- 1 dSIlwy 24.00 1485(अ) 29.03.2019 298 bQkohjsat dSIlwy 600 fexzk- 1 dSIlwy 62.54 1485(अ) 29.03.2019 299 bQkohjsat xksyh 200 fexzk- 1 xksyh 22.61 1485(अ) 29.03.2019 300 bQkohjsat xksyh 600 fexzk- 1 xksyh 70.81 1485(अ) 29.03.2019 301 bukykizhy xksyh 2-5 fexkz- 1 xksyh 1.93 1485(अ) 29.03.2019 302 bukykizhy xksyh 5 fexzk- 1 xksyh 3.20 1485(अ) 29.03.2019 303 buksDlkikfju batSD'ku 40 fexkz-@0-4 fefy- 0-1 fefy- 101.35 1485(अ) 29.03.2019 304 buksDlkikfju batSD'ku 60 fexkz-@0-6 fefy- 0-1 fefy- 101.35 1485(अ) 29.03.2019 305 buVsdkohj xksyh 0-5 fexkz- 1 xksyh 79.55 1485(अ) 29.03.2019 306 buVsdkohj xksyh 1 fexzk- 1 xksyh 126.40 1485(अ) 29.03.2019 307 ,fjFkzksiksbVhu batSD'ku 10000 vkbZ;w@fefy- izfr iSd 2593.87 1485(अ) 29.03.2019 308 ,fjFkzksiksbVhu batSD'ku 2000 vkbZ;w@fefy- izfr iSd 614.36 1485(अ) 29.03.2019 309 blhVkyksikze xksyh 10 fexkz- 1 xksyh 8.08 1485(अ) 29.03.2019 310 blhVkyksikze xksyh 20 fexkz- 1 xksyh 12.76 1485(अ) 29.03.2019 311 blhVkyksikze xksyh 5 fexzk- 1 xksyh 4.55 1485(अ) 29.03.2019 312 bleksyksy batSD'ku 10 fexkz-@fefy- 1 fefy- 21.60 1485(अ) 29.03.2019 313 bFkkecVq ksy xksyh 200 fexzk- 1 xksyh 1.05 1485(अ) 29.03.2019 314 bFkkecVq ksy xksyh 400 fexzk- 1 xksyh 2.39 1485(अ) 29.03.2019 315 bFkkecVq ksy xksyh 600 fexzk- 1 xksyh 3.53 1485(अ) 29.03.2019 316 bFkkecVq ksy xksyh 800 fexzk- 1 xksyh 4.22 1485(अ) 29.03.2019 317 bFkhuysLVkMhvksy xksyh 0-01 fexkz- 1 xksyh 2.34 1485(अ) 29.03.2019 318 bFkhuysLVkMhvksy xksyh 0-05 fexkz- 1 xksyh 3.74 1485(अ) 29.03.2019 319 bFkhuysLVkMhvksy xksyh 0-03 fexkz- ¼,½ $ 0-15 1 xksyh 3.44 1485(अ) 29.03.2019 ¼,½$ysoksuksxZLs Vªys fexkz ¼ch½ ¼ch½[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 11 320 bFkhukekbM xksyh 250 fexzk- 1 xksyh 15.74 1485(अ) 29.03.2019 321 bFkkbZy ,Ydksgy lksY;q”ku 70 izfr”kr 1 fefy- 0.42 959(अ) 03.03.2020 ¼MhuspjM½ 322 bVksikslkbM dSIlwy 50 fexzk- 1 dSIlwy 54.21 1485(अ) 29.03.2019 323 bVksikslkbM batSD'ku 20 fexkz-@fefy- 1 fefy- 35.75 1485(अ) 29.03.2019 324 QsuVkukby batSD'ku 50 ,elhth@fefy- 1 fefy- 22.64 1485(अ) 29.03.2019 325 Qsjl lkYV ¼,½ $ Xkksyh 100 fexzk- byheus Vy 1 xksyh 0.23 958 (अ) 03.03.2020 Qksfyd ,flM ¼ch½ vk;ju ¼,½ $ 500 ,elhth ¼ch½ 326 fQyxkzLVhe batSD'ku 300 ,elhth izfr iSd 1368.29 1485(अ) 29.03.2019 327 ¶ywdksuktksy dSIlwy 100 fexzk- 1 dSIlwy 25.19 1485(अ) 29.03.2019 328 ¶ywdksuktksy dSIlwy 150 fexzk- 1 dSIlwy 18.49 1485(अ) 29.03.2019 329 ¶ywdksuktksy dSIlwy 200 fexzk- 1 dSIlwy 36.40 1485(अ) 29.03.2019 330 ¶ywdksuktksy vksjy fyD;bw ZM 50 fexkz-@5 1 fefy- 2.61 1485(अ) 29.03.2019 fefy- 331 ¶ywdksuktksy xksyh 100 fexzk- 1 xksyh 7.96 1485(अ) 29.03.2019 332 ¶ywdksuktksy xksyh 150 fexzk- 1 xksyh 11.81 1485(अ) 29.03.2019 333 ¶ywdksuktksy xksyh 200 fexzk- 1 xksyh 18.73 1485(अ) 29.03.2019 334 ¶ywdksuktksy xksyh 400 fexzk- 1 xksyh 31.15 1485(अ) 29.03.2019 335 ¶ywdksuktksy batSD'ku 200 fexzk-@100 izfr iSd 106.11 1485(अ) 29.03.2019 fefy- 336 ¶ywukfjtkbu xksyh 10 fexkz- 1 xksyh 4.72 1485(अ) 29.03.2019 337 ¶ywukfjtkbu xksyh 5 fexzk- 1 xksyh 2.75 1485(अ) 29.03.2019 338 ¶ywDlsVkbu dSIlwy 10 fexzk- 1 dSIlwy 2.96 1485(अ) 29.03.2019 339 ¶ywDlsVkbu dSIlwy 20 fexzk- 1 dSIlwy 3.64 1485(अ) 29.03.2019 340 ¶ywDlsVkbu dSIlwy 40 fexzk- 1 dSIlwy 5.52 1485(अ) 29.03.2019 341 ¶ywDlsVkbu dSIlwy 60 fexzk- 1 dSIlwy 9.76 1485(अ) 29.03.2019 342 ¶ywDlsVkbu xksyh 10 fexkz- 1 xksyh 2.49 1485(अ) 29.03.2019 343 ¶ywDlsVkbu xksyh 20 fexkz- 1 xksyh 3.95 1485(अ) 29.03.2019 344 ¶ywDlsVkbu xksyh 40 fexkz- 1 xksyh 5.32 1485(अ) 29.03.2019 345 ¶ywDlsVkbu xksyh 60 fexkz- 1 xksyh 7.38 1485(अ) 29.03.2019 346 ¶ywQsuktkbu fMiksV batSD'ku 25 fexzk-@ 1 fefy- 49.88 1485(अ) 29.03.2019 fefy- 347 Qksfyd ,flM dSIlwy 5 fexzk- 1 dSIlwy 5.62 1485(अ) 29.03.2019 348 Qksfyd ,flM xksyh 5 fexzk- 1 xksyh 1.39 1485(अ) 29.03.2019 349 Qqjksles kbM vksjy fyD;bw ZM 10 fexkz-@ 1 fefy- 2.76 1485(अ) 29.03.2019 fefy- 350 Qqjksles kbM xksyh 40 fexkz- 1 xksyh 0.75 4461(अ) 13.12.2019 351 Qqjksles kbM batSD'ku 10 fexkz-@fefy- 1 fefy- 2.48 4461(अ) 13.12.2019 352 QqflfMd ,flM Øhe 2% 1 xkze 9.10 1485(अ) 29.03.2019 353 xkMkscsusV batSD'ku 529 fexzk-@fefy- 1 fefy- 108.67 1485(अ) 29.03.2019 354 xkulhDyksohj dSIlwy 250 fexzk- 1 dSIlwy 119.87 1485(अ) 29.03.2019 355 xkulhDykos hj batSD'ku ds fy, ikmMj 500 izfr iSd 1682.65 1485(अ) 29.03.2019 fexkz- 356 tsfQfVfuc xksyh 250 fexzk- 1 xksyh 427.35 1485(अ) 29.03.2019 357 tseflVkckbu batSD'ku ds fy, ikmMj 1 izfr iSd 5289.73 1485(अ) 29.03.2019 xkze 358 tseflVkckbu batSD'ku ds fy, ikmMj 200 izfr iSd 1168.23 1485(अ) 29.03.2019 fexkz-12 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 359 tsVa kekbflu MªksIl 0-3% 1 fefy- 0.91 1485(अ) 29.03.2019 360 tsVa kekbflu batSD'ku 10 fexkz-@fefy- 1 fefy- 3.17 1485(अ) 29.03.2019 361 tsVa kekbflu batSD'ku 40 fexkz-@fefy- izfr iSd ¼10 17.91 1485(अ) 29.03.2019 fefy-½ 362 tsVa kekbflu batSD'ku 40 fexkz-@fefy- izfr iSd ¼2 8.39 1485(अ) 29.03.2019 fefy-½ 363 tsVa kekbflu batSD'ku 40 fexkz-@fefy- izfr iSd ¼20 27.15 1485(अ) 29.03.2019 fefy-½ 364 tsVa kekbflu batSD'ku 40 fexkz-@fefy- izfr iSd ¼30 29.72 1485(अ) 29.03.2019 fefy-½ 365 XyhehfijkbM xksyh 1 fexzk- 1 xksyh 3.58 1485(अ) 29.03.2019 366 XyhehfijkbM xksyh 2 fexzk- 1 xksyh 5.69 1485(अ) 29.03.2019 367 Xywdkst batSD'ku 25% 1 fefy- 0.17 1485(अ) 29.03.2019 368 Xywdkst batSD'ku 50% 1 fefy- 0.49 1485(अ) 29.03.2019 369 Xywdkst batSD'ku 5% 1000 fefy- 64.04 1485(अ) 29.03.2019 Xykl 370 Xywdkst batSD'ku 5% 1000 fefy- 51.69 1485(अ) 29.03.2019 ukWu Xykl 371 Xywdkst batSD'ku 5% 100 fefy- 17.97 1485(अ) 29.03.2019 Xykl 372 Xywdkst batSD'ku 5% 100 fefy- 16.27 1485(अ) 29.03.2019 ukWu Xykl 373 Xywdkst batSD'ku 5% 250 fefy- 24.84 1485(अ) 29.03.2019 Xykl 374 Xywdkst batSD'ku 5% 250 fefy- 22.44 1485(अ) 29.03.2019 ukWu Xykl 375 Xywdkst batSD'ku 5% 500 fefy- 35.25 1485(अ) 29.03.2019 Xykl 376 Xywdkst batSD'ku 5% 500 fefy- 30.42 1485(अ) 29.03.2019 ukWu Xykl 377 Xywdkst batSD'ku 10% izfr iSd 25.75 1485(अ) 29.03.2019 ¼1000 fefy-½ 378 Xywdkst batSD'ku 10% izfr iSd 28.01 1485(अ) 29.03.2019 ¼500 fefy-½ 379 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% 1000 fefy- 64.45 1485(अ) 29.03.2019 lksfM;e DyksjkbM Xykl ¼ch½ ¼ch½ 380 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% 1000 fefy- 52.08 1485(अ) 29.03.2019 lksfM;e DyksjkbM ukWu Xykl ¼ch½ ¼ch½ 381 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% 100 fefy- 18.02 1485(अ) 29.03.2019 lksfM;e DyksjkbM Xykl ¼ch½ ¼ch½ 382 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% 100 fefy- 16.29 1485(अ) 29.03.2019 lksfM;e DyksjkbM ukWu Xykl ¼ch½ ¼ch½ 383 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% 250 fefy- 24.94 1485(अ) 29.03.2019 lksfM;e DyksjkbM Xykl ¼ch½ ¼ch½ 384 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0- 250 fefy- 22.52 1485(अ) 29.03.2019 lksfM;e DyksjkbM ukWu Xykl ¼ch½ 9%¼ch½ 385 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- 35.43 1485(अ) 29.03.2019 lksfM;e DyksjkbM Xykl ¼ch½ 386 Xywdkst ¼,½ $ batSD'ku 5% ¼,½ $ 0-9% 500 fefy- 30.61 1485(अ) 29.03.2019 lksfM;e DyksjkbM ¼ch½ ukWu Xykl ¼ch½[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 13 387 XywVkjkyMsgkbM lksyq'ku 2% 1 fefy- 0.06 1485(अ) 29.03.2019 388 fXyljhu vksjy fyD;bw ZM 1 fefy- 0.15 1485(अ) 29.03.2019 389 fXyljkby VªkbZfuVªVs batSD'ku 5 fexzk-@fefy- 1 fefy- 6.54 1485(अ) 29.03.2019 390 fXyljkby VªkbZfuVªVs lcfyaxq,y xksyh 0-5 fexzk- 1 xksyh 1.80 1485(अ) 29.03.2019 391 XykbdksikbjksysV batSD'ku 0-2 fexzk-@fefy- 1 fefy- 12.25 1485(अ) 29.03.2019 392 xhzlksQqyfou xksyh 125 fexzk- 1 xksyh 0.82 1485(अ) 29.03.2019 393 xhzlksQqyfou xksyh 250 fexzk- 1 xksyh 1.59 1485(अ) 29.03.2019 394 xhzlksQqyfou xksyh 375 fexzk- 1 xksyh 4.29 1485(अ) 29.03.2019 395 gseksMk;ylhl ¶ywM ykblasl ds vuqlkj 1 fefy- 0.04 1485(अ) 29.03.2019 396 gsyksisfjMksy batSD'ku 5 fexzk-@fefy- 1 fefy- 5.81 1485(अ) 29.03.2019 397 gsyksisfjMksy vksjy fyD;bw ZM 2 fexzk-@5 1 fefy- 2.05 1485(अ) 29.03.2019 fefy- 398 gsyksisfjMksy xksyh 1-5 fexkz- 1 xksyh 1.65 1485(अ) 29.03.2019 399 gsyksisfjMksy xksyh 10 fexkz- 1 xksyh 4.40 1485(अ) 29.03.2019 400 gsyksisfjMksy xksyh 20 fexkz- 1 xksyh 4.91 1485(अ) 29.03.2019 401 gsyksisfjMksy xksyh 5 fexzk- 1 xksyh 3.43 1485(अ) 29.03.2019 402 gsyksFksu bugys s'ku 1 fefy- 5.84 1485(अ) 29.03.2019 403 gsikfju batSD'ku 1000 vkbZ;w@fefy- 1 fefy- 16.26 1485(अ) 29.03.2019 404 gsikfju batSD'ku 5000 vkbZ;w@fefy- 1 fefy- 40.36 1485(अ) 29.03.2019 405 gsikVkbfVl ch izfr iSd 5492.20 1485(अ) 29.03.2019 bEequksXykscqfyu 406 gSikVkbfVl ch 1 fefy- 78.08 1485(अ) 29.03.2019 oSDlhu 407 gksekVªksikbu MªksIl 2% 1 fefy- 6.19 1485(अ) 29.03.2019 408 gkeksuZ fjfyftax bles a 52 fexkz- ysoksuksxZLs Vsªy 1 vkbZ;wMh 3856.86 1485(अ) 29.03.2019 vkbZ;wMh 'kkfey gS 409 g~;qeu dksfjvksfud batSD'ku 1000 vkbZ;w izfr iSd 211.90 1485(अ) 29.03.2019 xksukMksVªksfiu 410 g~;qeu dksfjvksfud batSD'ku 5000 vkbZ;w izfr iSd 416.14 1485(अ) 29.03.2019 xksukMksVªksfiu 411 g~;qeu ukWeZy lksyq”ku QkWj buQ~;wtu 5 1 fefy- 153.82 418(अ) 28.01.2020 bEequksXykscqfyu izfr”kr 412 g~;qeu ukWeZy lksyq”ku QkWj buQ~;wtu 10 1 fefy- 208.26 417(अ) 28.01.2020 bEequksXykscqfyu izfr”kr 413 gkbMªksDyksjksFkkbtkbM xksyh 12-5 fexkz- 1 xksyh 0.98 1485(अ) 29.03.2019 414 gkbMªksDyksjksFkkbtkbM xksyh 25 fexkz- 1 xksyh 1.68 1485(अ) 29.03.2019 415 gkbMªksDyksjksFkkbtkbM xksyh 50 fexkz- 1 xksyh 0.08 1485(अ) 29.03.2019 416 gkbMªksdksVhZlksu xksyh 10 fexkz- 1 xksyh 5.87 1485(अ) 29.03.2019 417 gkbMªksdksVhZlksu xksyh 5 fexzk- 1 xksyh 3.02 1485(अ) 29.03.2019 418 gkbMªksdksVhZlksu batSD'ku 100 fexzk- izfr iSd 38.80 1485(अ) 29.03.2019 419 gkbMªksdksVhZlksu batSD'ku 200 fexzk- izfr iSd 59.82 1485(अ) 29.03.2019 420 gkbMªksdksVhZlksu batSD'ku ds fy, ikmMj 100 izfr iSd 38.80 1485(अ) 29.03.2019 fexkz- 421 gkbMªkstu isjksDlkbM lksyq'ku 6% 1 fefy- 0.04 1485(अ) 29.03.2019 422 gkbMªksDlhDyksjksDohu xksyh 200 fexzk- 1 xksyh 5.91 1485(अ) 29.03.2019 423 gkbMªksDlhDyksjksDohu xksyh 400 fexzk- 1 xksyh 11.91 1485(अ) 29.03.2019 424 gkbMªksDlhizksikby batSD'ku 2% 1 fefy- 37.39 1485(अ) 29.03.2019 esFkkbylys qykst 425 gkbMªksDlh;wfj;k dSIlwy 500 fexzk- 1 dSIlwy 12.78 1485(अ) 29.03.2019 426 gk;kslhu batSD'ku 20 fexkz-@fefy- 1 fefy- 10.40 1485(अ) 29.03.2019 cqVhyczksekbM14 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 427 gk;kslhu xksyh 10 fexkz- 1 xksyh 2.96 1485(अ) 29.03.2019 cqVhyczksekbM 428 vkbZcqizksQqu dSIlwy 400 fexzk- 1 dSIlwy 1.05 1485(अ) 29.03.2019 429 vkbZcqizksQqu dSIlwy 200 fexzk- 1 lkWQ~V 2.67 2136(अ) 26.06.2019 tsysVkbu dSIlwy 430 vkbZcqizksQqu xksyh 200 fexzk- 1 xksyh 0.39 1485(अ) 29.03.2019 431 vkbZcqizksQqu xksyh 400 fexzk- 1 xksyh 0.69 1485(अ) 29.03.2019 432 vkbZcqizksQqu vksjy fyD;bw ZM 100 fexzk@5 1 fefy- 0.19 1485(अ) 29.03.2019 fefy- 433 vkbZQksLQkekbM batSD'ku ds fy, ikmMj 1 izfr iSd 360.78 1485(अ) 29.03.2019 xkze 434 vkbZQksLQkekbM batSD'ku ds fy, ikmMj 2 izfr iSd 947.01 1485(अ) 29.03.2019 xkze 435 besfVuhc dSIlwy 100 fexzk- 1 dSIlwy 77.40 1485(अ) 29.03.2019 436 besfVuhc dSIlwy 400 fexzk- 1 dSIlwy 254.67 1485(अ) 29.03.2019 437 besfVuhc xksyh 100 fexzk- 1 xksyh 79.19 1485(अ) 29.03.2019 438 besfVuhc xksyh 400 fexzk- 1 xksyh 229.24 1485(अ) 29.03.2019 439 balfqyu ¼lksyqcy½ batSD'ku 40 vkbZ;w@fefy- 1 fefy- 15.01 1485(अ) 29.03.2019 440 baVjesfM,V ,fDVxa batSD'ku 40 vkbZ;w@fefy- 1 fefy- 15.01 1485(अ) 29.03.2019 ¼,uih,p½ balfqyu 441 bvksgDs lksy batSD'ku 300 fexzk- 1 fefy- 16.58 1485(अ) 29.03.2019 vk;ksfMu@fefy- 442 vkbZizkVªksfi;e bugys s'ku 1 Mkst 0.61 1485(अ) 29.03.2019 ¼,eMhvkbZ@MhihvkbZ½ 20 ,elhth@Mkst 443 vkbZizkVªksfi;e jls fijVs kWjh lksyq'ku QkWj ;wt 1 fefy- 2.53 1485(अ) 29.03.2019 bu uscyq kbtj 250 ,elhth@fefy- 444 vk;ju lØq kst batSD'ku 20 fexkz-@fefy- 1 fefy- 53.59 1485(अ) 29.03.2019 445 vkbZlks¶yjq us bugys s'ku 1 fefy- 10.42 1485(अ) 29.03.2019 446 vkbZlksfuftM xksyh 100 fexzk- 1 xksyh 0.68 1485(अ) 29.03.2019 447 vkbZlksfuftM xksyh 300 fexzk- 1 xksyh 1.19 1485(अ) 29.03.2019 448 vkbZlkslksfcZM 5 xksyh 20 fexkz- 1 xksyh 3.27 1485(अ) 29.03.2019 eksuksuhVªVs 449 vkbZlkslksfcZM xksyh 10 fexkz- 1 xksyh 0.73 1485(अ) 29.03.2019 fMfuVªsV 450 vkbZlkslksfcZM xksyh 5 fexzk- 1 xksyh 0.75 1485(अ) 29.03.2019 fMfuVªVs 451 vkbZlkslksfcZM 5 & ,lvkj dSIlwy 30 fexzk- 1 dSIlwy 3.49 1485(अ) 29.03.2019 eksuksuhVªVs 452 vkbZlkslksfcZM 5 & ,lvkj dSIlwy 60 fexzk- 1 dSIlwy 3.47 1485(अ) 29.03.2019 eksuksuhVªVs 453 vkbZlkslksfcZM 5 & ,lvkj xksyh 30 fexkz- 1 xksyh 4.88 1485(अ) 29.03.2019 eksuksuhVªVs 454 vkbZlkslksfcZM 5 & ,lvkj xksyh 60 fexkz- 1 xksyh 6.37 1485(अ) 29.03.2019 eksuksuhVªVs 455 vkbZlkslksfcZM 5 & xksyh 10 fexkz- 1 xksyh 1.96 1485(अ) 29.03.2019 eksuksuhVªVs 456 bLik?kqyk xszU;wyl@gLd@ikmMj 1 xkze 0.77 1485(अ) 29.03.2019 457 vkbZ;wMh daVsfauxa ykblasl ds :i es a 1 vkbZ;wMh 286.65 1485(अ) 29.03.2019 dkWij 458 tkiuht 4 ,elhth ls 6 ,elhth izfr iSd 695.51 1485(अ) 29.03.2019 bulsQkfyfVl oSDlhu[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 15 459 tkiuht 3 ,elhth rd izfr iSd 529.88 1485(अ) 29.03.2019 bulsQkfyfVl oSDlhu 460 dSukekblhu batSD'ku ds fy, ikmMj 1 izfr iSd 38.99 1485(अ) 29.03.2019 xkze 461 dSukekblhu batSD'ku ds fy, ikmMj 500 izfr iSd 21.27 1485(अ) 29.03.2019 fexkz- 462 dSukekblhu batSD'ku ds fy, ikmMj 750 izfr iSd 36.34 1485(अ) 29.03.2019 fexkz- 463 dSVkekbu batSD'ku 10 fexkz-@fefy- 1 fefy- 10.56 1485(अ) 29.03.2019 464 dSVkekbu batSD'ku 50 fexkz-@fefy- 1 fefy- 10.42 1485(अ) 29.03.2019 465 yscVs kyksy batSD'ku 5 fexzk-@fefy- 1 fefy- 50.54 1485(अ) 29.03.2019 466 ySDVksykst vksjy fyD;bw ZM 10 xzke@15 1 fefy- 1.09 1485(अ) 29.03.2019 fefy- 467 ysfeoqMkbu ¼,½ xksyh 150 fexzk- ¼,½ $ 200 1 xksyh 15.56 1485(अ) 29.03.2019 $ufsojkikbu ¼ch½ fexkz-¼ch½ $ 30 fexzk- ¼lh½ $LVkoqMkbu ¼lh½ 468 ysfeoqMkbu ¼,½ $ xksyh 150 fexzk- ¼,½ $ 300 1 xksyh 20.00 1485(अ) 29.03.2019 ftMkscMq kbu ¼ch½ fexkz-¼ch½ 469 ysfeoqMkbu ¼,½ fMLiszflcy xksyh 30 fexzk- 1 xksyh 4.93 1485(अ) 29.03.2019 $ufsojkikbu ¼ch½ ¼,½ $ 50 fexkz-¼ch½ $ 6 $LVkoqMkbu ¼lh½ fexkz- ¼lh½ 470 ,y&,Lisjtkbul batSD'ku ds fy, ikmMj izfr iSd 1600.63 1485(अ) 29.03.2019 10000 ds;w 471 ,y&,Lisjtkbul batSD'ku ds fy, ikmMj izfr iSd 1033.19 1485(अ) 29.03.2019 5000 ds;w 472 ys¶yquksekbM xksyh 10 fexkz- 1 xksyh 9.98 1485(अ) 29.03.2019 473 ys¶yquksekbM xksyh 20 fexkz- 1 xksyh 19.48 1485(अ) 29.03.2019 474 ysVªkstksy xksyh 2-5 fexkz- 1 xksyh 40.65 1485(अ) 29.03.2019 475 ysofsVjklsVe batSD'ku 100 fexzk-@fefy- 1 fefy- 21.75 1485(अ) 29.03.2019 476 ysofsVjklsVe bZvkj xksyh 750 fexzk- 1 xksyh 17.34 1485(अ) 29.03.2019 477 ysofsVjklsVe xksyh 250 fexzk- 1 xksyh 5.83 1485(अ) 29.03.2019 478 ysofsVjklsVe xksyh 500 fexzk- 1 xksyh 11.79 1485(अ) 29.03.2019 479 ysofsVjklsVe xksyh 750 fexzk- 1 xksyh 18.13 1485(अ) 29.03.2019 480 ysofsVjklsVe vksjy fyD;bw ZM 100 fexzk-@ 1 fefy- 3.64 1485(अ) 29.03.2019 fefy- 481 ysoksMksik ¼,½ lhvkj xksyh 100 fexzk-¼,½ $ 1 xksyh 3.32 1485(अ) 29.03.2019 $dkfcZMksik ¼ch½ 25 fexzk- ¼ch½ 482 ysoksMksik ¼,½ xksyh 100 fexzk- ¼,½ $ 10 1 xksyh 1.55 1485(अ) 29.03.2019 $dkfcZMksik ¼ch½ fexkz- ¼ch½ 483 ysoksMksik ¼,½ xksyh 100 fexzk- ¼,½ $ 25 1 xksyh 2.25 1485(अ) 29.03.2019 $dkfcZMksik ¼ch½ fexkz- ¼ch½ 484 ysoksMksik ¼,½ xksyh 250 fexzk- ¼,½ $ 25 1 xksyh 3.73 1485(अ) 29.03.2019 $dkfcZMksik ¼ch½ fexkz- ¼ch½ 485 ysoksMksik ¼,½ lhvkj xksyh 200 fexzk-¼,½ $ 1 xksyh 4.10 1485(अ) 29.03.2019 $dkfcZMksik ¼ch½ 50 fexzk- ¼ch½ 486 ysoks¶yksDlklhu xksyh 250 fexzk- 1 xksyh 4.40 1485(अ) 29.03.2019 487 ysoks¶yksDlklhu xksyh 750 fexzk- 1 xksyh 10.90 1485(अ) 29.03.2019 488 ysoks¶yksDlklhu xksyh 500 fexzk- 1 xksyh 8.04 1485(अ) 29.03.2019 489 ysoksuksxZLs Vªsy xksyh 0-75 fexkz- 1 xksyh 22.95 1485(अ) 29.03.2019 490 ysoksFkkbjksDlhu xksyh 100 ,elhth 1 xksyh 1.19 1485(अ) 29.03.2019 491 ysoksFkkbjksDlhu xksyh 112 ,elhth 1 xksyh 1.43 1485(अ) 29.03.2019 492 ysoksFkkbjksDlhu xksyh 12-5 ,elhth 1 xksyh 1.34 1485(अ) 29.03.2019 493 ysoksFkkbjksDlhu xksyh 125 ,elhth 1 xksyh 1.53 1485(अ) 29.03.201916 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 494 ysoksFkkbjksDlhu xksyh 150 ,elhth 1 xksyh 1.54 1485(अ) 29.03.2019 495 ysoksFkkbjksDlhu xksyh 25 ,elhth 1 xksyh 1.30 1485(अ) 29.03.2019 496 ysoksFkkbjksDlhu xksyh 50 ,elhth 1 xksyh 0.98 1485(अ) 29.03.2019 497 ysoksFkkbjksDlhu xksyh 62-5 ,elhth 1 xksyh 1.40 1485(अ) 29.03.2019 498 ysoksFkkbjksDlhu xksyh 75 ,elhth 1 xksyh 1.29 1485(अ) 29.03.2019 499 ysoksFkkbjksDlhu xksyh 88 ,elhth 1 xksyh 1.53 1485(अ) 29.03.2019 500 fyXuksdsu batSD'ku 2% 1 fefy- 0.98 1485(अ) 29.03.2019 501 fyXuksdsu batSD'ku 2% ¼izstjosfVo Qzh 1 fefy- 0.97 1485(अ) 29.03.2019 QkWj IV ;wt 502 fyXuksdsu batSD'ku 1% izfr iSd 7.92 1485(अ) 29.03.2019 503 fyXuksdsu VkWfidy QkWeZ 2&5% 1 xkze vkSj 1 1.07 1485(अ) 29.03.2019 fefy- 504 fyXuksdsu batSD'ku 5% Xywdkst 7- 1 fefy- 3.67 1485(अ) 29.03.2019 5% ds lkFk 505 fyXuksdsu ¼,½ $ batSD'ku 1%¼,½ $ 1 fefy- 0.45 1485(अ) 29.03.2019 ,Mªus kykbu ¼ch½ 1%200000¼5 ,elhth@fefy-½ ¼ch½ 506 fyXuksdsu ¼,½ $ batSD'ku 2% ¼,½ $ 1 fefy- 0.92 1485(अ) 29.03.2019 ,Mªus kykbu ¼ch½ 1%200000 ¼5 ,elhth@fefy½ ¼ch½ 507 ykbutksfyM xksyh 600 fexzk- 1 xksyh 32.94 1485(अ) 29.03.2019 508 fyfFk;e xksyh 300 fexzk- 1 xksyh 1.46 1485(अ) 29.03.2019 509 ysijs kekbM dSIlwy 2 fexzk- 1 dSIlwy 3.57 1485(अ) 29.03.2019 510 ysijs kekbM xksyh 2 fexzk- 1 xksyh 1.97 1485(अ) 29.03.2019 511 yksfiukohj ¼,½ xksyh 100 fexzk- ¼,½ $ 25 1 xksyh 23.44 1485(अ) 29.03.2019 $fjVksukohj ¼ch½ fexkz- ¼ch½ 512 yksfiukohj ¼,½ xksyh 200 fexzk- ¼,½ $ 50 1 xksyh 45.43 1485(अ) 29.03.2019 $fjVksukohj ¼ch½ fexkz- ¼ch½ 513 yksjktsike batSD'ku 2 fexzk-@fefy- 1 fefy- 7.75 1485(अ) 29.03.2019 514 yksjktsike xksyh 1 fexzk- 1 xksyh 2.06 1485(अ) 29.03.2019 515 yksjktsike xksyh 2 fexzk- 1 xksyh 2.51 1485(अ) 29.03.2019 516 eSaxfuf'k;e lYQsV batSD'ku 500 fexzk-@fefy- 1 fefy- 4.76 1485(अ) 29.03.2019 517 esfuVksy batSD'ku 10% 1 fefy- 0.16 1485(अ) 29.03.2019 518 esfuVksy batSD'ku 20% 1 fefy- 0.30 1485(अ) 29.03.2019 519 fetyl :csyk izfr iSd ¼0-5 88.15 1485(अ) 29.03.2019 oSDlhu fefy-½ 520 fetyl oSDlhu oSDlhu izfr iSd ¼0-5 50.84 1485(अ) 29.03.2019 fefy-½ 521 esous Mktksy vksjy fyD;bw ZM 100 fexzk@5 1 fefy- 0.77 1485(अ) 29.03.2019 fefy- 522 esous Mktksy xksyh 100 fexzk- 1 xksyh 2.92 1485(अ) 29.03.2019 523 esMªksDlh izkxs Ls Vsjksu xksyh 10 fexkz- 1 xksyh 5.37 1485(अ) 29.03.2019 ,lsVVs 524 esQsukfed ,flM vksjy fyD;bw ZM 100 fexzk@5 1 fefy- 0.52 1485(अ) 29.03.2019 fefy- 525 esQsusfed ,flM xksyh 250 fexkz- 1 xksyh 1.93 1485(अ) 29.03.2019 526 esQsusfed ,flM xksyh 500 fexzk- 1 xksyh 2.45 1485(अ) 29.03.2019 527 es¶yksDohu xksyh 250 fexzk- 1 xksyh 50.83 1485(अ) 29.03.2019 528 esXyqekbu batSD'ku 60% MCY;w@oh 1 fefy- 8.24 1485(अ) 29.03.2019 MkbVªhtks,V 529 esXyqekbu batSD'ku 76% MCY;w@oh 1 fefy- 9.52 1485(अ) 29.03.2019 MkbVªhtks,V[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 17 530 esyQkyku xksyh 2 fexzk- 1 xksyh 97.82 1485(अ) 29.03.2019 531 esyQkyku xksyh 5 fexzk- 1 xksyh 167.77 1485(अ) 29.03.2019 532 esluk batSD'ku 100 fexzk-@fefy- 1 fefy- 16.72 1485(अ) 29.03.2019 533 esVQkWfeuZ bEesMsV fjfyt xksyh 500 1 xksyh 1.50 1485(अ) 29.03.2019 fexkz- 534 esVQkWfeuZ daVªksyM fjfyt xksyh 1000 1 xksyh 3.64 1485(अ) 29.03.2019 fexkz- 535 esVQkWfeuZ daVªksyM fjfyt xksyh 500 1 xksyh 1.91 1485(अ) 29.03.2019 fexkz- 536 esVQkWfeuZ daVªksyM fjfyt xksyh 750 1 xksyh 2.39 1485(अ) 29.03.2019 fexkz- 537 esVQkWfeuZ bEesMsV fjfyt xksyh 1000 1 xksyh 3.59 1485(अ) 29.03.2019 fexkz- 538 esVQkWfeuZ bEesMsV fjfyt xksyh 750 1 xksyh 3.03 1485(अ) 29.03.2019 fexkz- 539 esFkksVªDs lVs batSD'ku 25 fexkz-@fefy- 1 fefy- 47.96 1485(अ) 29.03.2019 540 esFkksVªDs lVs batSD'ku 50 fexkz-@fefy- 1 fefy- 39.94 1485(अ) 29.03.2019 541 esFkksVªDs lVs xksyh 10 fexkz- 1 xksyh 12.11 1485(अ) 29.03.2019 542 esFkksVªDs lVs xksyh 2-5 fexkz- 1 xksyh 4.77 1485(अ) 29.03.2019 543 esFkksVªDs lVs xksyh 7-5 fexkz- 1 xksyh 11.55 1485(अ) 29.03.2019 544 esFkksVªDs lVs xksyh 5 fexzk- 1 xksyh 8.35 1485(अ) 29.03.2019 545 eSfFkyMksik xksyh 250 fexzk- 1 xksyh 2.44 1485(अ) 29.03.2019 546 eSfFkyMksik xksyh 500 fexzk- 1 xksyh 4.67 1485(अ) 29.03.2019 547 eSfFkysxkseZ sVªhu batSD'ku 0-2 fexzk-@fefy- 1 fefy- 14.23 1485(अ) 29.03.2019 548 eSfFkysxkseZ sVªhu xksyh 0-125 fexzk- 1 xksyh 7.90 1485(अ) 29.03.2019 549 eSfFkyizsMuhlksyksu xksyh 16 fexkz- 1 xksyh 8.89 1485(अ) 29.03.2019 550 eSfFkyizsMuhlksyksu xksyh 8 fexzk- 1 xksyh 5.08 1485(अ) 29.03.2019 551 eSfFkyizsMuhlksyksu batSD'ku 40 fexkz-@fefy- 1 fefy- 53.81 1485(अ) 29.03.2019 552 esVksDyksizkekbM batSD'ku 5 fexzk-@fefy- 1 fefy- 1.42 1485(अ) 29.03.2019 ¼10 fefy- iSd½ 553 esVksDyksizkekbM batSD'ku 5 fexzk-@fefy- 1 fefy- 2.33 1485(अ) 29.03.2019 ¼2 fefy- iSd½ 554 esVksDyksizkekbM vksjy fyD;bw ZM 5 fexzk-@5 1 fefy- 0.44 1485(अ) 29.03.2019 fefy- 555 esVksDyksizkekbM xksyh 10 fexkz- 1 xksyh 1.16 1485(अ) 29.03.2019 556 esVksizksyksy dSIlwy 25 fexzk- 1 dSIlwy 4.22 1485(अ) 29.03.2019 557 esVksizksyksy dSIlwy 50 fexzk- 1 dSIlwy 6.43 1485(अ) 29.03.2019 558 esVksizksyksy ,lvkj xksyh 25 fexkz- 1 xksyh 4.02 1485(अ) 29.03.2019 559 esVksizksyksy ,lvkj xksyh 50 fexkz- 1 xksyh 5.76 1485(अ) 29.03.2019 560 esVksizksyksy xksyh 25 fexkz- 1 xksyh 3.10 1485(अ) 29.03.2019 561 esVksizksyksy xksyh 50 fexkz- 1 xksyh 4.70 1485(अ) 29.03.2019 562 esVªksfuMktksy batSD'ku 500 fexzk-@100 1 fefy- 0.20 4461(अ) 13.12.2019 fefy- 563 esVªksfuMktksy vksjy fyD;bw ZM 200 fexzk@5 1 fefy- 0.45 4461(अ) 13.12.2019 fefy- 564 esVªksfuMktksy xksyh 200 fexzk- 1 xksyh 0.69 4461(अ) 13.12.2019 565 esVªksfuMktksy xksyh 400 fexzk- 1 xksyh 1.27 4461(अ) 13.12.2019 566 feMktksye batSD'ku 1 fexzk-@fefy- 1 fefy- 5.89 1485(अ) 29.03.2019 567 feMktksye batSD'ku 5 fexzk-@fefy- 1 fefy- 14.47 1485(अ) 29.03.2019 568 feMktksye xksyh 7-5 fexkz- 1 xksyh 22.38 1485(अ) 29.03.201918 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 569 feQsihzLVksu xksyh 200 fexzk- 1 xksyh 320.77 1485(अ) 29.03.2019 570 felksikzsLVksy xksyh 100 ,elhth 1 xksyh 8.68 1485(अ) 29.03.2019 571 felksikzsLVksy xksyh 200 ,elhth 1 xksyh 16.65 1485(अ) 29.03.2019 572 eksQhZu batSD'ku 10 fexkz-@fefy- 1 fefy- 23.68 1485(अ) 29.03.2019 573 eksQhZu batSD'ku 15 fexkz-@fefy- 1 fefy- 29.55 1485(अ) 29.03.2019 574 eksQhZu ,lvkj xksyh 30 fexkz- 1 xksyh 5.43 1485(अ) 29.03.2019 575 eksQhZu xksyh 10 fexkz- 1 xksyh 5.31 1485(अ) 29.03.2019 576 eksDlh¶yksDlklhu xksyh 400 fexzk- 1 xksyh 25.26 1485(अ) 29.03.2019 577 ekbZdksQsuksysV xksyh 250 fexzk- 1 xksyh 41.4 1485(अ) 29.03.2019 eksQsfVy 578 ekbZdksQsuksysV xksyh 500 fexzk- 1 xksyh 81.89 1485(अ) 29.03.2019 eksQsfVy 579 ,u&,flVkbyflLVsu batSD'ku 200 fexzk-@fefy- 1 fefy- 22.34 1485(अ) 29.03.2019 580 ,u&,flVkbyflLVsu lpsV 200 fexzk- 1 xkze 8.97 1485(अ) 29.03.2019 581 ukyksDlksu batSD'ku 0-4 fexzk-@fefy- 1 fefy- 86.50 1485(अ) 29.03.2019 582 ukVkekblhu MªksIl 5% 1 fefy- 22.74 1485(अ) 29.03.2019 583 fuvksLVhtekbu batSD'ku 0-5 fexzk-@fefy- 1 fefy- 4.34 1485(अ) 29.03.2019 584 fuvksLVhtekbu xksyh 15 fexkz- 1 xksyh 4.66 1485(अ) 29.03.2019 585 uos hjkikbu vksjy fyD;bw ZM 50 fexkz-@ 1 fefy- 0.84 1485(अ) 29.03.2019 5 fefy- 586 uos hjkikbu xksyh 200 fexzk- 1 xksyh 14.27 1485(अ) 29.03.2019 587 fuQsfMikbu dSIlwy 10 fexzk- 1 dSIlwy 0.86 1485(अ) 29.03.2019 588 fuQsfMikbu xksyh 10 fexkz- 1 xksyh 1.23 1485(अ) 29.03.2019 589 fuVªksQqjku's ku vksjy fyD;bw ZM 25 fexkz-@ 1 fefy- 0.82 1485(अ) 29.03.2019 5 fefy- 590 fuVªksQqjku's ku xksyh 100 fexzk- 1 xksyh 7.21 1485(अ) 29.03.2019 591 fuVªksQqjku's ku dSIlwy 100 fexzk- 1 dSIlwy 7.83 1485(अ) 29.03.2019 592 ukbZVªl vkWDlkbM ?ku ehVj 232.96 1485(अ) 29.03.2019 593 uksjkMªus kykbu batSD'ku 2 fexzk-@fefy- 1 fefy- 25.69 1485(अ) 29.03.2019 594 uksjfsFkLVsjksu xksyh 5 fexzk- 1 xksyh 5.09 1485(अ) 29.03.2019 595 vksesikztksy dSIlwy 10 fexzk- 1 dSIlwy 2.11 1485(अ) 29.03.2019 596 vksesikztksy dSIlwy 20 fexzk- 1 dSIlwy 2.49 1485(अ) 29.03.2019 597 vksesikztksy dSIlwy 40 fexzk- 1 dSIlwy 4.92 1485(अ) 29.03.2019 598 vksesikztksy vksjy fyD;bw ZM ds fy, 1 xkze 1.22 1485(अ) 29.03.2019 ikmMj 20 fexzk- 599 vksesizktksy xksyh 10 fexkz- 1 xksyh 4.42 1485(अ) 29.03.2019 600 vksesikztksy xksyh 20 fexkz- 1 xksyh 4.91 1485(अ) 29.03.2019 601 vksesikztksy xksyh 40 fexkz- 1 xksyh 8.31 1485(अ) 29.03.2019 602 vksuMulsVªksu batSD'ku 2 fexzk-@fefy- 1 fefy- 5.83 1485(अ) 29.03.2019 603 vksuMulsVªksu vksjy fyD;bw ZM 2 fexzk-@ 1 fefy- 1.13 1485(अ) 29.03.2019 5 fefy- 604 vksuMulsVªksu xksyh 4 fexzk- 1 xksyh 4.69 1485(अ) 29.03.2019 605 vksuMulsVªksu xksyh 8 fexzk- 1 xksyh 9.73 1485(अ) 29.03.2019 606 vksjy fjgkbMª's ku ykblasl ds :i es a 1 xkze 0.89 1485(अ) 29.03.2019 lkYVl 607 vksjy fjgkbMª's ku ykblasl ds :i es a 1 fefy- 0.14 1485(अ) 29.03.2019 lkYVl 608 vksDlkyhIykVhu batSD'ku 100 fexzk-¼ykblasl izfr iSd 4455.90 1485(अ) 29.03.2019 ds :i es½a[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 19 609 vksDlkyhIykVhu batSD'ku 50 fexkz-¼ykblasl ds izfr iSd 2591.45 1485(अ) 29.03.2019 :i es½a 610 vkWDlhtu bugys s'ku ¼मेजडजसनल गैस½ ?ku ehVj 17.49 1485(अ) 29.03.2019 611 vkWDlhVkslhu batSD'ku 10 vkbZ;w@fefy- 1 fefy- 39.28 1485(अ) 29.03.2019 612 vkWDlhVkslhu batSD'ku 5 vkbZ;w@fefy- 1 fefy- 17.60 1485(अ) 29.03.2019 613 isdfyVkDlsy batSD'ku 100 fexzk-@16-7 1 fefy- 222.53 1461(अ) 02.04.2018 fefy- 614 isdfyVkDlsy batSD'ku 30 fexkz-@5 fefy- 1 fefy- 222.53 1461(अ) 02.04.2018 615 isuVksizktksy batSD'ku 40 fexkz- izfr iSd 44.39 1485(अ) 29.03.2019 616 ikjk&,feukslkfyflf xszU;wyl ¼ykblasl ds :i es½a 1 xkze 2.83 1485(अ) 29.03.2019 yd ,flM 617 isjkflVkeksy vksjy fyD;bw ZM 100 fexzk@ 1 fefy- 0.51 1485(अ) 29.03.2019 5 fefy- 618 isjkflVkeksy vksjy fyD;bw ZM 120 fexzk@ 1 fefy- 0.53 1485(अ) 29.03.2019 5 fefy- 619 isjkflVkeksy vksjy fyD;bw ZM 125 fexzk@ 1 fefy- 0.34 1485(अ) 29.03.2019 5 fefy- 620 isjkflVkeksy vksjy fyD;bw ZM 150 fexzk@ 1 fefy- 0.58 1485(अ) 29.03.2019 5 fefy- 621 isjkflVkeksy vksjy fyD;bw ZM 250 fexzk@ 1 fefy- 0.60 1485(अ) 29.03.2019 5 fefy- 622 isjkflVkeksy vksjy fyD;bw ZM 500 fexzk@ 1 fefy- 0.64 1485(अ) 29.03.2019 5 fefy- 623 isjkflVkeksy vksjy fyD;bw ZM 650 fexzk@ 1 fefy- 0.52 1485(अ) 29.03.2019 5 fefy- 624 isjkflVkeksy xksyh 500 fexzk- 1 xksyh 0.91 1485(अ) 29.03.2019 625 isjkflVkeksy xksyh 650 fexzk- 1 xksyh 1.83 1485(अ) 29.03.2019 626 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 3.06 1485(अ) 29.03.2019 ¼0-5 fefy-½ 627 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 4.19 1485(अ) 29.03.2019 ¼1 fefy-½ 628 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 6.43 1485(अ) 29.03.2019 ¼2 fefy-½ 629 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 8.68 1485(अ) 29.03.2019 ¼3 fefy-½ 630 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 10.93 1485(अ) 29.03.2019 ¼4 fefy-½ 631 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 13.18 1485(अ) 29.03.2019 ¼5 fefy-½ 632 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 17.68 1485(अ) 29.03.2019 ¼7 fefy-½ 633 isjkflVkeksy lIqiksftVªh 170 fexzk- izfr 7.67 1485(अ) 29.03.2019 lIqiksftVªh 634 isjkflVkeksy lIqiksftVªh 80 fexzk- izfr 6.49 1485(अ) 29.03.2019 lIqiksftVªh 635 iSjkflVkeksy vksjy 100 fexzk-@fefy- ¼isMªkfVd½ 1 fefy- 1.61 1485(अ) 29.03.2019 fyD;bw ZM 636 iSXysVsM baVjQsjkWu batSD'ku 180 ,elhth izfr iSd 7889.76 1485(अ) 29.03.2019 ,YQk 2 , 637 iSXysVsM baVjQsjkWu batSD'ku 100 ,elhth izfr iSd 15599.00 1485(अ) 29.03.2019 ,YQk 2 ch 638 iSXysVsM baVjQsjkWu batSD'ku 120 ,elhth izfr iSd 14527.08 1485(अ) 29.03.2019 ,YQk 2 ch 639 iSXysVsM baVjQsjkWu batSD'ku 80 ,elhth izfr iSd 12470.96 1485(अ) 29.03.2019 ,YQk 2 ch 640 isfuflykekbu dSIlwy 250 fexzk- 1 dSIlwy 14.82 1485(अ) 29.03.2019 641 iesFZ kzhu Øhe 1% 1 xkze 1.60 1485(अ) 29.03.201920 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 642 iesFZ kzhu Øhe 5% 1 xkze 1.73 1485(अ) 29.03.2019 643 iesFZ kzhu tSy 5% 1 xkze 1.46 1485(अ) 29.03.2019 644 iesFZ kzhu yks'ku 1% 1 xkze 0.91 1485(अ) 29.03.2019 645 iesFZ kzhu yks'ku 5% 1 fefy- 0.97 1485(अ) 29.03.2019 646 Qsuhjkekbu batSD'ku 22-75 fexzk-@fefy- 1 fefy- 2.28 4461(अ) 13.12.2019 ¼2 fefy-½ 647 Qsuhjkekbu batSD'ku 22-75 fexzk-@fefy- 1 fefy- 1.70 4461(अ) 13.12.2019 ¼10 fefy-½ 648 QsuksckjfcVksu batSD'ku 200 fexzk-@fefy- 1 fefy- 19.11 1485(अ) 29.03.2019 649 QsuksckjfcVksu xksyh 30 fexkz- 1 xksyh 1.22 1485(अ) 29.03.2019 650 QsuksckjfcVksu xksyh 60 fexkz- 1 xksyh 1.76 1485(अ) 29.03.2019 651 QsuksckjfcVksu vksjy fyD;wbMZ 20 fexkz-@5 1 fefy- 0.44 1485(अ) 29.03.2019 fefy- 652 QsuhyQs jhu MªksIl 10% 1 fefy- 8.06 1485(अ) 29.03.2019 653 QsuhyQs jhu MªksIl 5% 1 fefy- 3.72 1485(अ) 29.03.2019 654 QsuhVksbu dSIlwy 100 fexzk- 1 dSIlwy 1.52 1485(अ) 29.03.2019 655 QsuhVksbu dSIlwy 300 fexzk- 1 dSIlwy 3.800 1485(अ) 29.03.2019 656 QsuhVksbu bZvkj dSIlwy 300 fexzk- 1 dSIlwy 3.8 1485(अ) 29.03.2019 657 QsuhVksbu batSD'ku 25 fexkz-@fefy- 1 fefy- 2.51 1485(अ) 29.03.2019 658 QsuhVksbu batSD'ku 50 fexkz-@fefy- 1 fefy- 5.36 1485(अ) 29.03.2019 659 QsuhVksbu vksjy fyD;bw ZM 125 fexzk@5 1 fefy- 0.90 1485(अ) 29.03.2019 fefy- 660 QsuhVksbu vksjy fyD;bw ZM 30 fexkz-@5 1 fefy- 0.31 1768(अ) 26.04.2018 fefy- 661 QsuhVksbu bZvkj xksyh 300 fexzk- 1 xksyh 5.79 1485(अ) 29.03.2019 662 QsuhVksbu xksyh 100 fexzk- 1 xksyh 1.55 1485(अ) 29.03.2019 663 QsuhVksbu xksyh 300 fexzk- 1 xksyh 4.73 1485(अ) 29.03.2019 664 QsuhVksbu xksyh 50 fexkz- 1 xksyh 0.74 1485(अ) 29.03.2019 665 QkbVksesukMhvksu batSD'ku 10 fexkz-@fefy- 1 fefy- 47.74 1485(अ) 29.03.2019 ¼foVkfeu ds1½ 666 QkbVksesukMhvksu xksyh 10 fexkz- 1 xksyh 14.48 1485(अ) 29.03.2019 ¼foVkfeu ds1½ 667 fiyksdkjfiu MªksIl 2% 1 fefy- 10.08 1485(अ) 29.03.2019 668 fiyksdkjfiu MªksIl 4% 1 fefy- 11.65 1485(अ) 29.03.2019 669 fiisjkflfyu ¼,½ batSD'ku ds fy, ikmMj 1 izfr iSd 88.14 1485(अ) 29.03.2019 $Vts kscDs Ve ¼ch½ xkze ¼,½ $ 125 fexzk- ¼ch½ 670 fiisjkflfyu ¼,½ batSD'ku ds fy, ikmMj 2 izfr iSd 208.51 1485(अ) 29.03.2019 $Vts kscDs Ve ¼ch½ xkze ¼,½ $ 250 fexzk- ¼ch½ 671 fiisjkflfyu ¼,½ batSD'ku ds fy, ikmMj 4 izfr iSd 438.00 1485(अ) 29.03.2019 $Vts kscDs Ve ¼ch½ xkze ¼,½ $ 500 fexzk- ¼ch½ 672 iksVsf'k;e DyksjkbM batSD'ku 150 fexzk-@fefy- 1 fefy- 2.42 1485(अ) 29.03.2019 673 iksVsf'k;e DyksjkbM vksjy fyD;bw ZM 500 fexzk@5 1 fefy- 0.29 1485(अ) 29.03.2019 fefy- 674 iksVsf'k;e ijesxa usV fØLVy QkWj VkWfidy lksyq'ku 1 xkze 0.44 1485(अ) 29.03.2019 675 ikWfoMu vk;ksMhu vksbuVesVa 10% 1 xkze 5.19 4060(अ) 08.11.2019 676 ikWfoMu vk;ksMhu lksyq'ku 4% 1 fefy- 1.73 1485(अ) 29.03.2019 677 ikWfoMu vk;ksMhu lksyq'ku 7-5% 1 fefy- 0.77 1485(अ) 29.03.2019 678 ikWfoMu vk;ksMhu lksyq'ku 10% 1 fefy- 0.93 1485(अ) 29.03.2019 679 ikWfoMu vk;ksMhu lksyq'ku 5% 1 fefy- 0.39 1485(अ) 29.03.2019 680 izkfyMksDlhe batSD'ku 25 fexkz-@fefy- 1 fefy- 3.72 1485(अ) 29.03.2019 DyksjkbM ¼2&ih,,e½[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 21 681 izsMfulksyksu MªksIl 1% 1 fefy- 5.01 4461(अ) 13.12.2019 682 izsMfulksyksu batSD'ku 20 fexkz-@2 fefy- 1 fefy- 3.57 1485(अ) 29.03.2019 683 izsMfulksyksu vksjy fyD;bw ZM 15 fexkz-@5 1 fefy- 0.75 1485(अ) 29.03.2019 fefy- 684 izsMfulksyksu vksjy fyD;bw ZM 5 fexkz-@5 1 fefy- 0.43 1485(अ) 29.03.2019 fefy- 685 izsMfulksyksu xksyh 10 fexkz- 1 xksyh 0.97 1485(अ) 29.03.2019 686 izsMfulksyksu xksyh 20 fexkz- 1 xksyh 1.95 1485(अ) 29.03.2019 687 izsMfulksyksu xksyh 40 fexkz- 1 xksyh 2.80 1485(अ) 29.03.2019 688 izsMfulksyksu xksyh 5 fexzk- 1 xksyh 0.56 1485(अ) 29.03.2019 689 izsfeDl balfqyu batSD'ku 40 vkbZ;w@fefy- 1 fefy- 15.01 1485(अ) 29.03.2019 30%70 batSD'ku ¼jsxqyj%,uih,p½ 690 izhyksdsu ¼,½ $ Øhe 2-5% ¼,½ $ 2-5% ¼ch½ 1 xkze 20.39 1485(अ) 29.03.2019 fyXuksdsu ¼ch½ 691 izhekDohu xksyh 15 fexkz- 1 xksyh 4.56 1485(अ) 29.03.2019 692 izhekDohu xksyh 2-5 fexkz- 1 xksyh 1.55 1485(अ) 29.03.2019 693 izhekDohu xksyh 7-5 fexkz- 1 xksyh 2.11 1485(अ) 29.03.2019 694 izksdkckZftu dSIlwy 50 fexzk- 1 dSIlwy 34.47 1485(अ) 29.03.2019 695 izksdkckZftu xksyh 50 fexkz- 1 xksyh 46.97 1485(अ) 29.03.2019 696 izksikjkdsu MªksIl 0-5% 1 fefy- 9.94 1485(अ) 29.03.2019 697 izksiksQksy batSD'ku 10 fexkz-@fefy- 1 fefy- 7.20 1485(अ) 29.03.2019 698 izksizkuksyksy dSIlwy 40 fexzk- 1 dSIlwy 3.79 1485(अ) 29.03.2019 699 izksizkuksyksy dSIlwy 80 fexzk- 1 dSIlwy 5.76 1485(अ) 29.03.2019 700 izksizkuksyksy xksyh 10 fexkz- 1 xksyh 1.16 1485(अ) 29.03.2019 701 izksizkuksyksy xksyh 40 fexkz- 1 xksyh 2.75 1485(अ) 29.03.2019 702 izksizkuksyksy xksyh 80 fexkz- 1 xksyh 4.98 1485(अ) 29.03.2019 703 izksVkekbu batSD'ku 10 fexkz-@fefy- 1 fefy- 9.22 1485(अ) 29.03.2019 704 ikbjkftukekbM vksjy fyD;bw ZM 250 fexzk@5 1 fefy- 0.61 1485(अ) 29.03.2019 fefy- 705 ikbjkftukekbM xksyh 1000 fexzk- 1 xksyh 9.40 1485(अ) 29.03.2019 706 ikbjkftukekbM xksyh 1500 fexzk- 1 xksyh 10.41 1485(अ) 29.03.2019 707 ikbjkftukekbM xksyh 500 fexzk- 1 xksyh 4.22 1485(अ) 29.03.2019 708 ikbjkftukekbM xksyh 750 fexzk- 1 xksyh 6.42 1485(अ) 29.03.2019 709 ikbfjMksDlhu xksyh 100 fexzk- 1 xksyh 5.57 1485(अ) 29.03.2019 710 ikbfjMksDlhu xksyh 10 fexkz- 1 xksyh 0.11 1485(अ) 29.03.2019 711 Dquus batSD'ku 300 fexzk-@fefy- 1 fefy- 10.14 1485(अ) 29.03.2019 712 Dquus xksyh 300 fexzk- 1 xksyh 5.71 1485(अ) 29.03.2019 713 jfsct oSDlhu izfr iSd 340.72 1485(अ) 29.03.2019 714 jkyVxs kzohj xksyh 400 fexzk- 1 xksyh 156.04 1485(अ) 29.03.2019 715 jkfeizhy dSIlwy 2-5 fexkz- 1 dSIlwy 4.72 1485(अ) 29.03.2019 716 jkfeizhy dSIlwy 5 fexzk- 1 dSIlwy 7.37 1485(अ) 29.03.2019 717 jkfeizhy xksyh 2-5 fexkz- 1 xksyh 4.96 1485(अ) 29.03.2019 718 jkfeizhy xksyh 5 fexzk- 1 xksyh 7.81 1485(अ) 29.03.2019 719 jkfufVfMu vksjy fyD;bw ZM 75 fexkz-@5 1 fefy- 0.72 1485(अ) 29.03.2019 fefy- 720 jkfufVfMu xksyh 150 fexzk- 1 xksyh 0.73 1485(अ) 29.03.201922 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 721 jkfufVfMu batSD'ku 25 fexkz-@fefy- 1 fefy- 1.61 1485(अ) 29.03.2019 722 fjckfofju dSIlwy 200 fexzk- 1 dSIlwy 83.4 1485(अ) 29.03.2019 723 fjQkcqVhu dSIlwy 150 fexzk- 1 dSIlwy 39.55 1485(अ) 29.03.2019 724 fjQkcqVhu xksyh 150 fexzk- 1 xksyh 36.93 1485(अ) 29.03.2019 725 fjQefiflu dSIlwy 150 fexzk- 1 dSIlwy 2.00 1485(अ) 29.03.2019 726 fjQefiflu dSIlwy 300 fexzk- 1 dSIlwy 3.79 1485(अ) 29.03.2019 727 fjQefiflu dSIlwy 450 fexzk- 1 dSIlwy 4.92 1485(अ) 29.03.2019 728 fjQefiflu dSIlwy 600 fexzk- 1 dSIlwy 11.56 1485(अ) 29.03.2019 729 fjQefiflu vksjy fyD;bw ZM 100 fexzk@5 1 fefy- 0.39 1485(अ) 29.03.2019 fefy- 730 fjQefiflu xksyh 150 fexzk- 1 xksyh 1.61 1485(अ) 29.03.2019 731 fjQefiflu xksyh 300 fexzk- 1 xksyh 2.92 1485(अ) 29.03.2019 732 fjxa j ySDVsV batSD'ku 1000 fefy- izfr iSd 79.53 1485(अ) 29.03.2019 733 fjxa j ySDVsV batSD'ku 100 fefy- izfr iSd 20.83 1485(अ) 29.03.2019 734 fjxa j ySDVsV batSD'ku 250 fefy- izfr iSd 35.51 1485(अ) 29.03.2019 735 fjxa j ySDVsV batSD'ku 500 fefy- izfr iSd 45.25 1485(अ) 29.03.2019 736 fjlifsjMksu vksjy fyD;bw ZM 1 fexzk-@ 1 fefy- 1.93 1485(अ) 29.03.2019 fefy- 737 fjlifsjMksu xksyh 1 fexzk- 1 xksyh 3.07 1485(अ) 29.03.2019 738 fjlifsjMksu xksyh 2 fexzk- 1 xksyh 4.91 1485(अ) 29.03.2019 739 fjlifsjMksu xksyh 4 fexzk- 1 xksyh 9.97 1485(अ) 29.03.2019 740 fjVksukohj dSIlwy 100 fexzk- 1 dSIlwy 28.14 1485(अ) 29.03.2019 741 fjVksukohj xksyh 100 fexzk- 1 xksyh 28.94 1485(अ) 29.03.2019 742 fjVqDlheso batSD'ku 10 fexkz-@fefy- 1 fefy- 756.26 1485(अ) 29.03.2019 743 lys cqVkeksy dSIlwy 4 fexzk- 1 dSIlwy 0.60 1485(अ) 29.03.2019 744 lys cqVkeksy bugys s'ku 1 Mkst 0.40 1485(अ) 29.03.2019 ¼,eMhvkbZ@MhihvkbZ½ 100 ,elhth@Mkst 745 lys cqVkeksy vksjy fyD;bw ZM 2 fexzk-@5 1 fefy- 0.15 1485(अ) 29.03.2019 fefy- 746 lys cqVkeksy jls fijVs kWjh lksyq'ku QkWj ;wt 1 fefy- 0.70 1485(अ) 29.03.2019 bu uscyq kbtj 5 fexkz @ fefy- 747 lys cqVkeksy xksyh 2 fexzk- 1 xksyh 0.16 1485(अ) 29.03.2019 748 lys cqVkeksy xksyh 4 fexzk- 1 xksyh 0.18 1485(अ) 29.03.2019 749 lys hflfyd ,flM vksbaVesVa 6% 1 xkze 1.79 1485(अ) 29.03.2019 750 los ks¶ywjku bugys s'ku 1 fefy- 29.82 1485(अ) 29.03.2019 751 flYoj Øhe 1% 1 xkze 0.51 2942(अ) 14.08.2019 lYQkMkbftu 752 LuSd osukse ,aVhljs e batSD'ku ds fy, ikmMj 10 fefy- iSd 555.59 1485(अ) 29.03.2019 ykbvksfQykftM ikWyhosysVa 753 LuSd osukse ,aVhljs e batSD'ku izfr iSd 431.45 1485(अ) 29.03.2019 lksyqcy@fyD;wbM ¼10 fefy-½ ikWyhosysVa 754 lksfM;e ckbdkcksuZ Vs batSD'ku 7-5% 1 fefy- 1.40 1485(अ) 29.03.2019 755 lksfM;e ckbdkcksuZ Vs batSD'ku 8-4% 1 fefy- 1.28 1485(अ) 29.03.2019 756 lksfM;e DyksjkbM batSD'ku 0-9% 1000 fefy- 59.17 1485(अ) 29.03.2019 Xykl 757 lksfM;e DyksjkbM batSD'ku 0-9% 1000 fefy- 46.67 1485(अ) 29.03.2019 ukWu Xykl[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 23 758 lksfM;e DyksjkbM batSD'ku 0-9% 100 fefy- 17.50 1485(अ) 29.03.2019 Xykl 759 lksfM;e DyksjkbM batSD'ku 0-9% 100 fefy- 15.76 1485(अ) 29.03.2019 ukWu Xykl 760 lksfM;e DyksjkbM batSD'ku 0-9% 250 fefy- 23.60 1485(अ) 29.03.2019 Xykl 761 lksfM;e DyksjkbM batSD'ku 0-9% 250 fefy- 21.19 1485(अ) 29.03.2019 ukWu Xykl 762 lksfM;e DyksjkbM batSD'ku 0-9% 500 fefy- 32.81 1485(अ) 29.03.2019 Xykl 763 lksfM;e DyksjkbM batSD'ku 0-9% 500 fefy- 27.93 1485(अ) 29.03.2019 ukWu Xykl 764 lksfM;e batSD'ku 10 fexkz-@fefy- 1 fefy- 25.74 1485(अ) 29.03.2019 ukbVªksi:lkbM 765 lksfM;e osyizks,V batSD'ku 100 fexzk-@fefy- 1 fefy- 5.75 1485(अ) 29.03.2019 766 lksfM;e osyizks,V vksjy fyD;bw ZM 200 fexzk@5 1 fefy- 0.58 1485(अ) 29.03.2019 fefy- 767 lksfM;e osyizks,V lhvkj xksyh 300 fexzk- 1 xksyh 6.28 1485(अ) 29.03.2019 768 lksfM;e osyizks,V lhvkj xksyh 500 fexzk- 1 xksyh 9.72 1485(अ) 29.03.2019 769 lksfM;e osyizks,V xksyh 200 fexzk- 1 xksyh 3.09 1485(अ) 29.03.2019 770 lksfM;e osyizks,V xksyh 300 fexzk- 1 xksyh 3.96 1485(अ) 29.03.2019 771 lksfM;e osyizks,V xksyh 500 fexzk- 1 xksyh 6.92 1485(अ) 29.03.2019 772 lksQkscqohj xksyh 400 fexzk- 1 xksyh 665.52 1485(अ) 29.03.2019 773 lksekVksLVkVhu batSD'ku ds fy, ikmMj 3 izfr iSd 1580.17 1485(अ) 29.03.2019 fexkz- 774 LihjksuksysDVksu xksyh 25 fexkz- 1 xksyh 1.91 1485(अ) 29.03.2019 775 LihjksuksysDVksu xksyh 50 fexkz- 1 xksyh 3.79 1485(अ) 29.03.2019 776 LVkoqfMu ¼,½ $ xksyh 30 fexkz-¼,½ $ 150 1 xksyh 9.52 1485(अ) 29.03.2019 ykfeoqfMu ¼ch½ fexkz- ¼ch½ 777 LVªIsVksfdukl batSD'ku 1500000 vkbZ;w izfr iSd 1784.78 1485(अ) 29.03.2019 778 LVªIsVksfdukl batSD'ku 7]50]000 vkbZ;w izfr iSd 1255.28 1485(अ) 29.03.2019 779 LVªIsVksekbflu batSD'ku ds fy, ikmMj 750 izfr iSd 8.75 1485(अ) 29.03.2019 fexkz- 780 LVªIsVksekbflu batSD'ku ds fy, ikmMj 1 izfr iSd 10.40 1485(अ) 29.03.2019 xkze 781 lfDluhy dksfyu batSD'ku 50 fexkz-@fefy- 1 fefy- 4.82 1485(अ) 29.03.2019 782 lØq kyQsV vksjy fyD;bw ZM 1 xzke 1 fefy- 0.70 1485(अ) 29.03.2019 783 lYQklkyktkbu xksyh 500 fexzk- 1 xksyh 3.97 1485(अ) 29.03.2019 784 leq kVªhIVu xksyh 25 fexkz- 1 xksyh 33.19 1485(अ) 29.03.2019 785 leq kVªhIVu xksyh 50 fexkz- 1 xksyh 51.38 1485(अ) 29.03.2019 786 ljQsDVkaV lLis'a ku QkWj buVªkVªkpsy izfr iSd es a 66.69 1485(अ) 29.03.2019 buLVkbys'ku ¼ykblsla ds izfr fefy- :i es½a QksLQksfyfiM~l 787 VkØksfyeql dSIlwy 0-5 fexkz- 1 dSIlwy 22.05 1485(अ) 29.03.2019 788 VkØksfyeql dSIlwy 1 fexzk- 1 dSIlwy 38.95 1485(अ) 29.03.2019 789 VkØksfyeql dSIlwy 2 fexzk- 1 dSIlwy 76.30 1485(अ) 29.03.2019 790 VkeksDlhQsu xksyh 10 fexkz- 1 xksyh 2.57 1485(अ) 29.03.2019 791 VkeksDlhQsu xksyh 20 fexkz- 1 xksyh 2.90 1485(अ) 29.03.2019 792 Vys felkVuZ xksyh 20 fexkz- 1 xksyh 3.64 1485(अ) 29.03.2019 793 Vys felkVuZ xksyh 40 fexkz- 1 xksyh 6.57 1485(अ) 29.03.2019 794 Vys felkVuZ xksyh 80 fexkz- 1 xksyh 10.02 1485(अ) 29.03.201924 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 795 Ves kstksyksekbM dSIlwy 100 fexzk- 1 dSIlwy 2077.53 1485(अ) 29.03.2019 796 Ves kstksyksekbM dSIlwy 20 fexzk- 1 dSIlwy 594.68 1485(अ) 29.03.2019 797 Ves kstksyksekbM dSIlwy 250 fexzk- 1 dSIlwy 4672.75 1485(अ) 29.03.2019 798 Ves kstksyksekbM xksyh 100 fexzk- 1 xksyh 1542.12 1485(अ) 29.03.2019 799 Ves kstksyksekbM xksyh 20 fexkz- 1 xksyh 373.62 1485(अ) 29.03.2019 800 Ves kstksyksekbM xksyh 250 fexzk- 1 xksyh 3816.90 1485(अ) 29.03.2019 801 Vus ksQksohj xksyh 300 fexzk- 1 xksyh 47.05 1485(अ) 29.03.2019 802 Vus ksQksohj ¼,½ $ xksyh 300 fexzk- ¼,½ $ 300 1 xksyh 44.76 1485(अ) 29.03.2019 ykfeoqMkbu ¼ch½ fexkz- ¼ch½ 803 Vus ksQksohj ¼,½ $ xksyh 300 fexzk- ¼,½ $ 300 1 xksyh 102.77 1485(अ) 29.03.2019 ykfeoqMkbu ¼ch½ fexkz- ¼ch½ $ 600 fexzk- ¼lh½ $bQkohjsta ¼lh½ 804 VVs ul VkWDlkbM batSD'ku izfr iSd 10.81 2137(अ) 26.06.2019 ¼0-5 fefy-½ 805 VVs ul VkWDlkbM batSD'ku izfr iSd 23.37 2137(अ) 26.06.2019 ¼5 fefy-½ 806 FkkyhMksekbM dSIlwy 100 fexzk- 1 dSIlwy 60.92 1485(अ) 29.03.2019 807 FkkyhMksekbM dSIlwy 50 fexzk- 1 dSIlwy 35.19 1485(अ) 29.03.2019 808 Fkh;kekbu batSD'ku 100 fexzk-@fefy- 1 fefy- 24.73 1485(अ) 29.03.2019 809 Fkh;kekbu xksyh 100 fexzk- 1 xksyh 3.74 1485(अ) 29.03.2019 810 Fkhvksius VkWu batSD'ku ds fy, ikmMj 0-5 izfr iSd 40.61 1485(अ) 29.03.2019 xkze 811 Fkhvksius VkWu batSD'ku ds fy, ikmMj 1 izfr iSd 49.28 1485(अ) 29.03.2019 xkze 812 fVeksyksy MªksIl 0-25% 1 fefy- 5.15 1485(अ) 29.03.2019 813 fVeksyksy MªksIl 0-5% 1 fefy- 11.89 1485(अ) 29.03.2019 814 fVvksVªksfi;e bugys s'ku ¼MhihvkbZ½ 18 1 Mkst 2.40 4061(अ) 08.11.2019 ,elhth@Mkst 815 fVvksVªksfi;e bugys s'ku ¼,eMhvkbZ½ 9 1 Mkst 9.26 1485(अ) 29.03.2019 ,elhth@Mkst 816 VªkekMksy dSIlwy 50 fexzk- 1 dSIlwy 4.50 1485(अ) 29.03.2019 817 VªkekMksy batSD'ku 50 fexkz-@fefy- 1 fefy- 1.24 1485(अ) 29.03.2019 ¼20 fefy- iSd½ 818 VªkekMksy batSD'ku 50 fexkz-@fefy- 1 fefy- 10.44 1485(अ) 29.03.2019 ¼2 fefy- iSd rd½ 819 VªkekMksy xksyh 100 fexkz- 1 xksyh 19.61 1485(अ) 29.03.2019 820 VªkekMksy xksyh 50 fexkz- 1 xksyh 8.04 1485(अ) 29.03.2019 821 VªkekMksy dSIlwy 100 fexzk- 1 dSIlwy 9.57 1485(अ) 29.03.2019 822 VªkusDlkfed ,flM batSD'ku 100 fexzk-@fefy- 1 fefy- 14.90 1485(अ) 29.03.2019 823 VªkusDlkfed ,flM xksyh 500 fexzk- 1 xksyh 17.32 1485(अ) 29.03.2019 824 VªkLVtq qec batSD'ku 440 fexzk-@50 fefy- izfr iSd 59976.96 1485(अ) 29.03.2019 825 VªhgsDlhQsuhMhy xksyh 2 fexzk- 1 xksyh 1.21 1485(अ) 29.03.2019 826 VªksfidkekbM vkbZ Mªksi 1% 1 fefy- 10.03 1485(अ) 29.03.2019 827 osudksekblhu batSD'ku ds fy, ikmMj 1 izfr iSd 474.52 1485(अ) 29.03.2019 xkze 828 osudksekblhu batSD'ku ds fy, ikmMj 250 izfr iSd 221.09 1485(अ) 29.03.2019 fexkz- 829 osudksekblhu batSD'ku ds fy, ikmMj 500 izfr iSd 285.41 1485(अ) 29.03.2019 fexkz- 830 osdqjksfu;e batSD'ku ds fy, ikmMj 10 izfr iSd 188.52 1485(अ) 29.03.2019 fexkz- 831 osdqjksfu;e batSD'ku ds fy, ikmMj 4 izfr iSd 90.98 1485(अ) 29.03.2019 fexkz-[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 25 832 osjkikfey batSD'ku 2-5 fexzk-@fefy- 1 fefy- 1.16 1485(अ) 29.03.2019 833 osjkikfey xksyh 40 fexkz- 1 xksyh 0.74 1485(अ) 29.03.2019 834 osjkikfey xksyh 80 fexkz- 1 xksyh 1.39 1485(अ) 29.03.2019 835 fouOykLVhu batSD'ku 1 fexzk-@fefy- 1 fefy- 20.46 1485(अ) 29.03.2019 836 fouØhLVhu batSD'ku 1 fexzk-@fefy- 1 fefy- 51.96 1485(अ) 29.03.2019 837 foVkfeu , dSIlwy 50000 vkbZ;w 1 dSIlwy 0.55 1485(अ) 29.03.2019 838 foVkfeu , batSD'ku 50000 vkbZ;w@fefy- 1 fefy- 1.91 1485(अ) 29.03.2019 839 foVkfeu , xksyh 50000 vkbZ;w 1 xksyh 0.70 1485(अ) 29.03.2019 840 okjQfju xksyh 1 fexzk- 1 xksyh 2.41 1485(अ) 29.03.2019 841 okjQfju xksyh 2 fexzk- 1 xksyh 2.66 1485(अ) 29.03.2019 842 okjQfju xksyh 3 fexzk- 1 xksyh 3.11 1485(अ) 29.03.2019 843 okjQfju xksyh 5 fexzk- 1 xksyh 2.35 1485(अ) 29.03.2019 844 okVj QkWj batSD'ku batSD'ku izfr iSd 2.32 1485(अ) 29.03.2019 ¼10 fefy-½ 845 okVj QkWj batSD'ku batSD'ku izfr iSd 2.24 1485(अ) 29.03.2019 ¼5 fefy-½ 846 okbV iSVªksfy;e tsyh 100% 1 xkze 0.09 1485(अ) 29.03.2019 847 ,DlhyksesVktksykbu uts y MªksIl 0-05% 1 fefy- 3.92 1485(अ) 29.03.2019 848 ,DlhyksesVktksykbu uts y MªksIl 0-1% 1 fefy- 5.19 1485(अ) 29.03.2019 849 ftMksoMq kbu dSIlwy 300 fexzk- 1 dSIlwy 2.06 1485(अ) 29.03.2019 850 ftMksoMq kbu xksyh 300 fexzk- 1 xksyh 14.21 1485(अ) 29.03.2019 851 ftMksoMq kbu ¼,½ $ xksyh 300 fexzk- ¼,½ $ 150 1 xksyh 20.09 1485(अ) 29.03.2019 ykfeoqMkbu ¼ch½ $ fexkz- ¼ch½ $ 200 fexzk- ¼lh½ ufsojkikbu ¼lh½ 852 ftad lYQsV fMLiszflcy xksyh 20 fexzk- 1 xksyh 3.13 1485(अ) 29.03.2019 853 tksysMªksfud ,flM batSD'ku ds fy, ikmMj 4 izfr iSd 4188.87 1485(अ) 29.03.2019 fexkz- 854 tksyfiMse dSIlwy 5 fexzk- 1 dSIlwy 7.33 1485(अ) 29.03.2019 855 tksyfiMse xksyh 10 fexkz- 1 xksyh 8.42 1485(अ) 29.03.2019 856 tksyfiMse xksyh 5 fexzk- 1 xksyh 5.37 1485(अ) 29.03.2019 uksV%- ¼d½ vf/kdre ewY; fnukad 01-04-2020 ls ykxw gSa ¼vf/kdre eYw ;ks a eas 2018 dh vis{kk o"kZ 2019 ds fy, 1-88468 izfr“kr dh Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ dh nj “kkfey gSa½A ¼[k½ fofufeZfr;ks a ftudk vf/kdre eYw ; izfr iSd ds vk/kkj ij fu/kkZfjr fd;k x;k gS] muds fdlh vU; iSd vkdkj ds fy, fofuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkns“k] 2013 ds iSjkxzkQ 11¼3½ ds varxZr bldh fofufeZfr;ks a ds fy, fo'ks"k eYw ; vuqeksnukFkZ ,uihih, ls laidZ djsxkA lksfM;e oSyijks,V dh fofufeZfr es a lksfM;e oSyijks,V vkSj osyizksbd ,flM nksuks a dk lfEeJ.k gS tks dfFkr izcyrk ds lksfM;e oSyijks,V ds vuq:i gSA ¼x½ fdlh vU; vuqlwfpr fofufeZfr ds ckj s eas ftlds fy, vf/kdre eYw ; Åij of.kZr ugha fd;k gS] fofuekZrk viuh fofufeZfr;ks a ds fy, fo'ks"k eYw ; ds vuqeksnukFkZ laxr lwpuk lfgr ,uihih, ls laidZ djsxkA ¼?k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼oLrq ,oa lsok dj] tk s ykxw gk½sa ls vf/kd dher ij vulq wfpr fofufeZfr;ks a ds czkaMsM ;k tsufsjd ;k nksuksa :ikarjks a dks csp jgs vuqlwfpr fofufeZfr;ks a ds lHkh fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher ¼oLrq ,oa lsok dj] tks ykxw gk]sa ;fn dksbZ gS½ ls vf/kd lHkh ,slh fofufeZfr;ks a dh dher dk v/kkseq[kh iqujh{k.k djsxa sA ¼M+½ lHkh ekStwnk fuekZrkvks a dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ks a ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 13¼2½ ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o"kZ26 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 2019 ds fy, 1-88468 izfr“kr dh nj ls Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ks a dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la“kksf/kr dj ldr s gSa ¼p½ vxj fuekZrkvks a u s mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher ij ljdkj dks okLro eas Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dk s tksM+ ldr s gSA ¼N½ vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 11 eas fn, x, izko/kkuks a ds rgr lEcfU/kr fuekZrkvks a dks mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ks a ds iSdkas ds fy, vf/kdre dher fu/kkZfjr djsAa fuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkns“k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V es a vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d eYw ; lwph tkjh djas rFkk mldh dkWih jkT; vkS”kf/k fu;a=dks a vkSj fofuekZrk forjd dks tkjh djasA ¼t½ vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds 24 ¼4½ ds mica/kks a ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i eas ,sl s ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke“kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`“; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf“kZr djsxkA ¼>½ mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vulq wfpr fofufeZfr;ks a ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igy s vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds rgr lwph II es a fofufnZ"V QkeZ I ds ek/;e ls ,uihih, es a eYw ; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼.k½ mi;qZDr vulq wfpr fofufeZfr;ks a dh mRiknu@vk;kr vkSj fcØh ds lEcU/k eas fuekZrkvks a dks vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds lwph II ds QkWeZ III dk s vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ks a ds fuekZ.k dks dkbs Z fuekZrk mRiknu cUn dju s dk bPNqd gks rks bldh lwpuk ,uihih, dk s voxr djk;sxkA blds lEcU/k eas vxj vuqlwfpr fofufeZfr;ks a ds mRiknu vkSj vk;kr dks cUn dju s dk bPNqd gS rks cUn dju s dh frfFk ls N% eghus igy s lwph II ds QkWeZ IV es a Hkjdj ,uihih, dks izLrqr djsxkA ¼V½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh es a n“kkZ;s vf/kdre ewY; vkSj “krks± dk ikyu ugha djrh gSa rks os vko“;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuks a ds v/khu C;kt lfgr vf/kizHkkfjr jkf“k dks tek djus ds fy, nk;h gksxa sA ¼B½ bl vkns“k eas mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V eas fofufnZ"V ,slh fofufeZfr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre vkSj [kqnjk eYw ; fu/kkZfjr vkns“k ;fn dksbZ gks] tks bl vkns“k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk;sxa sA [dk-al-a@206@74@2020@,Q@Qk- la- 8¼74½@2020@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs“kd MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 25 March, 2020 S. O. 1213(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column No. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of goods and services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 27 TABLE Price Revision as per Annual Wholesale Price Index (WPI) @ 1.88468% increase. Sl Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2020 with WPI @ 1.88468%) (1) (2) (3) (4) (5) 6(a) 6(b) 1. 5-aminosalicylic Acid Suppository 500 1 Suppository 16.86 1485(E) 29.03.2019 mg Retention Enema 2. 5-aminosalicylic Acid Tablet 400 mg 1 Tablet 7.45 1485(E) 29.03.2019 3. 5-Fluorouracil Injection 250 1 ml 2.33 1485(E) 29.03.2019 mg/5 ml 4. 6-Mercaptopurine Tablet 50mg 1 Tablet 6.44 1485(E) 29.03.2019 5. Abacavir Tablet 300 mg 1 Tablet 47.02 1485(E) 29.03.2019 6. Abacavir (A) + Lamivudine Tablet 60 mg(A) + 1 Tablet 20.02 1485(E) 29.03.2019 (B) 30 mg(B) 7. Abacavir (A) + Lamivudine Tablet 600 1 Tablet 90.86 1485(E) 29.03.2019 (B) mg(A)+ 300 mg(B) 8. Acetazolamide Capsule 250 mg 1 Capsule 4.51 1485(E) 29.03.2019 9. Acetazolamide Tablet 250 mg 1 Tablet 3.65 1485(E) 29.03.2019 10. Acetylsalicylic acid Effervescent/ 1 Tablet 0.18 1485(E) 29.03.2019 Dispersible/ Enteric coated Tablet 100 mg 11. Acetylsalicylic acid Effervescent/ 1 Tablet 1.20 1485(E) 29.03.2019 Dispersible/ Enteric coated Tablet 150 mg 12. Acetylsalicylic acid Effervescent/ 1 Tablet 1.22 1485(E) 29.03.2019 Dispersible/ Enteric coated Tablet 75 mg 13. Acetylsalicylic acid Tablet 100 mg 1 Tablet 0.17 1485(E) 29.03.2019 14. Acetylsalicylic acid Tablet 150 mg 1 Tablet 0.41 1485(E) 29.03.2019 15. Acetylsalicylic acid Tablet 325mg 1 Tablet 0.55 1485(E) 29.03.2019 16. Acetylsalicylic acid Tablet 350mg 1 Tablet 0.31 1485(E) 29.03.2019 17. Acetylsalicylic acid Tablet 75 mg 1 Tablet 0.31 1485(E) 29.03.2019 18. Actinomycin D Powder for Each Pack 316.20 1485(E) 29.03.2019 Injection 0.5mg 19. Acyclovir Ointment 3% 1 gm 10.38 1485(E) 29.03.2019 20. Acyclovir Oral Liquid 400 1 ml 1.26 1485(E) 29.03.2019 mg/5ml 21. Acyclovir Tablet 200 mg 1 Tablet 6.75 1485(E) 29.03.2019 22. Acyclovir Tablet 400 mg 1 Tablet 12.27 1485(E) 29.03.2019 23. Acyclovir Powder for Each Pack 354.27 1485(E) 29.03.2019 Injection 250 mg 24. Acyclovir Powder for Each Pack 457.58 1485(E) 29.03.2019 Injection 500 mg 25. Adenosine Injection 3mg/ml 1 ml 98.17 1485(E) 29.03.2019 26. Adrenaline Injection 1 mg/ml 1 ml 15.61 1485(E) 29.03.2019 27. Albendazole Oral Liquid 200 1 ml 1.59 1485(E) 29.03.2019 mg/5ml 28. Albendazole Tablet 400 mg 1 Tablet 7.68 1485(E) 29.03.2019 29. Allopurinol Tablet 100 mg 1 Tablet 1.90 1485(E) 29.03.2019 30. Allopurinol Tablet 300 mg 1 Tablet 7.46 1485(E) 29.03.2019 31. All-trans Retinoic Acid Capsule 10 mg 1 Capsule 81.56 958(E) 03.03.202028 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 32. Alprostadil Injection 0.5 1 ml 5646.64 1485(E) 29.03.2019 mg/ml 33. Alteplase Powder for Each Pack 18938.45 1485(E) 29.03.2019 Injection 20 mg 34. Alteplase Powder for Each Pack 39541.63 1485(E) 29.03.2019 Injection 50 mg 35. Amiodarone Injection 50 1 ml 22.24 1485(E) 29.03.2019 mg/ml 36. Amiodarone Tablet 100 mg 1 Tablet 5.70 1485(E) 29.03.2019 37. Amiodarone Tablet 200 mg 1 Tablet 11.29 1485(E) 29.03.2019 38. Amitriptyline Tablet 10 mg 1 Tablet 2.28 1485(E) 29.03.2019 39. Amitriptyline Tablet 25 mg 1 Tablet 2.25 1485(E) 29.03.2019 40. Amitriptyline Tablet 50 mg 1 Tablet 5.79 1485(E) 29.03.2019 41. Amitriptyline Tablet 75 mg 1 Tablet 5.59 1485(E) 29.03.2019 42. Amlodipine Tablet 10 mg 1 Tablet 5.05 1485(E) 29.03.2019 43. Amlodipine Tablet 2.5 mg 1 Tablet 1.65 1485(E) 29.03.2019 44. Amlodipine Tablet 5mg 1 Tablet 2.60 1485(E) 29.03.2019 45. Amoxicillin Capsule 250 mg 1 Capsule 2.20 1485(E) 29.03.2019 46. Amoxicillin Oral Liquid 250 1 ml 1.34 1485(E) 29.03.2019 mg/5ml 47. Amoxicillin Capsule 500mg 1 Capsule 6.44 1485(E) 29.03.2019 48. Amoxicillin (A) + Dry Syrup 125 1 ml 2.16 1485(E) 29.03.2019 Clavulanic acid (B) mg(A) + 31.25 (B)/5 ml 49. Amoxicillin (A) + Oral Liquid 200 1 ml 1.8 1485(E) 29.03.2019 Clavulanic acid (B) mg(A) + 28.5 mg(B)/5ml 50. Amoxicillin (A) + Powder for Each Pack 89.76 1485(E) 29.03.2019 Clavulanic acid (B) Injection 500 mg(A) + 100 mg(B) 51. Amoxicillin (A) Tablet 500mg(A) 1 Tablet 17.91 1485(E) 29.03.2019 +Clavulanic acid (B) +125mg(B) 52. Amoxicillin (A) Powder for Each Pack 125.22 1485(E) 29.03.2019 +Clavulanic acid (B) Injection 1g (A) +200mg(B) 53. Amphotericin B (Lipid) Powder for 3195.93 2943(E) 14.08.2019 Each Pack Injection 50 mg 54. Amphotericin B Powder for 7444.31 2943(E) 14.08.2019 Each Pack (Liposomal) Injection 50 mg 55. Amphotericin B – Powder for Each Pack 308.82 1485(E) 29.03.2019 Conventional Injection 50 mg 56. Ampicillin Powder for Each Pack 21.28 1485(E) 29.03.2019 Injection 1 gm 57. Ampicillin Powder for Each Pack 13.11 1485(E) 29.03.2019 Injection 500 mg 58. Anti-D immunoglobulin Injection 300mcg Each Pack 2128.25 1485(E) 29.03.2019 59. Anti-D Immunoglobulin Injection 150mcg Each Vial 1658.90 1485(E) 29.03.2019 60. Anti-rabies immunoglobulin Injection 150 1 ml 2766.21 1485(E) 29.03.2019 IU/ml 61. Anti-rabies immunoglobulin Injection 300 1 ml 97.52 1485(E) 29.03.2019 IU/ml 62. Anti-tetanus 250IU Each Pack 1108.05 1485(E) 29.03.2019 immunoglobulin 63. Arsenic Trioxide Injection 1mg/ml 1 ml 54.14 1485(E) 29.03.2019 64. Artemether (A) + Oral Liquid 80 1 ml 4.02 1485(E) 29.03.2019 Lumefantrine (B) mg(A) +480 mg(B) /5ml 65. Artemether (A) + Tablet 20 mg(A) + 1 Tablet 12.48 1485(E) 29.03.2019 Lumefantrine (B) 120 mg(B)[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 29 66. Artemether (A) + Tablet 40 mg(A) + 1 Tablet 16.09 1485(E) 29.03.2019 Lumefantrine (B) 240 mg(B) 67. Artemether (A) + Tablet 80 mg(A) + 1 Tablet 23.10 1485(E) 29.03.2019 Lumefantrine (B) 480 mg(B) 68. Artesunate Powder for Each Pack 414.90 1485(E) 29.03.2019 Injection 120 mg 69. Artesunate Powder for Each Pack 217.93 1485(E) 29.03.2019 Injection 60 mg 70. Artesunate (A) + Tablet 100 mg(A) Combi pack 29.41 1485(E) 29.03.2019 Sulphadoxine - + 1 Tablet (750 Pyrimethamine (B) mg+ 37.5 mg) (B) 71. Artesunate (A) + Tablet 150 mg(A) Combi pack 39.93 1485(E) 29.03.2019 Sulphadoxine - + 2 Tablet (500 Pyrimethamine (B) mg+ 25 mg) (B) 72. Artesunate (A) + Tablet 200 mg(A) Combi pack 36.40 1485(E) 29.03.2019 Sulphadoxine - + 2 Tablet (750 Pyrimethamine (B) mg+ 37.5 mg) (B) 73. Artesunate (A) + Tablet 25 mg(A) + Combi pack 19.6 1485(E) 29.03.2019 Sulphadoxine - 1 Tablet (250 mg+ Pyrimethamine (B) 12.5 mg) (B) 74. Artesunate (A) + 1 Tablet 50 Combi Pack 21.16 1485(E) 29.03.2019 Sulphadoxine - mg(A) + 1 Tablet Pyrimethamine (B) (500 mg+ 25 mg) (B) 75. Ascorbic Acid (Vitamin C) Tablet 100mg 1 Tablet 0.19 1485(E) 29.03.2019 76. Ascorbic Acid (Vitamin C) Tablet 500 mg 1 Tablet 1.37 4461(E) 13.12.2019 77. Atazanavir (A) + Ritonavir Tablet 300 mg(A) 1 Tablet 98.43 1485(E) 29.03.2019 (B) + 100 mg(B) 78. Atenolol Tablet 100 mg 1 Tablet 3.47 1485(E) 29.03.2019 79. Atenolol Tablet 50 mg 1 Tablet 1.78 1485(E) 29.03.2019 80. Atorvastatin Tablet 10 mg 1 Tablet 5.47 1485(E) 29.03.2019 81. Atorvastatin Tablet 20 mg 1 Tablet 13.25 1485(E) 29.03.2019 82. Atorvastatin Tablet 40 mg 1 Tablet 19.24 1485(E) 29.03.2019 83. Atracurium Injection 10 Each Pack 52.27 1485(E) 29.03.2019 mg/ml 84. Atropine Ointment 1% 1 gm 3.77 1485(E) 29.03.2019 85. Atropine Injection 0.6 1 ml 4.18 1485(E) 29.03.2019 mg/ml 86. Atropine Drops 1% 1 ml 3.42 1485(E) 29.03.2019 87. Azathioprine Tablet 50 mg 1 Tablet 10.12 1485(E) 29.03.2019 88. Azithromycin Capsule 250 mg 1 Capsule 10.47 1485(E) 29.03.2019 89. Azithromycin Capsule 500 mg 1 Capsule 16.53 1485(E) 29.03.2019 90. Azithromycin Oral Liquid 200 1 ml 3.07 1485(E) 29.03.2019 mg/5ml 91. Azithromycin Tablet 250mg 1 Tablet 10.52 1485(E) 29.03.2019 92. Azithromycin Tablet 500mg 1 Tablet 21.23 1485(E) 29.03.2019 93. Azithromycin Powder for Each Pack 191.70 1485(E) 29.03.2019 Injection 500mg 94. Baclofen Tablet 10 mg 1 Tablet 10.72 1485(E) 29.03.2019 95. Baclofen Tablet 20 mg 1 Tablet 14.75 1485(E) 29.03.2019 96. Baclofen Tablet 5 mg 1 Tablet 5.52 1485(E) 29.03.2019 97. BCG vaccine Each Dose 8.91 4461(E) 13.12.2019 98. Benzathine benzylpenicillin Powder for Each Pack 18.18 4461(E) 13.12.2019 Injection 12 lac units 99. Benzathine benzylpenicillin Powder for Each Pack 12.03 4461(E) 13.12.2019 Injection 6 lac units 100. Benzoyl Peroxide Cream 2.5% 1 gm 2.33 1485(E) 29.03.2019 101. Benzoyl Peroxide Gel 2.5% 1 gm 3.74 1485(E) 29.03.201930 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 102. Benzyl penicillin Powder for Each Pack 7.78 4461(E) 13.12.2019 Injection 10 Lac Units 103. Betamethasone Cream 0.05% 1 gm 0.58 1485(E) 29.03.2019 104. Betamethasone Cream 0.1% 1 gm 0.84 1485(E) 29.03.2019 105. Betamethasone Gel 0.05% 1 gm 0.53 1485(E) 29.03.2019 106. Betamethasone Lotion 0.1% 1 ml 0.82 1485(E) 29.03.2019 107. Betamethasone Lotion 0.5% 1 ml 0.53 1485(E) 29.03.2019 108. Betamethasone Injection 4 mg/ml 1 ml 4.19 1485(E) 29.03.2019 109. Bicalutamide Tablet 50 mg 1 Tablet 68.41 1485(E) 29.03.2019 110. Bisacodyl Suppository 5 mg 1 Suppository 8.41 1485(E) 29.03.2019 111. Bisacodyl Tablet 5 mg 1 Tablet 1.00 1485(E) 29.03.2019 112. Bleomycin Powder for Each Pack 618.94 1485(E) 29.03.2019 Injection 15 Units 113. Bortezomib Powder for Each Pack 12263.10 1485(E) 29.03.2019 Injection 2 mg 114. Budesonide Nasal Spray 100 1 Dose 0.91 1485(E) 29.03.2019 mcg/dose 115. Budesonide Nasal Spray 50 1 Dose 1.01 1485(E) 29.03.2019 mcg/dose 116. Budesonide Respiratory 1 ml 10.68 1485(E) 29.03.2019 Solution for use in Nebulizer 0.5 mg/ml 117. Budesonide Respiratory 1 ml 12.88 1485(E) 29.03.2019 Solution for use in Nebulizer 1 mg/ml 118. Budesonide Inhalation (MDI) Per Metered 1.26 1485(E) 29.03.2019 100 mcg/dose Dose 119. Budesonide Inhalation (MDI) Per metered 1.57 1485(E) 29.03.2019 200 mcg/dose Dose 120. Budesonide Inhalation (DPI) Per Dose 1.99 1485(E) 29.03.2019 100 mcg/dose 121. Budesonide Inhalation (DPI) Per Dose 2.88 1485(E) 29.03.2019 200 mcg/dose 122. Budesonide (A)+ Inhalation (MDI) Per Metered 1.88 1485(E) 29.03.2019 Formoterol (B) 100 mcg (A) + 6 Dose mcg (B) 123. Budesonide (A)+ Inhalation (MDI) Per Metered 2.67 1485(E) 29.03.2019 Formoterol (B) 200 mcg (A) + 6 Dose mcg (B) 124. Budesonide (A)+ Inhalation (MDI) Per Metered 3.04 1485(E) 29.03.2019 Formoterol (B) 400 mcg (A) + 6 Dose mcg (B) 125. Budesonide (A)+ Inhalation (DPI) Per Dose 3.78 1485(E) 29.03.2019 Formoterol (B) 100 mcg (A) + 6 mcg (B) 126. Budesonide (A)+ Inhalation (DPI) Per Dose 5.02 1485(E) 29.03.2019 Formoterol (B) 200 mcg (A) + 6 mcg (B) 127. Budesonide (A)+ Inhalation (DPI) Per Dose 6.42 1485(E) 29.03.2019 Formoterol (B) 400 mcg (A) + 6 mcg (B) 128. Bupivacaine Injection 0.25% 1 ml 2.45 1485(E) 29.03.2019 129. Bupivacaine Injection 0.5% 1 ml 6.19 1485(E) 29.03.2019 with 7.5% glucose 130. Bupivacaine Injection 0.50% 1 ml 3.91 1485(E) 29.03.2019 131. Caffeine Injection 20 1 ml 250.27 1485(E) 29.03.2019 mg/ml[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 31 132. Caffeine Oral Liquid 20 1 ml 212.56 1485(E) 29.03.2019 mg/ml 133. Calamine Lotion (As per IP) 1 ml 0.85 1485(E) 29.03.2019 134. Calcium Carbonate Tablet 500mg 1 Tablet 1.72 959(E) 03.03.2020 135. Calcium folinate Tablet 15 mg 1 Tablet 40.67 1485(E) 29.03.2019 136. Calcium gluconate Injection 100 1 ml 0.55 1485(E) 29.03.2019 mg/ml 137. Capecitabine Tablet 500 mg 1 Tablet 126.01 1485(E) 29.03.2019 138. Capreomycin Powder for Each Pack 345.37 1485(E) 29.03.2019 Injection 1 gm 139. Carbamazepine Oral Liquid 100 1 ml 0.19 1485(E) 29.03.2019 mg/5ml 140. Carbamazepine CR Tablet 200 mg 1 Tablet 1.55 1485(E) 29.03.2019 141. Carbamazepine CR Tablet 400 mg 1 Tablet 3.05 1485(E) 29.03.2019 142. Carbamazepine Tablet 100 mg 1 Tablet 0.68 1485(E) 29.03.2019 143. Carbamazepine Tablet 200 mg 1 Tablet 1.39 1485(E) 29.03.2019 144. Carbamazepine Tablet 400 mg 1 Tablet 3.29 1485(E) 29.03.2019 145. Carbimazole Tablet 10 mg 1 Tablet 3.69 1485(E) 29.03.2019 146. Carbimazole Tablet 5 mg 1 Tablet 1.90 1485(E) 29.03.2019 147. Carboplatin Injection 10 1 ml 53.06 1485(E) 29.03.2019 mg/ml 148. Carboxymethylcellulose Drops 0.5% 1 ml 12.74 1485(E) 29.03.2019 149. Carboxymethylcellulose Drops 1% 1 ml 17.66 1485(E) 29.03.2019 150. Cefadroxil Capsule 500 mg 1 Capsule 7.13 1485(E) 29.03.2019 151. Cefadroxil Oral Liquid 125 1 ml 0.63 1485(E) 29.03.2019 mg/5ml 152. Cefadroxil Tablet 1 gm 1 Tablet 6.27 1485(E) 29.03.2019 153. Cefadroxil Tablet 500 mg 1 Tablet 4.02 1485(E) 29.03.2019 154. Cefazolin Powder for Each Pack 24.48 1485(E) 29.03.2019 Injection 1 gm 155. Cefazolin Powder for Each Pack 15.52 1485(E) 29.03.2019 Injection 500 mg 156. Cefixime Capsule 200 mg 1 Capsule 14.39 1485(E) 29.03.2019 157. Cefixime Capsule 400 mg 1 Capsule 29.15 1485(E) 29.03.2019 158. Cefixime Oral Liquid 100 1 ml 2.15 1485(E) 29.03.2019 mg/5ml 159. Cefixime Oral Liquid 50 1 ml 1.45 1485(E) 29.03.2019 mg/5ml 160. Cefixime Tablet 400 mg 1 Tablet 22.00 1485(E) 29.03.2019 161. Cefixime Tablet 200mg 1 Tablet 9.57 1485(E) 29.03.2019 162. Cefotaxime Powder for Each Pack 34.22 1485(E) 29.03.2019 Injection 1 gm 163. Cefotaxime Powder for Each Pack 15.56 1485(E) 29.03.2019 Injection 250 mg 164. Cefotaxime Powder for Each Pack 20.46 1485(E) 29.03.2019 Injection 500 mg 165. Ceftazidime Powder for Each Pack 208.68 1485(E) 29.03.2019 Injection 1 gm 166. Ceftazidime Powder for Each Pack 64.90 1485(E) 29.03.2019 Injection 250 mg 167. Ceftriaxone Powder for Each Pack 53.75 1485(E) 29.03.2019 Injection 1gm 168. Ceftriaxone Powder for Each Pack 127.77 1485(E) 29.03.2019 Injection 2 gm 169. Ceftriaxone Powder for Each Pack 24.61 1485(E) 29.03.2019 Injection 250 mg 170. Ceftriaxone Powder for Each Pack 44.95 1485(E) 29.03.2019 Injection 500 mg 171. Cetirizine Capsule 10 mg 1 Capsule 2.37 1485(E) 29.03.201932 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 172. Cetirizine Oral Liquid 5 1 ml 0.59 1485(E) 29.03.2019 mg/5ml 173. Cetirizine Tablet 10 mg 1 Tablet 1.65 1485(E) 29.03.2019 174. Cetrimide Solution 20% 1 ml 0.32 1485(E) 29.03.2019 (concentrate for dilution) 175. Chlorambucil Tablet 2 mg 1 Tablet 36.80 1485(E) 29.03.2019 176. Chlorambucil Tablet 5 mg 1 Tablet 82.70 1485(E) 29.03.2019 177. Chlorhexidine Solution 5% 1 ml 0.15 1485(E) 29.03.2019 (Concentrate for dilution) 178. Chloroquine Oral Liquid 50 1 ml 0.30 1485(E) 29.03.2019 mg/5ml 179. Chloroquine Tablet 150mg 1 Tablet 1.18 4461(E) 13.12.2019 180. Chlorpheniramine Tablet 4 mg 1 Tablet 0.09 1485(E) 29.03.2019 181. Cholecalciferol Capsule 1000 IU 1 Capsule 4.76 1485(E) 29.03.2019 182. Cholecalciferol Capsule 60000 IU 1 Capsule 29.44 1485(E) 29.03.2019 183. Cholecalciferol Oral Liquid 400 1 ml 2.34 1485(E) 29.03.2019 IU/ml 184. Cholecalciferol Tablet 1000 IU 1 Tablet 3.74 1485(E) 29.03.2019 185. Cholecalciferol Tablet 60000 IU 1 Tablet 24.18 1485(E) 29.03.2019 186. Ciprofloxacin Ointment 0.3% 1 gm 1.13 1485(E) 29.03.2019 187. Ciprofloxacin Drops 0.30% 1 ml 1.52 1485(E) 29.03.2019 188. Ciprofloxacin Injection 200 1 ml 0.17 1485(E) 29.03.2019 mg/100ml 189. Ciprofloxacin Oral Liquid 250 1 ml 0.63 1485(E) 29.03.2019 mg/5ml 190. Ciprofloxacin Tablet 250mg 1 Tablet 2.07 1485(E) 29.03.2019 191. Ciprofloxacin Tablet 500mg 1 Tablet 3.64 1485(E) 29.03.2019 192. Cisplatin Injection 1 mg/ml 1 ml 6.87 1485(E) 29.03.2019 193. Clarithromycin Oral Liquid 125 1 ml 4.30 1485(E) 29.03.2019 mg/5ml 194. Clarithromycin Tablet 250 mg 1 Tablet 27.92 1485(E) 29.03.2019 195. Clarithromycin Tablet 500 mg 1 Tablet 49.21 1485(E) 29.03.2019 196. Clindamycin Capsule 150 mg 1 Capsule 14.43 1485(E) 29.03.2019 197. Clindamycin Capsule 300 mg 1 Capsule 23.56 1485(E) 29.03.2019 198. Clindamycin Tablet 300 mg 1 Tablet 15.20 1485(E) 29.03.2019 199. Clobazam Tablet 10 mg 1 Tablet 9.01 1485(E) 29.03.2019 200. Clobazam Tablet 5 mg 1 Tablet 5.12 1485(E) 29.03.2019 201. Clofaziminea Capsule 100 mg 1 Capsule 3.70 4461(E) 13.12.2019 202. Clofazimine Capsule 50 mg 1 Capsule 2.17 4461(E) 13.12.2019 203. Clomiphene Capsule 100 mg 1 Capsule 55.50 1485(E) 29.03.2019 204. Clomiphene Capsule 50 mg 1 Capsule 30.53 1485(E) 29.03.2019 205. Clomiphene Tablet 100mg 1 Tablet 12.18 1485(E) 29.03.2019 206. Clomiphene Tablet 50mg 1 Tablet 8.30 1485(E) 29.03.2019 207. Clomipramine Tablet 10 mg 1 Tablet 2.51 1485(E) 29.03.2019 208. Clomipramine Tablet 25 mg 1 Tablet 5.53 1485(E) 29.03.2019 209. Clomipramine Tablet 75 mg 1 Tablet 14.30 1485(E) 29.03.2019 210. Clonazepam Tablet 0.25 mg 1 Tablet 1.82 1485(E) 29.03.2019 211. Clonazepam Tablet 0.5 mg 1 Tablet 3.10 1485(E) 29.03.2019 212. Clonazepam Tablet 1 mg 1 Tablet 4.22 1485(E) 29.03.2019 213. Clopidogrel Tablet 75 mg 1 Tablet 6.93 1485(E) 29.03.2019 214. Clotrimazole Cream 1% 1 gm 2.90 1485(E) 29.03.2019 215. Clotrimazole Drops 1% 1 ml 3.02 1485(E) 29.03.2019 216. Clotrimazole Lotion 1% 1 ml 3.57 1485(E) 29.03.2019 217. Clotrimazole Pessary 100 mg 1 Pessary 8.66 1485(E) 29.03.2019 218. Cloxacillin Capsule 250mg 1 Capsule 1.13 1485(E) 29.03.2019 219. Cloxacillin Capsule 500mg 1 Capsule 1.90 1485(E) 29.03.2019 220. Cloxacillin Tablet 250mg 1 Tablet 1.72 1485(E) 29.03.2019[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 33 221. Cloxacillin Powder for Each Pack 4.43 1485(E) 29.03.2019 Injection250mg 222. Clozapine Tablet 100 mg 1 Tablet 7.72 1485(E) 29.03.2019 223. Clozapine Tablet 25 mg 1 Tablet 2.51 1485(E) 29.03.2019 224. Clozapine Tablet 50 mg 1 Tablet 4.79 1485(E) 29.03.2019 225. Coagulation factor IX Powder for Each Pack 12284.99 1485(E) 29.03.2019 Injection 600 IU 226. Coagulation factor VIII Powder for Each pack 3724.11 1485(E) 29.03.2019 Injection 250 IU 227. Coagulation factor VIII Powder for Each Pack 9138.70 1485(E) 29.03.2019 Injection 500 IU 228. Colchicine Tablet 0.5 mg 1 Tablet 3.10 1485(E) 29.03.2019 229. Co-trimoxazole Oral Liquid 200 1 ml 0.33 4461(E) 13.12.2019 (Sulphamethoxazole mg(A)+40 (A)+Trimethoprim (B)] mg(B)/5ml 230. Co-trimoxazole Tablet 400 1 Tablet 0.78 4461(E) 13.12.2019 (Sulphamethoxazole mg(A)+80 mg(B) (A)+Trimethoprim (B)] 231. Co-trimoxazole Tablet 800 1 Tablet 2.02 4461(E) 13.12.2019 (Sulphamethoxazole mg(A)+160 (A)+Trimethoprim (B)] mg(B) 232. Cyclophosphamide Tablet 50 mg 1 Tablet 4.04 1485(E) 29.03.2019 233. Cyclophosphamide Powder for Each Pack 79.58 1485(E) 29.03.2019 Injection 500 mg 234. Cycloserine Capsule 250 mg 1 Capsule 54.13 1485(E) 29.03.2019 235. Cycloserine Tablet 250 mg 1 Tablet 46.54 1485(E) 29.03.2019 236. Cyclosporine Capsule 100 mg 1 Capsule 102.20 1485(E) 29.03.2019 237. Cyclosporine Capsule 25 mg 1 Capsule 27.43 1485(E) 29.03.2019 238. Cyclosporine Capsule 50 mg 1 Capsule 52.49 1485(E) 29.03.2019 239. Cyclosporine Injection 50 1 ml 268.93 1485(E) 29.03.2019 mg/ml 240. Cyclosporine Oral Liquid 100 1 ml 94.24 1485(E) 29.03.2019 mg/ml 241. Cytosine arabinoside Injection 100 Each Pack 198.09 1485(E) 29.03.2019 mg/ml 242. Cytosine arabinoside Powder for Each Pack 1068.41 1485(E) 29.03.2019 Injection 1000 mg 243. Cytosine arabinoside Powder for Each Pack 510.65 1485(E) 29.03.2019 Injection 500 mg 244. Dacarbazine Powder for Each Pack 438.03 1485(E) 29.03.2019 Injection 200 mg 245. Dacarbazine Powder for Each Pack 988.15 1485(E) 29.03.2019 Injection 500 mg 246. Dapsone Tablet 100 mg 1 Tablet 0.36 4461(E) 13.12.2019 247. Darunavir Tablet 600 mg 1 Tablet 166.43 1485(E) 29.03.2019 248. Daunorubicin Powder for I.V. Each pack 242.47 959(E) 03.03.2020 Injection 20 mg (5 mg/ml) 249. Desferrioxamine Powder for Each pack 160.34 1485(E) 29.03.2019 Injection 500mg 250. Dexamethasone Tablet 0.5 mg 1 Tablet 0.19 1485(E) 29.03.2019 251. Dexamethasone Injection 4 mg/ml Each Pack 13.73 1485(E) 29.03.2019 (10 ml) 252. Dexamethasone Injection 4 mg/ml Each Pack (2 9.29 1485(E) 29.03.2019 ml) 253. Dexamethasone Injection 4 mg/ml Each Pack 26.32 1485(E) 29.03.2019 (20 ml) 254. Dexamethasone Injection 4 mg/ml Each Pack 35.17 1485(E) 29.03.2019 (30 ml) 255. Dextran-40 Injection 10% 1 ml 0.85 1485(E) 29.03.2019 256. Diazepam Injection 5 mg/ml 1 ml 6.04 1485(E) 29.03.201934 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 257. Diazepam Oral Liquid 2 1 ml 2.73 1485(E) 29.03.2019 mg/5ml 258. Diazepam Suppository 5 mg 1 Suppository 5.96 1485(E) 29.03.2019 259. Diazepam Tablet 2 mg 1 Tablet 1.50 1485(E) 29.03.2019 260. Diazepam Tablet 5 mg 1 Tablet 1.42 1485(E) 29.03.2019 261. Diclofenac Capsule 50 mg 1 Capsule 0.61 1485(E) 29.03.2019 262. Diclofenac Injection 25 1 ml 1.46 1485(E) 29.03.2019 mg/ml 263. Diclofenac Tablet 50 mg 1 Tablet 1.91 1485(E) 29.03.2019 264. Dicyclomine Injection 10 1 ml 2.05 1485(E) 29.03.2019 mg/ml (10ml & 30ml Pack) 265. Dicyclomine Injection 10 1 ml 3.18 1485(E) 29.03.2019 mg/ml (1ml & 2ml Pack) 266. Dicyclomine Oral Solution 1 ml 0.16 1485(E) 29.03.2019 10mg/5ml 267. Dicyclomine Tablet 10mg 1 Tablet 0.11 1485(E) 29.03.2019 268. Diethylcarbamazine Oral Liquid 120 1 ml 0.49 1485(E) 29.03.2019 mg/5ml 269. Diethylcarbamazine Tablet 100 mg 1 Tablet 1.41 1485(E) 29.03.2019 270. Diethylcarbamazine Tablet 50 mg 1 Tablet 0.56 1485(E) 29.03.2019 271. Digoxin Injection 0.25 1 ml 3.32 1485(E) 29.03.2019 mg/ml 272. Digoxin Oral liquid 0.05 1 ml 1.26 1485(E) 29.03.2019 mg/ml 273. Digoxin Tablet 0.25 mg 1 Tablet 1.19 1485(E) 29.03.2019 274. Diloxanide furoate Tablet 500mg 1 Tablet 1.05 1485(E) 29.03.2019 275. Diltiazem Capsule 90 mg 1 Capsule 9.58 1485(E) 29.03.2019 276. Diltiazem Injection 5 mg/ml 1 ml 3.15 1485(E) 29.03.2019 277. Diltiazem SR Tablet 90 mg 1 Tablet 9.30 1485(E) 29.03.2019 278. Diltiazem Tablet 30 mg 1 Tablet 2.39 1485(E) 29.03.2019 279. Diltiazem Tablet 60 mg 1 Tablet 4.87 1485(E) 29.03.2019 280. Dimercaprol Injection 50 1 ml 199.55 1485(E) 29.03.2019 mg/ml 281. Dinoprostone Gel 0.5 mg 1 gm 80.83 1485(E) 29.03.2019 282. Dinoprostone Tablet 0.5mg 1 Tablet 49.90 1485(E) 29.03.2019 283. Diphtheria antitoxin 10000 IU Each Pack 1306.76 1485(E) 29.03.2019 284. Dobutamine Injection 50 Each Pack 37.39 1485(E) 29.03.2019 mg/ml 285. Docetaxel Powder for Each Pack 2984.59 1485(E) 29.03.2019 Injection 20 mg 286. Docetaxel Powder for Each Pack 11347.62 1485(E) 29.03.2019 Injection 80 mg 287. Domperidone Oral Liquid 1 1 ml 1.07 1485(E) 29.03.2019 mg/ml 288. Domperidone Tablet 10 mg 1 Tablet 2.41 1485(E) 29.03.2019 289. Donepezil Tablet 10 mg 1 Tablet 16.00 1485(E) 29.03.2019 290. Donepezil Tablet 5 mg 1 Tablet 11.21 1485(E) 29.03.2019 291. Dopamine Injection 40 1 ml 5.63 1485(E) 29.03.2019 mg/ml 292. Doxorubicin Injection 2 mg/ml 1 ml 35.80 1485(E) 29.03.2019 293. Doxycycline Capsule 100 mg 1 Capsule 2.50 1485(E) 29.03.2019 294. Doxycycline Tablet 100 mg 1 Tablet 0.97 1485(E) 29.03.2019 295. DPT + Hib + Hep B vaccine Per 0.1 ml 80.08 1485(E) 29.03.2019 296. DPT vaccine Per 0.5 ml 14.12 1485(E) 29.03.2019 297. Efavirenz Capsule 200 mg 1 Capsule 24.00 1485(E) 29.03.2019 298. Efavirenz Capsule 600 mg 1 Capsule 62.54 1485(E) 29.03.2019 299. Efavirenz Tablet 200 mg 1 Tablet 22.61 1485(E) 29.03.2019 300. Efavirenz Tablet 600 mg 1 Tablet 70.81 1485(E) 29.03.2019[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 35 301. Enalapril Tablet 2.5 mg 1 Tablet 1.93 1485(E) 29.03.2019 302. Enalapril Tablet 5 mg 1 Tablet 3.20 1485(E) 29.03.2019 303. Enoxaparin Injection 40 0.1 ml 101.35 1485(E) 29.03.2019 mg/0.4ml 304. Enoxaparin Injection 60 0.1 ml 101.35 1485(E) 29.03.2019 mg/0.6ml 305. Entecavir Tablet 0.5 mg 1 Tablet 79.55 1485(E) 29.03.2019 306. Entecavir Tablet 1 mg 1 Tablet 126.40 1485(E) 29.03.2019 307. Erythropoietin Injection 10000 Each pack 2593.87 1485(E) 29.03.2019 IU/ml 308. Erythropoietin Injection 2000 Each pack 614.36 1485(E) 29.03.2019 IU/ml 309. Escitalopram Tablet 10 mg 1 Tablet 8.08 1485(E) 29.03.2019 310. Escitalopram Tablet 20 mg 1 Tablet 12.76 1485(E) 29.03.2019 311. Escitalopram Tablet 5 mg 1 Tablet 4.55 1485(E) 29.03.2019 312. Esmolol Injection 10mg/ml 1 ml 21.60 1485(E) 29.03.2019 313. Ethambutol Tablet 200 mg 1 Tablet 1.05 1485(E) 29.03.2019 314. Ethambutol Tablet 400 mg 1 Tablet 2.39 1485(E) 29.03.2019 315. Ethambutol Tablet 600 mg 1 Tablet 3.53 1485(E) 29.03.2019 316. Ethambutol Tablet 800 mg 1 Tablet 4.22 1485(E) 29.03.2019 317. Ethinylestradiol Tablet 0.01 mg 1 Tablet 2.34 1485(E) 29.03.2019 318. Ethinylestradiol Tablet 0.05 mg 1 Tablet 3.74 1485(E) 29.03.2019 319. Ethinylestradiol (A) + Tablet 0.03 mg(A) 1 Tablet 3.44 1485(E) 29.03.2019 Levonorgestrel (B) + 0.15 mg(B) 320. Ethionamide Tablet 250 mg 1 Tablet 15.74 1485(E) 29.03.2019 321. Ethyl Alcohol (Denatured) Solution 70% 1 ml 0.42 959(E) 03.03.2020 322. Etoposide Capsule 50 mg 1 Capsule 54.21 1485(E) 29.03.2019 323. Etoposide Injection 20 1 ml 35.75 1485(E) 29.03.2019 mg/ml 324. Fentanyl Injection 1 ml 22.64 1485(E) 29.03.2019 50mcg/ml 325. Ferrous Salt (A) + Folic Tablet 100mg 1 Tablet 0.23 958 (E) 03.03.2020 Acid (B) elemental iron (A) + 500mcg (B) 326. Filgrastim Injection 300 mcg Each pack 1368.29 1485(E) 29.03.2019 327. Fluconazole Capsule 100 mg 1 Capsule 25.19 1485(E) 29.03.2019 328. Fluconazole Capsule 150 mg 1 Capsule 18.49 1485(E) 29.03.2019 329. Fluconazole Capsule 200 mg 1 Capsule 36.40 1485(E) 29.03.2019 330. Fluconazole Oral Liquid 1 ml 2.61 1485(E) 29.03.2019 50mg/5ml 331. Fluconazole Tablet 100 mg 1 Tablet 7.96 1485(E) 29.03.2019 332. Fluconazole Tablet 150 mg 1 Tablet 11.81 1485(E) 29.03.2019 333. Fluconazole Tablet 200 mg 1 Tablet 18.73 1485(E) 29.03.2019 334. Fluconazole Tablet 400 mg 1 Tablet 31.15 1485(E) 29.03.2019 335. Fluconazole Injection 200 Each Pack 106.11 1485(E) 29.03.2019 mg/100 ml 336. Flunarizine Tablet 10 mg 1 Tablet 4.72 1485(E) 29.03.2019 337. Flunarizine Tablet 5 mg 1 Tablet 2.75 1485(E) 29.03.2019 338. Fluoxetine Capsule 10 mg 1 Capsule 2.96 1485(E) 29.03.2019 339. Fluoxetine Capsule 20 mg 1 Capsule 3.64 1485(E) 29.03.2019 340. Fluoxetine Capsule 40 mg 1 Capsule 5.52 1485(E) 29.03.2019 341. Fluoxetine Capsule 60 mg 1 Capsule 9.76 1485(E) 29.03.2019 342. Fluoxetine Tablet 10 mg 1 Tablet 2.49 1485(E) 29.03.2019 343. Fluoxetine Tablet 20 mg 1 Tablet 3.95 1485(E) 29.03.2019 344. Fluoxetine Tablet 40 mg 1 Tablet 5.32 1485(E) 29.03.2019 345. Fluoxetine Tablet 60 mg 1 Tablet 7.38 1485(E) 29.03.2019 346. Fluphenazine Depot Injection 25 1 ml 49.88 1485(E) 29.03.2019 mg/ml 347. Folic Acid Capsule 5 mg 1 Capsule 5.62 1485(E) 29.03.2019 348. Folic Acid Tablet 5 mg 1 Tablet 1.39 1485(E) 29.03.201936 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 349. Furosemide Oral liquid 10 1 ml 2.76 1485(E) 29.03.2019 mg/ml 350. Furosemide Tablet 40 mg 1 Tablet 0.75 4461(E) 13.12.2019 351. Furosemide Injection 10mg/ml 1 ml 2.48 4461(E) 13.12.2019 352. Fusidic acid Cream 2% 1 gm 9.10 1485(E) 29.03.2019 353. Gadobenate Injection 529 1 ml 108.67 1485(E) 29.03.2019 mg/ml 354. Ganciclovir Capsule 250 mg 1 Capsule 119.87 1485(E) 29.03.2019 355. Ganciclovir Powder for Each Pack 1682.65 1485(E) 29.03.2019 Injection 500 mg 356. Gefitinib Tablet 250 mg 1 Tablet 427.35 1485(E) 29.03.2019 357. Gemcitabine Powder for Each Pack 5289.73 1485(E) 29.03.2019 Injection 1 gm 358. Gemcitabine Powder for Each Pack 1168.23 1485(E) 29.03.2019 Injection 200mg 359. Gentamicin Drops 0.3% 1 ml 0.91 1485(E) 29.03.2019 360. Gentamicin Injection 10 1 ml 3.17 1485(E) 29.03.2019 mg/ml 361. Gentamicin Injection 40 Each Pack 17.91 1485(E) 29.03.2019 mg/ml (10 ml) 362. Gentamicin Injection 40 Each Pack (2 8.39 1485(E) 29.03.2019 mg/ml ml) 363. Gentamicin Injection 40 Each Pack 27.15 1485(E) 29.03.2019 mg/ml (20 ml) 364. Gentamicin Injection 40 Each Pack 29.72 1485(E) 29.03.2019 mg/ml (30 ml) 365. Glimepiride Tablet 1 mg 1 Tablet 3.58 1485(E) 29.03.2019 366. Glimepiride Tablet 2 mg 1 Tablet 5.69 1485(E) 29.03.2019 367. Glucose Injection 25% 1 ml 0.17 1485(E) 29.03.2019 368. Glucose Injection 50% 1 ml 0.49 1485(E) 29.03.2019 369. Glucose Injection 5% 1000ml Glass 64.04 1485(E) 29.03.2019 370. Glucose Injection 5% 1000ml Non- 51.69 1485(E) 29.03.2019 Glass 371. Glucose Injection 5% 100ml Glass 17.97 1485(E) 29.03.2019 372. Glucose Injection 5% 100ml Non- 16.27 1485(E) 29.03.2019 Glass 373. Glucose Injection 5% 250ml Glass 24.84 1485(E) 29.03.2019 374. Glucose Injection 5% 250ml Non- 22.44 1485(E) 29.03.2019 Glass 375. Glucose Injection 5% 500ml Glass 35.25 1485(E) 29.03.2019 376. Glucose Injection 5% 500ml Non- 30.42 1485(E) 29.03.2019 Glass 377. Glucose Injection 10% Each Pack 25.75 1485(E) 29.03.2019 (1000 ml) 378. Glucose Injection 10% Each Pack 28.01 1485(E) 29.03.2019 (500 ml) 379. Glucose (A) + Sodium Injection 5% (A) 1000ml Glass 64.45 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) 380. Glucose (A) + Sodium Injection 5% (A) 1000ml Non- 52.08 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) Glass 381. Glucose (A) + Sodium Injection 5% (A) 100ml Glass 18.02 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) 382. Glucose (A) + Sodium Injection 5% (A) 100ml Non- 16.29 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) Glass 383. Glucose (A) + Sodium Injection 5% (A) 250ml Glass 24.94 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) 384. Glucose (A) + Sodium Injection 5% (A) 250ml Non- 22.52 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) Glass 385. Glucose (A) + Sodium Injection 5% (A) 500ml Glass 35.43 1485(E) 29.03.2019 Chloride (B) + 0.9% (B)[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 37 386. Glucose (A) + Sodium Injection 5% (A) 500ml Non- 30.61 1485(E) 29.03.2019 Chloride (B) + 0.9% (B) Glass 387. Glutaraldehyde Solution 2% 1 ml 0.06 1485(E) 29.03.2019 388. Glycerin Oral Liquid 1 ml 0.15 1485(E) 29.03.2019 389. Glyceryl Trinitrate Injection 5 mg/ml 1 ml 6.54 1485(E) 29.03.2019 390. Glyceryl Trinitrate Sublingual Tablet 1 Tablet 1.80 1485(E) 29.03.2019 0.5 mg 391. Glycopyrrolate Injection 0.2 1 ml 12.25 1485(E) 29.03.2019 mg/ml 392. Griseofulvin Tablet 125mg 1 Tablet 0.82 1485(E) 29.03.2019 393. Griseofulvin Tablet 250 mg 1 Tablet 1.59 1485(E) 29.03.2019 394. Griseofulvin Tablet 375 mg 1 Tablet 4.29 1485(E) 29.03.2019 395. Haemodialysis fluid As license 1 ml 0.04 1485(E) 29.03.2019 396. Haloperidol Injection 5 mg/ml 1 ml 5.81 1485(E) 29.03.2019 397. Haloperidol Oral Liquid 2 mg/ 1 ml 2.05 1485(E) 29.03.2019 5ml 398. Haloperidol Tablet 1.5 mg 1 Tablet 1.65 1485(E) 29.03.2019 399. Haloperidol Tablet 10 mg 1 Tablet 4.4 1485(E) 29.03.2019 400. Haloperidol Tablet 20 mg 1 Tablet 4.91 1485(E) 29.03.2019 401. Haloperidol Tablet 5 mg 1 Tablet 3.43 1485(E) 29.03.2019 402. Halothane Inhalation 1 ml 5.84 1485(E) 29.03.2019 403. Heparin Injection 1000 1 ml 16.26 1485(E) 29.03.2019 IU/ml 404. Heparin Injection 5000 1 ml 40.36 1485(E) 29.03.2019 IU/ml 405. Hepatitis B immunoglobulin Each Pack 5492.20 1485(E) 29.03.2019 406. Hepatitis B vaccine 1 ml 78.08 1485(E) 29.03.2019 407. Homatropine Drops 2% 1 ml 6.19 1485(E) 29.03.2019 408. Hormone releasing IUD Contains 52 mgof 1 IUD 3856.86 1485(E) 29.03.2019 Levonorgestrel 409. Human chorionic Injection 1000 IU Each Pack 211.90 1485(E) 29.03.2019 Gonadotropin 410. Human chorionic Injection 5000 IU Each Pack 416.14 1485(E) 29.03.2019 Gonadotropin 411. Human Normal Solution for 1 ml 153.82 418(E) 28.01.2020 Immunoglobulin infusion 5% 412. Human Normal Solution for 1 ml 208.26 417(E) 28.01.2020 Immunoglobulin infusion 10% 413. Hydrochlorothiazide Tablet 12.5 mg 1 Tablet 0.98 1485(E) 29.03.2019 414. Hydrochlorothiazide Tablet 25 mg 1 Tablet 1.68 1485(E) 29.03.2019 415. Hydrochlorothiazide Tablet 50 mg 1 Tablet 0.08 1485(E) 29.03.2019 416. Hydrocortisone Tablet 10 mg 1 Tablet 5.87 1485(E) 29.03.2019 417. Hydrocortisone Tablet 5 mg 1 Tablet 3.02 1485(E) 29.03.2019 418. Hydrocortisone Injection 100 mg Each Pack 38.80 1485(E) 29.03.2019 419. Hydrocortisone Injection 200 mg Each Pack 59.82 1485(E) 29.03.2019 420. Hydrocortisone Powder for Each Pack 38.80 1485(E) 29.03.2019 Injection 100 mg 421. Hydrogen peroxide Solution 6% 1 ml 0.04 1485(E) 29.03.2019 422. Hydroxychloroquine Tablet 200 mg 1 Tablet 5.91 1485(E) 29.03.2019 423. Hydroxychloroquine Tablet 400 mg 1 Tablet 11.91 1485(E) 29.03.2019 424. Hydroxypropyl Injection 2% 1 ml 37.39 1485(E) 29.03.2019 methylcellulose 425. Hydroxyurea Capsule 500 mg 1 Capsule 12.78 1485(E) 29.03.2019 426. Hyoscine butylbromide Injection 20 1 ml 10.40 1485(E) 29.03.2019 mg/ml 427. Hyoscine Butylbromide Tablet 10 mg 1 Tablet 2.96 1485(E) 29.03.2019 428. Ibuprofen Capsule 400 mg 1 Capsule 1.05 1485(E) 29.03.2019 429. Ibuprofen Capsule 200 mg 1 soft gelatin 2.67 2136(E) 26.06.2019 capsule 430. Ibuprofen Tablet 200 mg 1 Tablet 0.39 1485(E) 29.03.201938 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 431. Ibuprofen Tablet 400 mg 1 Tablet 0.69 1485(E) 29.03.2019 432. Ibuprofen Oral Liquid 1 ml 0.19 1485(E) 29.03.2019 100mg/5ml 433. Ifosfamide Powder for Each Pack 360.78 1485(E) 29.03.2019 Injection 1g 434. Ifosfamide Powder for Each Pack 947.01 1485(E) 29.03.2019 Injection 2g 435. Imatinib Capsule 100 mg 1 Capsule 77.40 1485(E) 29.03.2019 436. Imatinib Capsule 400 mg 1 Capsule 254.67 1485(E) 29.03.2019 437. Imatinib Tablet 100 mg 1 Tablet 79.19 1485(E) 29.03.2019 438. Imatinib Tablet 400 mg 1 Tablet 229.24 1485(E) 29.03.2019 439. Insulin (Soluble) Injection 40 IU/ml 1 ml 15.01 1485(E) 29.03.2019 440. Intermediate Acting (NPH) Injection 40 IU/ml 1 ml 15.01 1485(E) 29.03.2019 Insulin 441. Iohexol Injection 1 ml 16.58 1485(E) 29.03.2019 300mgiodine/ml 442. Ipratropium Inhalation 1 Dose 0.61 1485(E) 29.03.2019 (MDI/DPI) 20 mcg/dose 443. Ipratropium Respirator 1 ml 2.53 1485(E) 29.03.2019 solution for use in Nebulizer 250 mcg/ml 444. Iron sucrose Injection 20 1 ml 53.59 1485(E) 29.03.2019 mg/ml 445. Isoflurane Inhalation 1 ml 10.42 1485(E) 29.03.2019 446. Isoniazid Tablet 100mg 1 Tablet 0.68 1485(E) 29.03.2019 447. Isoniazid Tablet 300mg 1 Tablet 1.19 1485(E) 29.03.2019 448. Isosorbide 5 Mononitrate Tablet 20 mg 1 Tablet 3.27 1485(E) 29.03.2019 449. Isosorbide dinitrate Tablet 10 mg 1 Tablet 0.73 1485(E) 29.03.2019 450. Isosorbide dinitrate Tablet 5 mg 1 Tablet 0.75 1485(E) 29.03.2019 451. Isosorbide-5-mononitrate SR Capsule 30 mg 1 Capsule 3.49 1485(E) 29.03.2019 452. Isosorbide-5-mononitrate SR Capsule 60 mg 1 Capsule 3.47 1485(E) 29.03.2019 453. Isosorbide-5-mononitrate SR Tablet 30 mg 1 Tablet 4.88 1485(E) 29.03.2019 454. Isosorbide-5-mononitrate SR Tablet 60 mg 1 Tablet 6.37 1485(E) 29.03.2019 455. Isosorbide-5-mononitrate Tablet 10 mg 1 Tablet 1.96 1485(E) 29.03.2019 456. Ispaghula Granules/ Husk/ 1 gm 0.77 1485(E) 29.03.2019 Powder 457. IUD containing Copper As licensed 1 IUD 286.65 1485(E) 29.03.2019 458. Japanese Encephalitis 4mcg to 6mcg Each Pack 695.51 1485(E) 29.03.2019 Vaccine 459. Japanese Encephalitis up to 3mcg Each Pack 529.88 1485(E) 29.03.2019 Vaccine 460. Kanamycin Powder for Each Pack 38.99 1485(E) 29.03.2019 Injection 1 gm 461. Kanamycin Powder for Each Pack 21.27 1485(E) 29.03.2019 Injection 500 mg 462. Kanamycin Powder for Each Pack 36.34 1485(E) 29.03.2019 Injection 750 mg 463. Ketamine Injection 10 1 ml 10.56 1485(E) 29.03.2019 mg/ml 464. Ketamine Injection 50 1 ml 10.42 1485(E) 29.03.2019 mg/ml 465. Labetalol Injection 5 mg/ml 1 ml 50.54 1485(E) 29.03.2019 466. Lactulose Oral Liquid 10 1 ml 1.09 1485(E) 29.03.2019 g/15 ml 467. Lamivudine (A) + Tablet 150 mg(A) 1 Tablet 15.56 1485(E) 29.03.2019 Nevirapine (B) + Stavudine + 200 mg(B) + 30 (C) mg(C) 468. Lamivudine (A) + Tablet 150 mg(A) 1 Tablet 20.00 1485(E) 29.03.2019 Zidovudine (B) + 300 mg(B)[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 39 469. Lamivudine (A)+ Dispersible Tablet 1 Tablet 4.93 1485(E) 29.03.2019 Nevirapine (B) + Stavudine 30 mg(A) + 50 (C) mg(B) + 6 mg(C) 470. L-Asparaginase Powder for Each Pack 1600.63 1485(E) 29.03.2019 Injection 10000 KU 471. L-Asparaginase Powder for Each Pack 1033.19 1485(E) 29.03.2019 Injection 5000KU 472. Leflunomide Tablet 10 mg 1 Tablet 9.98 1485(E) 29.03.2019 473. Leflunomide Tablet 20 mg 1 Tablet 19.48 1485(E) 29.03.2019 474. Letrozole Tablet 2.5 mg 1 Tablet 40.65 1485(E) 29.03.2019 475. Levetiracetam Injection 100 1 ml 21.75 1485(E) 29.03.2019 mg/ml 476. Levetiracetam ER Tablet 750 mg 1 Tablet 17.34 1485(E) 29.03.2019 477. Levetiracetam Tablet 250 mg 1 Tablet 5.83 1485(E) 29.03.2019 478. Levetiracetam Tablet 500 mg 1 Tablet 11.79 1485(E) 29.03.2019 479. Levetiracetam Tablet 750 mg 1 Tablet 18.13 1485(E) 29.03.2019 480. Levetiracetam Oral Liquid 100 1 ml 3.64 1485(E) 29.03.2019 mg/ml 481. Levodopa (A) + Carbidopa CR Tablet 100 1 Tablet 3.32 1485(E) 29.03.2019 (B) mg(A) + 25 mg(B) 482. Levodopa (A) + Carbidopa Tablet 100 mg(A) 1 Tablet 1.55 1485(E) 29.03.2019 (B) + 10 mg(B) 483. Levodopa (A) + Carbidopa Tablet 100 mg(A) 1 Tablet 2.25 1485(E) 29.03.2019 (B) + 25 mg(B) 484. Levodopa (A) + Carbidopa Tablet 250 mg(A) 1 Tablet 3.73 1485(E) 29.03.2019 (B) + 25 mg(B) 485. Levodopa (A) + Carbidopa CR Tablet 200 1 Tablet 4.10 1485(E) 29.03.2019 (B) mg(A) + 50 mg(B) 486. Levofloxacin Tablet 250 mg 1 Tablet 4.40 1485(E) 29.03.2019 487. Levofloxacin Tablet 750 mg 1 Tablet 10.90 1485(E) 29.03.2019 488. Levofloxacin Tablet 500mg 1 Tablet 8.04 1485(E) 29.03.2019 489. Levonorgestrel Tablet 0.75 mg 1 Tablet 22.95 1485(E) 29.03.2019 490. Levothyroxine Tablet 100 mcg 1 Tablet 1.19 1485(E) 29.03.2019 491. Levothyroxine Tablet 112mcg 1 Tablet 1.43 1485(E) 29.03.2019 492. Levothyroxine Tablet 12.5 mcg 1 Tablet 1.34 1485(E) 29.03.2019 493. Levothyroxine Tablet 125 mcg 1 Tablet 1.53 1485(E) 29.03.2019 494. Levothyroxine Tablet 150 mcg 1 Tablet 1.54 1485(E) 29.03.2019 495. Levothyroxine Tablet 25 mcg 1 Tablet 1.30 1485(E) 29.03.2019 496. Levothyroxine Tablet 50 mcg 1 Tablet 0.98 1485(E) 29.03.2019 497. Levothyroxine Tablet 62.5mcg 1 Tablet 1.40 1485(E) 29.03.2019 498. Levothyroxine Tablet 75 mcg 1 Tablet 1.29 1485(E) 29.03.2019 499. Levothyroxine Tablet 88 mcg 1 Tablet 1.53 1485(E) 29.03.2019 500. Lignocaine Injection 2% 1 ml 0.98 1485(E) 29.03.2019 501. Lignocaine Injection 1 ml 0.97 1485(E) 29.03.2019 2%(Preservative free for IV use) 502. Lignocaine Injection 1% Each Pack 7.92 1485(E) 29.03.2019 503. Lignocaine Topical Forms 2- 1 gm or 1 ml 1.07 1485(E) 29.03.2019 5% 504. Lignocaine Injection 5% with 1 ml 3.67 1485(E) 29.03.2019 7.5% Glucose 505. Lignocaine (A) + Injection 1% (A) 1 ml 0.45 1485(E) 29.03.2019 Adrenaline (B) + 1:200000 (5 mcg/ml) (B) 506. Lignocaine (A) + Injection 2% (A) 1 ml 0.92 1485(E) 29.03.2019 Adrenaline (B) + 1:200000 (5mcg/ml) (B) 507. Linezolid Tablet 600 mg 1 Tablet 32.94 1485(E) 29.03.201940 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 508. Lithium Tablet 300 mg 1 Tablet 1.46 1485(E) 29.03.2019 509. Loperamide Capsule 2 mg 1 Capsule 3.57 1485(E) 29.03.2019 510. Loperamide Tablet 2 mg 1 Tablet 1.97 1485(E) 29.03.2019 511. Lopinavir (A) + Ritonavir Tablet 100 mg(A) 1 Tablet 23.44 1485(E) 29.03.2019 (B) + 25 mg(B) 512. Lopinavir (A) + Ritonavir Tablet 200 mg(A) 1 Tablet 45.43 1485(E) 29.03.2019 (B) + 50 mg(B) 513. Lorazepam injection 2 mg/ml 1 ml 7.75 1485(E) 29.03.2019 514. Lorazepam Tablet 1 mg 1 Tablet 2.06 1485(E) 29.03.2019 515. Lorazepam Tablet 2 mg 1 Tablet 2.51 1485(E) 29.03.2019 516. Magnesium Sulphate Injection 500 1 ml 4.76 1485(E) 29.03.2019 mg/ml 517. Mannitol Injection 10% 1 ml 0.16 1485(E) 29.03.2019 518. Mannitol Injection 20% 1 ml 0.30 1485(E) 29.03.2019 519. Measles Rubbela Vaccine Each Pack 88.15 1485(E) 29.03.2019 (0.5ml) 520. Measles vaccine Vaccine Each Pack 50.84 1485(E) 29.03.2019 (0.5ml) 521. Mebendazole Oral Liquid 100 1 ml 0.77 1485(E) 29.03.2019 mg/5ml 522. Mebendazole Tablet 100 mg 1 Tablet 2.92 1485(E) 29.03.2019 523. Medroxyprogesteroneacetate Tablet 10 mg 1 Tablet 5.37 1485(E) 29.03.2019 524. Mefenamic acid Oral Liquid 100 1 ml 0.52 1485(E) 29.03.2019 mg/5ml 525. Mefenamic acid Tablet 250 mg 1 Tablet 1.93 1485(E) 29.03.2019 526. Mefenamic acid Tablet 500 mg 1 Tablet 2.45 1485(E) 29.03.2019 527. Mefloquine Tablet 250 mg 1 Tablet 50.83 1485(E) 29.03.2019 528. Meglumine Diatrizoate Injection 60%w/v 1 ml 8.24 1485(E) 29.03.2019 529. Meglumine Diatrizoate Injection 76%w/v 1 ml 9.52 1485(E) 29.03.2019 530. Melphalan Tablet 2 mg 1 Tablet 97.82 1485(E) 29.03.2019 531. Melphalan Tablet 5 mg 1 Tablet 167.77 1485(E) 29.03.2019 532. Mesna Injection 100 1 ml 16.72 1485(E) 29.03.2019 mg/ml 533. Metformin Immediate 1 Tablet 1.50 1485(E) 29.03.2019 Release Tablet 500 mg 534. Metformin Controlled 1 Tablet 3.64 1485(E) 29.03.2019 Release Tablet 1000 mg 535. Metformin Controlled 1 Tablet 1.91 1485(E) 29.03.2019 Release Tablet 500 mg 536. Metformin controlled 1 Tablet 2.39 1485(E) 29.03.2019 Released Tablet 750 mg 537. Metformin Immediate 1 Tablet 3.59 1485(E) 29.03.2019 Release Tablet 1000 mg 538. Metformin Immediate 1 Tablet 3.03 1485(E) 29.03.2019 Release Tablet 750 mg 539. Methotrexate Injection 25 1 ml 47.96 1485(E) 29.03.2019 mg/ml 540. Methotrexate Injection 50 1 ml 39.94 1485(E) 29.03.2019 mg/ml 541. Methotrexate Tablet 10 mg 1 Tablet 12.11 1485(E) 29.03.2019 542. Methotrexate Tablet 2.5 mg 1 Tablet 4.77 1485(E) 29.03.2019 543. Methotrexate Tablet 7.5 mg 1 Tablet 11.55 1485(E) 29.03.2019 544. Methotrexate Tablet 5 mg 1 Tablet 8.35 1485(E) 29.03.2019 545. Methyldopa Tablet 250 mg 1 Tablet 2.44 1485(E) 29.03.2019 546. Methyldopa Tablet 500 mg 1 Tablet 4.67 1485(E) 29.03.2019[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 41 547. Methylergometrine Injection 0.2 1 ml 14.23 1485(E) 29.03.2019 mg/ml 548. Methylergometrine Tablet 0.125 mg 1 Tablet 7.90 1485(E) 29.03.2019 549. Methylprednisolone Tablet 16 mg 1 Tablet 8.89 1485(E) 29.03.2019 550. Methylprednisolone Tablet 8 mg 1 Tablet 5.08 1485(E) 29.03.2019 551. Methylprednisolone Injection 40mg/ml 1 ml 53.81 1485(E) 29.03.2019 552. Metoclopramide Injection 5 mg/ml 1 ml 1.42 1485(E) 29.03.2019 (10 ml Pack) 553. Metoclopramide Injection 5 mg/ml 1 ml 2.33 1485(E) 29.03.2019 (2 ml Pack) 554. Metoclopramide Oral Liquid 5 1 ml 0.44 1485(E) 29.03.2019 mg/5ml 555. Metoclopramide Tablet 10 mg 1 Tablet 1.16 1485(E) 29.03.2019 556. Metoprolol Capsule 25 mg 1 Capsule 4.22 1485(E) 29.03.2019 557. Metoprolol Capsule 50 mg 1 Capsule 6.43 1485(E) 29.03.2019 558. Metoprolol SR Tablet 25 mg 1 Tablet 4.02 1485(E) 29.03.2019 559. Metoprolol SR Tablet 50 mg 1 Tablet 5.76 1485(E) 29.03.2019 560. Metoprolol Tablet 25 mg 1 Tablet 3.10 1485(E) 29.03.2019 561. Metoprolol Tablet 50 mg 1 Tablet 4.70 1485(E) 29.03.2019 562. Metronidazole Injection 1 ml 0.20 4461(E) 13.12.2019 500mg/100ml 563. Metronidazole Oral Liquid 200 1 ml 0.45 4461(E) 13.12.2019 mg/5ml 564. Metronidazole Tablet 200 mg 1 Tablet 0.69 4461(E) 13.12.2019 565. Metronidazole Tablet 400 mg 1 Tablet 1.27 4461(E) 13.12.2019 566. Midazolam Injection 1 mg/ml 1 ml 5.89 1485(E) 29.03.2019 567. Midazolam Injection 5 mg/ml 1 ml 14.47 1485(E) 29.03.2019 568. Midazolam Tablet 7.5mg 1 Tablet 22.38 1485(E) 29.03.2019 569. Mifepristone Tablet 200 mg 1 Tablet 320.77 1485(E) 29.03.2019 570. Misoprostol Tablet 100 mcg 1 Tablet 8.68 1485(E) 29.03.2019 571. Misoprostol Tablet 200 mcg 1 Tablet 16.65 1485(E) 29.03.2019 572. Morphine Injection 10 1 ml 23.68 1485(E) 29.03.2019 mg/ml 573. Morphine Injection 15 1 ml 29.55 1485(E) 29.03.2019 mg/ml 574. Morphine SR Tablet 30 mg 1 Tablet 5.43 1485(E) 29.03.2019 575. Morphine Tablet 10 mg 1 Tablet 5.31 1485(E) 29.03.2019 576. Moxifloxacin Tablet 400 mg 1 Tablet 25.26 1485(E) 29.03.2019 577. Mycophenolate mofetil Tablet 250 mg 1 Tablet 41.40 1485(E) 29.03.2019 578. Mycophenolate mofetil Tablet 500 mg 1 Tablet 81.89 1485(E) 29.03.2019 579. N-acetylcysteine Injection 200 1 ml 22.34 1485(E) 29.03.2019 mg/ml 580. N-acetylcysteine Sachet 200mg 1 gm 8.97 1485(E) 29.03.2019 581. Naloxone injection 0.4 1 ml 86.50 1485(E) 29.03.2019 mg/ml 582. Natamycin Drops 5% 1 ml 22.74 1485(E) 29.03.2019 583. Neostigmine injection 0.5 1 ml 4.34 1485(E) 29.03.2019 mg/ml 584. Neostigmine Tablet 15 mg 1 Tablet 4.66 1485(E) 29.03.2019 585. Nevirapine Oral Liquid 50 1 ml 0.84 1485(E) 29.03.2019 mg/5ml 586. Nevirapine Tablet 200 mg 1 Tablet 14.27 1485(E) 29.03.2019 587. Nifedipine Capsule 10 mg 1 Capsule 0.86 1485(E) 29.03.2019 588. Nifedipine Tablet 10 mg 1 Tablet 1.23 1485(E) 29.03.2019 589. Nitrofurantoin Oral Liquid 25 1 ml 0.82 1485(E) 29.03.2019 mg/5ml 590. Nitrofurantoin Tablet 100 mg 1 Tablet 7.21 1485(E) 29.03.2019 591. Nitrofurantoin Capsule 100mg 1 Capsule 7.83 1485(E) 29.03.2019 592. Nitrous Oxide Inhalation Cubic Meter 232.96 1485(E) 29.03.2019 593. Noradrenaline Injection 2 mg/ml 1 ml 25.69 1485(E) 29.03.201942 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 594. Norethisterone Tablet 5 mg 1 Tablet 5.09 1485(E) 29.03.2019 595. Omeprazole Capsule 10 mg 1 Capsule 2.11 1485(E) 29.03.2019 596. Omeprazole Capsule 20 mg 1 Capsule 2.49 1485(E) 29.03.2019 597. Omeprazole Capsule 40 mg 1 Capsule 4.92 1485(E) 29.03.2019 598. Omeprazole Powder for oral 1 gm 1.22 1485(E) 29.03.2019 Liquid 20 mg 599. Omeprazole Tablet 10 mg 1 Tablet 4.42 1485(E) 29.03.2019 600. Omeprazole Tablet 20 mg 1 Tablet 4.91 1485(E) 29.03.2019 601. Omeprazole Tablet 40 mg 1 Tablet 8.31 1485(E) 29.03.2019 602. Ondansetron Injection 2 mg/ml 1 ml 5.83 1485(E) 29.03.2019 603. Ondansetron Oral Liquid 2 1 ml 1.13 1485(E) 29.03.2019 mg/5ml 604. Ondansetron Tablet 4 mg 1 Tablet 4.69 1485(E) 29.03.2019 605. Ondansetron Tablet 8 mg 1 Tablet 9.73 1485(E) 29.03.2019 606. Oral Rehydration Salts As Licensed 1 gm 0.89 1485(E) 29.03.2019 607. Oral Rehydration Salts As Licensed 1 ml 0.14 1485(E) 29.03.2019 608. Oxaliplatin Injection Each Pack 4455.90 1485(E) 29.03.2019 100mg(as licensed) 609. Oxaliplatin Injection 50mg(as Each Pack 2591.45 1485(E) 29.03.2019 licensed) 610. Oxygen Inhalation Cubic Meter 17.49 1485(E) 29.03.2019 (Medicinal gas) 611. Oxytocin Injection 10 IU/ml 1 ml 39.28 1485(E) 29.03.2019 612. Oxytocin Injection 5IU/ml 1 ml 17.60 1485(E) 29.03.2019 613. Paclitaxel Injection 100 1 ml 222.53 1461(E) 02.04.2018 mg/16.7 ml 614. Paclitaxel Injection 30 mg/ 1 ml 222.53 1461(E) 02.04.2018 5ml 615. Pantoprazole Injection 40 mg Each Pack 44.39 1485(E) 29.03.2019 616. Para-aminosalicylic acid Granules (As 1 gm 2.83 1485(E) 29.03.2019 licensed) 617. Paracetamol Oral Liquid 100 1 ml 0.51 1485(E) 29.03.2019 mg/5ml 618. Paracetamol Oral Liquid 120 1 ml 0.53 1485(E) 29.03.2019 mg/5ml 619. Paracetamol Oral Liquid 125 1 ml 0.34 1485(E) 29.03.2019 mg/5ml 620. Paracetamol Oral Liquid 150 1 ml 0.58 1485(E) 29.03.2019 mg/5ml 621. Paracetamol Oral Liquid 250 1 ml 0.60 1485(E) 29.03.2019 mg/5ml 622. Paracetamol Oral Liquid 500 1 ml 0.64 1485(E) 29.03.2019 mg/5ml 623. Paracetamol Oral Liquid 650 1 ml 0.52 1485(E) 29.03.2019 mg/5ml 624. Paracetamol Tablet 500 mg 1 Tablet 0.91 1485(E) 29.03.2019 625. Paracetamol Tablet 650 mg 1 Tablet 1.83 1485(E) 29.03.2019 626. Paracetamol Injection 150 Each Pack 3.06 1485(E) 29.03.2019 mg/ml ( 0.5 ml) 627. Paracetamol Injection 150 Each Pack 4.19 1485(E) 29.03.2019 mg/ml (1 ml) 628. Paracetamol Injection 150 Each Pack 6.43 1485(E) 29.03.2019 mg/ml 2 ml) 629. Paracetamol Injection 150 Each Pack 8.68 1485(E) 29.03.2019 mg/ml (3 ml) 630. Paracetamol Injection 150 Each Pack 10.93 1485(E) 29.03.2019 mg/ml (4 ml) 631. Paracetamol Injection 150 Each Pack 13.18 1485(E) 29.03.2019 mg/ml (5 ml)[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 43 632. Paracetamol Injection 150 Each Pack 17.68 1485(E) 29.03.2019 mg/ml (7 ml) 633. Paracetamol Suppository 170 Each 7.67 1485(E) 29.03.2019 mg Suppository 634. Paracetamol Suppository 80 Each 6.49 1485(E) 29.03.2019 mg Suppository 635. Paracetamol Oral Liquid 100 mg/ml 1 ml 1.61 1485(E) 29.03.2019 (pediatric) 636. Pegylated interferon alfa 2a Injection 180mcg Each Pack 7889.76 1485(E) 29.03.2019 637. Pegylated interferon alfa 2b Injection 100mcg Each Pack 15599.00 1485(E) 29.03.2019 638. Pegylated interferon alfa 2b Injection 120mcg Each Pack 14527.08 1485(E) 29.03.2019 639. Pegylated interferon alfa 2b Injection 80mcg Each Pack 12470.96 1485(E) 29.03.2019 640. Penicillamine Capsule 250 mg 1 Capsule 14.82 1485(E) 29.03.2019 641. Permethrin Cream 1% 1 gm 1.60 1485(E) 29.03.2019 642. Permethrin Cream 5% 1 gm 1.73 1485(E) 29.03.2019 643. Permethrin Gel 5% 1 gm 1.46 1485(E) 29.03.2019 644. Permethrin Lotion 1% 1 gm 0.91 1485(E) 29.03.2019 645. Permethrin Lotion 5% 1 ml 0.97 1485(E) 29.03.2019 646. Pheniramine Injection 22.75 1 ml 2.28 4461(E) 13.12.2019 mg/ml (2ml) 647. Pheniramine Injection 22.75 1 ml 1.70 4461(E) 13.12.2019 mg/ml(10ml) 648. Phenobarbitone Injection 200 1 ml 19.11 1485(E) 29.03.2019 mg/ml 649. Phenobarbitone Tablet 30 mg 1 Tablet 1.22 1485(E) 29.03.2019 650. Phenobarbitone Tablet 60 mg 1 Tablet 1.76 1485(E) 29.03.2019 651. Phenobarbitone Oral liquid 20 1 ml 0.44 1485(E) 29.03.2019 mg/5 ml 652. Phenylephrine Drop 10% 1 ml 8.06 1485(E) 29.03.2019 653. Phenylephrine Drops 5% 1 ml 3.72 1485(E) 29.03.2019 654. Phenytoin Capsule 100 mg 1 Capsule 1.52 1485(E) 29.03.2019 655. Phenytoin Capsule 300 mg 1 Capsule 3.80 1485(E) 29.03.2019 656. Phenytoin ERCapsule 300 1 Capsule 3.80 1485(E) 29.03.2019 mg 657. Phenytoin injection 25 1 ml 2.51 1485(E) 29.03.2019 mg/ml 658. Phenytoin Injection 50 1 ml 5.36 1485(E) 29.03.2019 mg/ml 659. Phenytoin Oral Liquid 125 1 ml 0.90 1485(E) 29.03.2019 mg/5ml 660. Phenytoin Oral Liquid 30 1 ml 0.31 1768(E) 26.04.2018 mg/5ml 661. Phenytoin ER Tablet 300 mg 1 Tablet 5.79 1485(E) 29.03.2019 662. Phenytoin Tablet 100 mg 1 Tablet 1.55 1485(E) 29.03.2019 663. Phenytoin Tablet 300 mg 1 Tablet 4.73 1485(E) 29.03.2019 664. Phenytoin Tablet 50 mg 1 Tablet 0.74 1485(E) 29.03.2019 665. Phytomenadione (Vitamin Injection 1 ml 47.74 1485(E) 29.03.2019 K1) 10mg/ml 666. Phytomenadione (Vitamin Tablet 10mg 1 Tablet 14.48 1485(E) 29.03.2019 K1) 667. Pilocarpine Drops 2% 1 ml 10.08 1485(E) 29.03.2019 668. Pilocarpine Drops 4% 1 ml 11.65 1485(E) 29.03.2019 669. Piperacillin (A) + Powder for Each Pack 88.14 1485(E) 29.03.2019 Tazobactam (B) Injection 1 g (A) + 125 mg(B) 670. Piperacillin (A) + Powder for Each Pack 208.51 1485(E) 29.03.2019 Tazobactam (B) Injection 2 g (A) + 250 mg(B) 671. Piperacillin (A) + Powder for Each Pack 438.00 1485(E) 29.03.2019 Tazobactam (B) Injection 4 g (A) + 500 mg(B)44 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 672. Potassium chloride Injection 150 1 ml 2.42 1485(E) 29.03.2019 mg/ml 673. Potassium chloride Oral Liquid 500 1 ml 0.29 1485(E) 29.03.2019 mg/5ml 674. Potassium permanganate Crystals for 1 gm 0.44 1485(E) 29.03.2019 topical solution 675. Povidone iodine Ointment 10% 1 gm 5.19 4060(E) 08.11.2019 676. Povidone iodine Solution 4% 1 ml 1.73 1485(E) 29.03.2019 677. Povidone iodine Solution 7.5% 1 ml 0.77 1485(E) 29.03.2019 678. Povidone Iodine Solution 10% 1 ml 0.93 1485(E) 29.03.2019 679. Povidone Iodine Solution 5% 1 ml 0.39 1485(E) 29.03.2019 680. Pralidoxime chloride (2- Injection 25 1 ml 3.72 1485(E) 29.03.2019 PAM) mg/ml 681. Prednisolone Drops 1% 1 ml 5.01 4461(E) 13.12.2019 682. Prednisolone Injection 20 1 ml 3.57 1485(E) 29.03.2019 mg/2ml 683. Prednisolone Oral Liquid 15 1 ml 0.75 1485(E) 29.03.2019 mg/ 5ml 684. Prednisolone Oral Liquid 5 mg/ 1 ml 0.43 1485(E) 29.03.2019 5ml 685. Prednisolone Tablet 10 mg 1 Tablet 0.97 1485(E) 29.03.2019 686. Prednisolone Tablet 20 mg 1 Tablet 1.95 1485(E) 29.03.2019 687. Prednisolone Tablet 40 mg 1 Tablet 2.80 1485(E) 29.03.2019 688. Prednisolone Tablet 5 mg 1 Tablet 0.56 1485(E) 29.03.2019 689. Premix Insulin 30:70 Injection 40 IU 1 ml 15.01 1485(E) 29.03.2019 Injection (Regular:NPH) /ml 690. Prilocaine (A) + Lignocaine Cream 2.5% (A) + 1 gm 20.39 1485(E) 29.03.2019 (B) 2.5% (B ) 691. Primaquine Tablet 15 mg 1 Tablet 4.56 1485(E) 29.03.2019 692. Primaquine Tablet 2.5 mg 1 Tablet 1.55 1485(E) 29.03.2019 693. Primaquine Tablet 7.5 mg 1 Tablet 2.11 1485(E) 29.03.2019 694. Procarbazine Capsule 50 mg 1 Capsule 34.47 1485(E) 29.03.2019 695. Procarbazine Tablet 50 mg 1 Tablet 46.97 1485(E) 29.03.2019 696. Proparacaine Drops 0.5% 1 ml 9.94 1485(E) 29.03.2019 697. Propofol Injection 10 1 ml 7.20 1485(E) 29.03.2019 mg/ml 698. Propranolol Capsule 40 mg 1 Capsule 3.79 1485(E) 29.03.2019 699. Propranolol Capsule 80 mg 1 Capsule 5.76 1485(E) 29.03.2019 700. Propranolol Tablet 10 mg 1 Tablet 1.16 1485(E) 29.03.2019 701. Propranolol Tablet 40 mg 1 Tablet 2.75 1485(E) 29.03.2019 702. Propranolol Tablet 80 mg 1 Tablet 4.98 1485(E) 29.03.2019 703. Protamine Injection 10 1 ml 9.22 1485(E) 29.03.2019 mg/ml 704. Pyrazinamide Oral Liquid 250 1 ml 0.61 1485(E) 29.03.2019 mg/5ml 705. Pyrazinamide Tablet 1000 mg 1 Tablet 9.40 1485(E) 29.03.2019 706. Pyrazinamide Tablet 1500 mg 1 Tablet 10.41 1485(E) 29.03.2019 707. Pyrazinamide Tablet 500 mg 1 Tablet 4.22 1485(E) 29.03.2019 708. Pyrazinamide Tablet 750 mg 1 Tablet 6.42 1485(E) 29.03.2019 709. Pyridoxine Tablet 100 mg 1 Tablet 5.57 1485(E) 29.03.2019 710. Pyridoxine Tablet 10mg 1 Tablet 0.11 1485(E) 29.03.2019 711. Quinine Injection 300 1 ml 10.14 1485(E) 29.03.2019 mg/ml 712. Quinine Tablet 300 mg 1 Tablet 5.71 1485(E) 29.03.2019 713. Rabies Vaccine Each Pack 340.72 1485(E) 29.03.2019 714. Raltegravir Tablet 400 mg 1 Tablet 156.04 1485(E) 29.03.2019 715. Ramipril Capsule 2.5 mg 1 Capsule 4.72 1485(E) 29.03.2019 716. Ramipril Capsule 5 mg 1 Capsule 7.37 1485(E) 29.03.2019 717. Ramipril Tablet 2.5 mg 1 Tablet 4.96 1485(E) 29.03.2019 718. Ramipril Tablet 5 mg 1 Tablet 7.81 1485(E) 29.03.2019[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 45 719. Ranitidine Oral Liquid 75 1 ml 0.72 1485(E) 29.03.2019 mg/5ml 720. Ranitidine Tablet 150 mg 1 Tablet 0.73 1485(E) 29.03.2019 721. Ranitidine Injection 25mg/ml 1 ml 1.61 1485(E) 29.03.2019 722. Ribavirin Capsule 200 mg 1 Capsule 83.40 1485(E) 29.03.2019 723. Rifabutin Capsule 150mg 1 Capsule 39.55 1485(E) 29.03.2019 724. Rifabutin Tablet 150mg 1 Tablet 36.93 1485(E) 29.03.2019 725. Rifampicin Capsule 150 mg 1 Capsule 2.00 1485(E) 29.03.2019 726. Rifampicin Capsule 300 mg 1 Capsule 3.79 1485(E) 29.03.2019 727. Rifampicin Capsule 450 mg 1 Capsule 4.92 1485(E) 29.03.2019 728. Rifampicin Capsule 600 mg 1 Capsule 11.56 1485(E) 29.03.2019 729. Rifampicin Oral Liquid 100 1 ml 0.39 1485(E) 29.03.2019 mg/5ml 730. Rifampicin Tablet 150 mg 1 Tablet 1.61 1485(E) 29.03.2019 731. Rifampicin Tablet 300 mg 1 Tablet 2.92 1485(E) 29.03.2019 732. Ringer Lactate Injection 1000ml Each Pack 79.53 1485(E) 29.03.2019 733. Ringer Lactate Injection 100ml Each Pack 20.83 1485(E) 29.03.2019 734. Ringer Lactate Injection 250ml Each Pack 35.51 1485(E) 29.03.2019 735. Ringer Lactate Injection 500ml Each Pack 45.25 1485(E) 29.03.2019 736. Risperidone Oral Liquid 1 1 ml 1.93 1485(E) 29.03.2019 mg/ml 737. Risperidone Tablet 1 mg 1 Tablet 3.07 1485(E) 29.03.2019 738. Risperidone Tablet 2 mg 1 Tablet 4.91 1485(E) 29.03.2019 739. Risperidone Tablet 4 mg 1 Tablet 9.97 1485(E) 29.03.2019 740. Ritonavir Capsule 100 mg 1 Capsule 28.14 1485(E) 29.03.2019 741. Ritonavir Tablet 100 mg 1 Tablet 28.94 1485(E) 29.03.2019 742. Rituximab Injection 10 1 ml 756.26 1485(E) 29.03.2019 mg/ml 743. Salbutamol Capsule 4 mg 1 Capsule 0.60 1485(E) 29.03.2019 744. Salbutamol Inhalation 1 Dose 0.40 1485(E) 29.03.2019 (MDI/DPI) 100 mcg/dose 745. Salbutamol Oral Liquid 2 1 ml 0.15 1485(E) 29.03.2019 mg/5ml 746. Salbutamol Respirator 1 ml 0.70 1485(E) 29.03.2019 solution for use in Nebulizer 5 mg/ml 747. Salbutamol Tablet 2 mg 1 Tablet 0.16 1485(E) 29.03.2019 748. Salbutamol Tablet 4 mg 1 Tablet 0.18 1485(E) 29.03.2019 749. Salicylic acid Ointment 6% 1 gm 1.79 1485(E) 29.03.2019 750. Sevoflurane Inhalation 1 ml 29.82 1485(E) 29.03.2019 751. Silver Sulphadiazine Cream 1% 1 gm 0.51 2942(E) 14.08.2019 752. Snake venom antiserum- Powder for 10 ml Pack 555.59 1485(E) 29.03.2019 Lyophilized polyvalent Injection 753. Snake Venom Antiserum- Injection Each Pack 431.45 1485(E) 29.03.2019 Soluble/ Liquid Polyvalent (10 ML) 754. Sodium Bicarbonate Injection 7.5% 1 ml 1.40 1485(E) 29.03.2019 755. Sodium Bicarbonate Injection 8.4% 1 ml 1.28 1485(E) 29.03.2019 756. Sodium Chloride Injection 0.9% 1000ml Glass 59.17 1485(E) 29.03.2019 757. Sodium Chloride Injection 0.9% 1000ml Non- 46.67 1485(E) 29.03.2019 Glass 758. Sodium Chloride Injection 0.9% 100ml Glass 17.50 1485(E) 29.03.2019 759. Sodium Chloride Injection 0.9% 100ml Non- 15.76 1485(E) 29.03.2019 Glass 760. Sodium Chloride Injection 0.9% 250ml Glass 23.60 1485(E) 29.03.2019 761. Sodium Chloride Injection 0.9% 250ml Non- 21.19 1485(E) 29.03.2019 Glass 762. Sodium Chloride Injection 0.9% 500ml Glass 32.81 1485(E) 29.03.201946 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 763. Sodium Chloride Injection 0.9% 500ml Non- 27.93 1485(E) 29.03.2019 Glass 764. Sodium Nitroprusside Injection 10 1 ml 25.74 1485(E) 29.03.2019 mg/ml 765. Sodium Valproate Injection 100 1 ml 5.75 1485(E) 29.03.2019 mg/ml 766. Sodium Valproate Oral Liquid 200 1 ml 0.58 1485(E) 29.03.2019 mg/5ml 767. Sodium Valproate CR Tablets 1 Tablet 6.28 1485(E) 29.03.2019 300mg 768. Sodium Valproate CR Tablets 1 Tablet 9.72 1485(E) 29.03.2019 500mg 769. Sodium Valproate Tablet 200 mg 1 Tablet 3.09 1485(E) 29.03.2019 770. Sodium Valproate Tablet 300 mg 1 Tablet 3.96 1485(E) 29.03.2019 771. Sodium Valproate Tablet 500 mg 1 Tablet 6.92 1485(E) 29.03.2019 772. Sofosbuvir Tablet 400 mg 1 Tablet 665.52 1485(E) 29.03.2019 773. Somatostatin Powder for Each pack 1580.17 1485(E) 29.03.2019 Injection 3 mg 774. Spironolactone Tablet 25 mg 1 Tablet 1.91 1485(E) 29.03.2019 775. Spironolactone Tablet 50 mg 1 Tablet 3.79 1485(E) 29.03.2019 776. Stavudine (A) + Lamivudine Tablet 30 mg(A) 1 Tablet 9.52 1485(E) 29.03.2019 (B) +150 mg(B) 777. Streptokinase Injection Each Pack 1784.78 1485(E) 29.03.2019 15,00,000 IU 778. Streptokinase Injection 7,50,000 Each Pack 1255.28 1485(E) 29.03.2019 IU 779. Streptomycin Powder for Each Pack 8.75 1485(E) 29.03.2019 Injection 750 mg 780. Streptomycin Powder for Each Pack 10.40 1485(E) 29.03.2019 Injection 1 gm 781. Succinyl Choline Injection 50 1 ml 4.82 1485(E) 29.03.2019 mg/ml 782. Sucralfate Oral Liquid 1 g 1 ml 0.70 1485(E) 29.03.2019 783. Sulfasalazine Tablet 500 mg 1 Tablet 3.97 1485(E) 29.03.2019 784. Sumatriptan Tablet 25mg 1 Tablet 33.19 1485(E) 29.03.2019 785. Sumatriptan Tablet 50mg 1 Tablet 51.38 1485(E) 29.03.2019 786. Surfactant Suspension for Per mg of 66.69 1485(E) 29.03.2019 intratracheal Phospholipids instillation (As in the pack liensed) 787. Tacrolimus Capsule 0.5 mg 1 Capsule 22.05 1485(E) 29.03.2019 788. Tacrolimus Capsule 1 mg 1 Capsule 38.95 1485(E) 29.03.2019 789. Tacrolimus Capsule 2 mg 1 Capsule 76.30 1485(E) 29.03.2019 790. Tamoxifen Tablet 10 mg 1 Tablet 2.57 1485(E) 29.03.2019 791. Tamoxifen Tablet 20 mg 1 Tablet 2.90 1485(E) 29.03.2019 792. Telmisartan Tablet 20 mg 1 Tablet 3.64 1485(E) 29.03.2019 793. Telmisartan Tablet 40 mg 1 Tablet 6.57 1485(E) 29.03.2019 794. Telmisartan Tablet 80 mg 1 Tablet 10.02 1485(E) 29.03.2019 795. Temozolomide Capsule 100 mg 1 Capsule 2077.53 1485(E) 29.03.2019 796. Temozolomide Capsule 20 mg 1 Capsule 594.68 1485(E) 29.03.2019 797. Temozolomide Capsule 250 mg 1 Capsule 4672.75 1485(E) 29.03.2019 798. Temozolomide Tablet 100 mg 1 Tablet 1542.12 1485(E) 29.03.2019 799. Temozolomide Tablet 20 mg 1 Tablet 373.62 1485(E) 29.03.2019 800. Temozolomide Tablet 250 mg 1 Tablet 3816.90 1485(E) 29.03.2019 801. Tenofovir Tablet 300 mg 1 Tablet 47.05 1485(E) 29.03.2019 802. Tenofovir (A) + Lamivudine Tablet 300 mg(A) 1 Tablet 44.76 1485(E) 29.03.2019 (B) + 300 mg(B) 803. Tenofovir (A) + Lamivudine Tablet 300 mg(A) 1 Tablet 102.77 1485(E) 29.03.2019 (B) + Efavirenz (C) + 300 mg(B) + 600 mg(C)[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 47 804. Tetanus Toxoid Injection Each Pack 10.81 2137(E) 26.06.2019 (0.5ml) 805. Tetanus Toxoid Injection Each Pack 23.37 2137(E) 26.06.2019 (5 ml) 806. Thalidomide Capsule 100 mg 1 Capsule 60.92 1485(E) 29.03.2019 807. Thalidomide Capsule 50 mg 1 Capsule 35.19 1485(E) 29.03.2019 808. Thiamine Injection 100 1 ml 24.73 1485(E) 29.03.2019 mg/ml 809. Thiamine Tablet 100 mg 1 Tablet 3.74 1485(E) 29.03.2019 810. Thiopentone Powder for Each Pack 40.61 1485(E) 29.03.2019 Injection 0.5 gm 811. Thiopentone Powder for Each Pack 49.28 1485(E) 29.03.2019 Injection 1 gm 812. Timolol Drops 0.25% 1 ml 5.15 1485(E) 29.03.2019 813. Timolol Drops 0.5% 1 ml 11.89 1485(E) 29.03.2019 814. Tiotropium Inhalation (MDI) Per Metered 2.40 4061(E) 08.11.2019 9 mcg/dose Dose 815. Tiotropium Inhalation (DPI) Per Dose 9.26 1485(E) 29.03.2019 18 mcg/dose 816. Tramadol Capsule 50 mg 1 Capsule 4.50 1485(E) 29.03.2019 817. Tramadol Injection 50 1 ml 1.24 1485(E) 29.03.2019 mg/ml (20 ml Pack) 818. Tramadol Injection 50 1 ml 10.44 1485(E) 29.03.2019 mg/ml (upto 2 ml Pack) 819. Tramadol Tablet 100 mg 1 Tablet 19.61 1485(E) 29.03.2019 820. Tramadol Tablet 50 mg 1 Tablet 8.04 1485(E) 29.03.2019 821. Tramadol Capsule 100 mg 1 Capsule 9.57 1485(E) 29.03.2019 822. Tranexamic acid Injection 100 1 ml 14.90 1485(E) 29.03.2019 mg/ml 823. Tranexamic acid Tablet 500 mg 1 Tablet 17.32 1485(E) 29.03.2019 824. Trastuzumab Injection 440 Each Pack 59976.96 1485(E) 29.03.2019 mg/50 ml 825. Trihexyphenidyl Tablet 2 mg 1 Tablet 1.21 1485(E) 29.03.2019 826. Tropicamide Eye Drop 1% 1 ml 10.03 1485(E) 29.03.2019 827. Vancomycin Powder for Each Pack 474.52 1485(E) 29.03.2019 Injection 1 gm 828. Vancomycin Powder for Each Pack 221.09 1485(E) 29.03.2019 Injection 250 mg 829. Vancomycin Powder for Each Pack 285.41 1485(E) 29.03.2019 Injection 500 mg 830. Vecuronium Powder for Each Pack 188.52 1485(E) 29.03.2019 Injection 10 mg 831. Vecuronium Powder for Each Pack 90.98 1485(E) 29.03.2019 Injection 4 mg 832. Verapamil Injection 2.5 1 ml 1.16 1485(E) 29.03.2019 mg/ml 833. Verapamil Tablet 40 mg 1 Tablet 0.74 1485(E) 29.03.2019 834. Verapamil Tablet 80 mg 1 Tablet 1.39 1485(E) 29.03.2019 835. Vinblastine Injection 1mg/ml 1 ml 20.46 1485(E) 29.03.2019 836. Vincristine Injection 1 mg/ml 1 ml 51.96 1485(E) 29.03.2019 837. Vitamin A Capsule 50000 IU 1 Capsule 0.55 1485(E) 29.03.2019 838. Vitamin A Injection 50000 1 ml 1.91 1485(E) 29.03.2019 IU/ml 839. Vitamin A Tablet 50000 IU 1 Tablet 0.70 1485(E) 29.03.2019 840. Warfarin Tablet 1 mg 1 Tablet 2.41 1485(E) 29.03.2019 841. Warfarin Tablet 2 mg 1 Tablet 2.66 1485(E) 29.03.2019 842. Warfarin Tablet 3 mg 1 Tablet 3.11 1485(E) 29.03.2019 843. Warfarin Tablet 5 mg 1 Tablet 2.35 1485(E) 29.03.201948 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 844. Water for Injection Injection Each Pack 2.32 1485(E) 29.03.2019 (10 ml) 845. Water for Injection Injection Each Pack 2.24 1485(E) 29.03.2019 (5 ml) 846. White Petrolatum Jelly 100% 1 gm 0.09 1485(E) 29.03.2019 847. Xylometazoline Nasal Drops 1 ml 3.92 1485(E) 29.03.2019 0.05% 848. Xylometazoline Nasal Drops 0.1% 1 ml 5.19 1485(E) 29.03.2019 849. Zidovudine Capsule 300 mg 1 Capsule 2.06 1485(E) 29.03.2019 850. Zidovudine Tablet 300 mg 1 Tablet 14.21 1485(E) 29.03.2019 851. Zidovudine (A) + Tablet 300 mg(A) 1 Tablet 20.09 1485(E) 29.03.2019 Lamivudine (B) + + 150 mg(B) + Nevirapine (C) 200 mg(C) 852. Zinc sulphate Dispersible Tablet 1 Tablet 3.13 1485(E) 29.03.2019 20mg 853. Zoledronic Acid Powder for Each Pack 4188.87 1485(E) 29.03.2019 Injection 4 mg 854. Zolpidem Capsule 5 mg 1 Capsule 7.33 1485(E) 29.03.2019 855. Zolpidem Tablet 10 mg 1 Tablet 8.42 1485(E) 29.03.2019 856. Zolpidem Tablet 5 mg 1 Tablet 5.37 1485(E) 29.03.2019 Notes:- (a) The ceiling prices are applicable with effect from 01.04.2020 (ceiling prices are inclusive of Wholesale Price Index (WPI) @1.88468% for the year 2019 over 2018). (b) In respect of formulation where pack wise ceiling price is notified, for any other pack size manufactured, the manufacturer shall approach NPPA under para 11(3) of DPCO, 2013 for specific price approval for its formulations. The formulation of Sodium Valproate includes combination of Sodium Valproate and Valproic Acid both together corresponding to Sodium Valproate of the stated strength. (c) In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturer shall approach NPPA for specific price approval for its formulations. (d) All manufacturers of scheduled formulations, selling branded or generic or both the versions of scheduled formulations at price higher than the ceiling price (plus goods and services taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services taxes as applicable, if any. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if any), may revise the existing MRP of their formulations, on the basis of WPI @ 1.88468% for year 2019 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (f) The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 49 DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)superseded. [PN/206/74/2020/F/F. No. 8(74)/2020/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director vkns'k ubZ fnYyh] 25 ekpZ] 2020 dk-vk-1214¼v½.—jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼ewY; fu;a=.k½ vkn's k] 2013 ds iSjk 4] 6] 10] 11] 14, 16, 17 vkSj 18 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k dk- vk- la[;k vkSj fnukad fofufnZ"V uhp s LraHk 6¼aaa½ vkSj 6¼b½ dk s vf/kØe.k djr s gq,] uhp s dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ eas dh Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ e sa dh rRLFkkuh izfof"V es a fofufnZ"V vulq wfpr fofufeZfr;ks a eas ls izR;sd dh] oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i eas fu;r djrh gSA lkj.kh okf"kZd Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij la'kksf/kr ewY; @ (1.88468%) c<+kdj Ø- la- nokb;ka [kqjkd :i ,oa vf/kdre dher orZeku dk- vk- la[;k izcyrk ¼Fkksd ewY; lwpdkad vkSj fnukad bdkbZ lfgr 1.88468% dh nj ls 01-04-2020 ls izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 6(a) 6(b) ,lhVkby 1 lkfyflfyd xksyh 300 fexzk 1 xksyh 0.22566 1486 ¼v½ 29.03.2019 ,flM 2 dSfY'k;e dkcksZusV xksyh 250 fexzk 1 xksyh 1.95 1486 ¼v½ 29.03.2019 3 daMksel 1 daMkse 9.10 1486 ¼v½ 29.03.2019 4 Msilksu xksyh 50 fexzk 1 xksyh 0.2353 1486 ¼v½ 29.03.2019 5 bVksikls kbM dSIlwy 100 fexzk- 1 dSIlwy 60.37 1486 ¼v½ 29.03.2019 ÝkekblsVhu 6 lYQsV Øhe 0-50 % 1 xzke 0.87 1486 ¼v½ 29.03.2019 tsafVu ok;ksysV 7 1% 1 fefy- 0.06516 1486 ¼v½ 29.03.2019 isVa flji 100 fexzk- 8 vkbZlksfutkbM 1 fefy- 0.25772 1486 ¼v½ 29.03.2019 @5 fefy- eMs ªksDlh 9 izksxsLVjs ksu xksyh 5 fexzk 1 xksyh 2.98 1486 ¼v½ 29.03.2019 ,flVsV vksjy 10 ikWyhekbfyfVl lksyq'ku 1 fefy- 120.24 1486 ¼v½ 29.03.2019 oSDlhu ¼,y,½ 11 izkftD;wuVys xksyh 600 fexzk 1 xksyh 28.74 1486 ¼v½ 29.03.2019 12 fjQefiflu xksyh 450 fexzk 1 xksyh 4.42 1486 ¼v½ 29.03.2019 batSD'ku 30 fexzk- 13 lksfM;e ukbZVªsV 1 fefy- 21.51 1486 ¼v½ 29.03.2019 @fefy-50 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] uksV%- ¼d½ vf/kdre eYw ; fnukad 01-04-2020 ls ykxw gSa ¼vf/kdre ewY;ks a eas 2018 dh vis{kk o"kZ 2019 ds fy, 1-88468 izfr“kr dh Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ dh nj “kkfey gSa½A ¼[k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gks]a ;fn dkbs Z gS½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ks a ds mijksDr mRikn@czkaM dks csp jgs vuqlwfpr fofufeZfr;ks a ds fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher /ku oLrq ,oa lsok dj] tk s ykxw gks]a ;fn dksbZ gS] ls vf/kd lHkh ,slh fofufeZfr;ks a dh dher dk v/kkseq[kh iqujh{k.k djsxa sA ¼x½ lHkh ekStwnk fuekZrkvks a dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ks a ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 13¼2½ ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o"kZ 2019 ds fy, 1-88468 izfr“kr dh nj ls Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ks a dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la“kksf/kr dj ldr s gSa ¼?k½ vxj fuekZrkvks a us mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher ij ljdkj dks okLro eas Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldr s gSA ¼M+½ vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 11 eas fn, x, izko/kkuks a ds rgr lEcfU/kr fuekZrkvks a dks mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ks a ds iSdkas ds fy, vf/kdre dher fu/kkZfjr djsAa fuekZrk vkS"k/k ¼eYw ; fu;a=.k½ vkns“k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V es a vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d eYw ; lwph tkjh djas rFkk mldh dkWih jkT; vkS"kf/k fu;a=dks a vkSj fofuekZrk forjd dks tkjh djsAa ¼p½ vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds 24 ¼4½ ds mica/kks a ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i eas ,sl s ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke“kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`“; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf“kZr djsxkA ¼N½ mi;qZDr lkj.kh es a fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ks a ds fofufnZ"V fofHkUu [kqjkd vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvks a }kjk ,d ubZ vkS"kf/k dk s ykap djrk gS rks mls igy s vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns“k] 2013 ds rgr lwph II es a fofufnZ"V QkeZ I ds ek/;e ls ,uihih, eas ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼t½ mi;qZDr vulq wfpr fofufeZfr;ks a dh mRiknu@vk;kr vkSj fcØh ds lEcU/k eas fuekZrkvks a dks vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ks a ds fuekZ.k dks dkbs Z fuekZrk mRiknu cUn dju s dk bPNqd gks rks bldh lwpuk ,uihih, dk s voxr djk;sxkA blds lEcU/k eas vxj vuqlwfpr fofufeZfr;ks a ds mRiknu vkSj vk;kr dks cUn dju s dk bPNqd gS rks cUn dju s dh frfFk ls N% eghus igy s Mhihlhvks] 2013 dh lwph II ds QkWeZ IV es a Hkjdj ,uihih, dks izLrqr djsxkA ¼>½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh es a n“kkZ;s vf/kdre ewY; vkSj “krks± dk ikyu ugha djrh gSa rks os vko“;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuks a ds v/khu C;kt lfgr vf/kizHkkfjr jkf“k dks tek djus ds fy, mRrjnk;h gksxa sA ¼´½ bl vkn“s k es a mijksDr lkj.kh ds LraHk ¼2½ eas dh rRLFkkuh izfof"V es a fofufnZ"V ,slh fofufeZfr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre vkSj [kqnjk eYw ; fu/kkZfjr vkns“k ;fn dksbZ gks] tks bl vkns“k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk;sxa sA [dka-l-a@206@74@2020@,Q@Qk- la- 8¼74½@2020@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs“kd ORDER New Delhi, the 25th March, 2020 S. O. 1214(E).— In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column No. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 51 ceiling prices exclusive of goods and services tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Price Revision as per Annual Wholesale Price Index (WPI) @ 1.88468% increase. Sl. No. Medicines Dosage form Unit Ceiling price (wef Existing S.O. No. & and Strength 01.04.2020 with Date WPI @ 1.88468%) (1) (2) (3) (4) (5) 6(a) 6(b) Acetyl Salicylic 1 Tablet 300mg 1 Tablet 0.22566 1486 (E) 29.03.2019 Acid Calcium 2 Tablet 250 mg 1 Tablet 1.95 1486 (E) 29.03.2019 carbonate 3 Condoms 1 Condom 9.10 1486 (E) 29.03.2019 4 Dapsone Tablet 50 mg 1 Tablet 0.2353 1486 (E) 29.03.2019 5 Etoposide Capsules 100 mg 1 Capsule 60.37 1486 (E) 29.03.2019 Framycetin 6 Cream 0.50% 1 GM 0.87 1486 (E) 29.03.2019 Sulphate Gentian Violet 7 1% 1 ML 0.06516 1486 (E) 29.03.2019 Paint Syrup 100 8 Isoniazid 1 ML 0.25772 1486 (E) 29.03.2019 mg/5ml Medroxy 9 Progesterone Tablet 5mg 1 Tablet 2.98 1486 (E) 29.03.2019 Acetate Oral 10 Poliomyelitis Solution 1 ML 120.24 1486 (E) 29.03.2019 vaccine (LA) 11 Praziquantel Tablet 600 mg 1 Tablet 28.74 1486 (E) 29.03.2019 12 Rifampicin Tablet 450mg 1 Tablet 4.42 1486 (E) 29.03.2019 Injection 13 Sodium Nitrite 1 ML 21.51 1486 (E) 29.03.2019 30mg/ml Notes:- (a) The ceiling prices are applicable with effect from 01.04.2020 (ceiling prices are inclusive of Wholesale Price Index (WPI) @1.88468% for the year 2019 over 2018). (b) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services taxes as applicable, if any. (c) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 1.88468% for year 2019 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (f) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.52 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (g) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (h) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (i) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (j) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/206/74/2020/F/ F. No. 8(74)/2020/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director ubZ fnYyh] 25 ekpZ] 2020 dk-vk- 1215¼v½-—Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi&iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] ¼jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k½ ds 'kqf)&i= vkn's k dk- vk- 2062¼v½ fnukad 9 twu] 2016 ds lkFk ifBr dk-vk- 1993¼v½ fnukad 3 twu] 2016, dk-vk- 2210¼v½ fnukad 24 twu] 2016, dk- vk- 2578¼v½ fnukad 1 vxLr 2016, dk- vk- 3161¼v½ fnukad 6 vDrcwj 2016, dk- vk- 1051¼v½ fnukad 1 vizSy 2017, dk- vk- 2062¼v½ fnukad 30 twu 2017, dk- vk- 1463¼v½ fnukad 02 vizSy 2018, dk- vk- 1531¼v½ fnukad 06 vizSy 2018 vkSj dk- vk- 1487¼v½ fnukad 29 ekpZ 2019 vkn's k ds vf/kØe.k eas tgk¡ rd mldk lEcU/k uhp s dh lkj.kh ^d* es a fofufeZr iSdks a ds fo'ks"k fo'ks"krkvks a lfgr xSj&dk¡p ds :i eas ¼dk-vk- 1993¼v½ fnukad 3 twu] 2016 esa xSj&ihohlh ds #i eas ;Fkk&of.kZr½] l'akks/ku fd;k] uhps nh xbZ lkj.kh [k eas fofufnZ"V fuekZrk ds fo'ks"k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djr s gq, ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k dju s dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2019 ij vk/kkfjr la”kks/ku djrk gS] tSlk fd uhps dh lkj.kh ^d* ds LraHk ¼5½ es a fofufnZ"V gS] vf/kdre dher dk s mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ eas dh xbZ Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LrHa k ¼2½ es a dh xbZ rRLFkkuh izfof"V eas fofufnZ"V vuqlwfpr fofufeZfr;ks a es a ls izR;sd dh oLrq ,oa lsok dj] ;fn dksbZ gS] dk s NksM+dj vf/kdre dher ds #i eas fu;r djrh gSA lkj.kh d @ 1.88468% c<+kdj Ø- la- nokb;ka [kqjkd :i ,oa bdkbZ vf/kdre dher izcyrk ¼@ 1.88468% dh nj ls 01-04-2020 ls izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 1000 fefy xSj&dk¡p 1 Xywdkst batsD”ku 5% fo'ks"k fo'ks’krkvks a lfgr 76.17 500 fefy xSj&dk¡p 2 Xywdkst batsD”ku 5% fo'ks"k fo'ks’krkvks a lfgr 65.90 Xywdkst ¼,½$lksfM;e batsD”ku 5% ¼,½$0- 1000 fefy xSj&dk¡p 3 80.04 DyksjkbM ¼ch½ fo'ks"k fo'ks’krkvks a lfgr 9% ¼ch½ Xywdkst ¼,½$lksfM;e 500 fefy xSj&dk¡p 4 DyksjkbM ¼ch½ batsD”ku 5% ¼,½$ 0- fo'ks"k fo'ks’krkvks a 68.49[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 53 lfgr 9% ¼ch½ 100 fefy xSj&dk¡p 5 lksfM;e DyksjkbM batsD”ku 0-9% fo'ks"k fo'ks’krkvks a lfgr 33.68 250 fefy xSj&dk¡p 6 lksfM;e DyksjkbM batsD”ku 0-9% fo'ks"k fo'ks”krkvks a 49.74 lfgr 500 fefy xSj&dk¡p 7 lksfM;e DyksjkbM batsD”ku 0-9% fo'ks"k fo'ks’krkvks a lfgr 70.43 1000 fefy xSj&dk¡p 8 lksfM;e DyksjkbM batsD”ku 0-9% fo'ks"k fo'ks’krkvks a 78.89 lfgr lkj.kh ^[k^ dz-la- fuekZrkvks a dk uke mRikn@czkaM dk uke ¼1½ ¼2½ ¼3½ 1- elSlZ ch- czkmu efsMdy ¼bafM;k½ izk- fyfeVMs bdk¶s yds Iyl cksry ;wjksgsM lfgr 2- eSllZ veUrk gsYFkds;j fyfeVsM LVsjhiksVZ cksry 3- elSlZ ,D;wykbQ gsYFk ds;j izk- fyfeVMs ,D;wykbQ cksry ;wjksgsM lfgr 4- eSllZ ,ycVZ MsfoM fyfeVsM ,ycVZ MsfoM cksry ;wjksgsM lfgr 5- eSllZ Msful dse fyfeVMs ,DokiYl ;wjksgsM lfgr 6- eSllZ Dysfjl ykbQ lkbalsl fyfeVMs Dyfsjl cksry ;wjksgsM lfgr 7- eSllZ Ýslfsu;l dkch bafM;k izk- fyfeVsM Ýh¶yDs l cxs 8- elSlZ vksVlqdk QkekZL;wfVdYl bafM;k izkbosV fyfeVMs ;wuhcsx ¼igy s Dyfsjl vksVlqdk izkbosV fyfeVMs ds uke ls tkuk tkrk Fkk½ 9- eSllZ ,s'ko;kZ ykbQlkblsla fy¶;wt+u ;wjksgsM cksry 10- eSllZ csDlVj ¼bafM;k½ izk- fyfeVsM ok;k¶ysDl csx 11- elSlZ vksVlqdk QkekZL;wfVdYl bafM;k izkbosV fyfeVMs ;wjksgsM cksry ¼igy s Dyfsjl vksVlqdk izkbosV fyfeVMs ds uke ls tkuk tkrk Fkk½ 12- eSllZ Ýslfu;l dkch bafM;k izk- fyfeVsM ;wjksgsM cksry uksV%- ¼d½ vf/kdre eYw ; fnukad 01-04-2020 ls ykxw gSa ¼vf/kdre eYw ;ks a eas 2018 dh vis{kk o"kZ 2019 ds fy, 1-88468% dh Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ dh nj “kkfey gS½A ¼[k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tk s ykxw gk]sa ;fn dksbZ gS½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ks a ds mijksDr mRikn@czkaM dks csp jgs vuqlwfpr fofufeZfr;ks a ds fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher /ku oLrq ,oa lsok dj] tk s ykxw gks]a ;fn dksbZ gS] ls vf/kd lHkh ,slh fofufeZfr;ks a dh dher dk v/kkseq[kh iqujh{k.k djsxa sA ¼x½ lHkh ekStwnk fuekZrkvks a dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ks a ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 13¼2½ ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o"kZ 2019 ds fy, 1-88468% dh nj ls Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ks a dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la“kksf/kr dj ldrs gSa ¼?k½ vxj fofuekZrkvks a u s mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher ij ljdkj dk s okLro eas Hkqxrku fd;k gS ;k ;fn ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldr s gSA54 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼M-½ vU; dksbZ fofuekZrk fo'ks"k fo'ks"krkvks a lfgr xSj&dk¡p iSd ds fo'ks"k vf/kdre dher ds fy, vyx ls nkok djrk gS rks mlds fy, mls fooj.k ds lkFk izekf.kr djuk gksxk fd mlds iSd es a O;kid lqfo/kkvks a tSls fd ¼i½ Lo;a fleVus vkSj Lo;a lhyfscfyVh ¼lhy yxuk½ ¼ii½ ,;j osVa ugh a gksus vkSj ¼iii½ fofuekZ.k ds nkSjku lapkj@,MfefDlax Lrjks a ij lanw"k.k dh laHkkouk ugh gSa] ds leFkZu es a nLrkostks a vkSj izn“kZu lfgr ,uihih, dk s vkonsu djxs kA ¼p½ fofuekZrk viuh fofufeZfr;ks a dh fdlh Hkh vU; fo'ks"k fo'ks"krkvks a dk nkok ;k vU; iSd vkdkj ds fy, fo'ks"k eYw ; fu/kkZj.k ds fy, ,uihih, eas vkosnu djsxkA ¼N½ vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 11 es a fn, x, izko/kkuks a ds rgr lEcfU/kr fuekZrkvks a dks mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ks a ds iSdks a ds fy, vf/kdre dher fu/kkZfjr djsAa fofuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V eas vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsxk rFkk mldh dkWih jkT; vkS"kf/k fu;a=dks a vkSj fofuekZrk forjd dk s tkjh djsxkA ¼t½ vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds iSjk 24 ¼4½ ds vulq kj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i es a ,sl s ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke“kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`“; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf“kZr djsxkA ¼>½ mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ks a ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvks a }kjk ,d ubZ vkS"kf/k ykap djrk gS rks mls igy s vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns“k] 2013 ds rgr lwph II es a fofufnZ"V QkeZ I ds ek/;e ls ,uihih, eas ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼.k½ mi;qZDr vuqlwfpr fofufeZfr;ks a ds mRiknu@vk;kr vkSj fcØh ds lEcU/k eas fuekZrkvks a dks vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 dh lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djuh gksxhA mi;qZDr vuqlwfpr fofufeZfr;ks a ds fofuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gks rks bldh lwpuk ls ,uihih, dks voxr djk;sxkA blds lEcU/k eas vxj vuqlwfpr fofufeZfr;ks a ds mRiknu vkSj vk;kr dks cUn dju s dk bPNqd gS] rks cUn dju s dh frfFk ls N% eghu s igys lwph II ds QkWeZ IV eas Hkjdj ,uihih, dks izLrqr djsxkA ¼V½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh eas n“kkZ;s vf/kdre ewY; vkSj uksV dk ikyu ugh a djrh gSa rks os vko“;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuks a ds v/khu C;kt lfgr vf/kizHkkfjr jkf’k dk s tek dju s ds fy, mRrjnk;h gksxa sA ¼B½ bl vkn“s k eas mijksDr lkj.kh ds LraHk ¼2½ es a dh xbZ rRLFkkuh izfof"V es a fofufnZ"V ,slh fofufeZfr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre ;k [kqnjk eYw ; fu/kkZfjr vkns“k] ;fn dksbZ gks] tk s bl vkns“k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk;sxa sA [dk-ala-@206@74@2020@,Q@Qk- la- 8¼74½@2020@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs“kd ORDER New Delhi, the 25th March, 2020 S.O. 1215 (E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O 1993(E) dated 3rd June,2016 read with Corrigendum order S.O 2062 dated 9th June, 2016, S.O 2210(E) dated 24th June 2016, S.O 2578(E) dated 1st August 2016, S.O. 3161(E) dated 6th October 2016, S.O. 1051(E) dated 1st April 2017, S.O. 2062(E) dated 30th June 2017, S.O. 1463(E) dated 2nd April 2018, S.O. 1531(E) dated 6th April 2018 and S.O. 1487(E) dated 29th March 2019 in so far as they relate to formulation packs of Non-Glass with special features (mentioned as Non-PVC in S.O. 1993(E) dated 3rd June 2016) mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2019 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if any in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof:[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 55 TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 1.88468% increase. Sl. Medicines Dosage form and Unit Ceiling price (wef No. Strength 01.04.2020 with WPI @ 1.88468%) (1) (2) (3) (4) (5) 1000ml Non Glass 1 Glucose Injection 5% 76.17 with special features 500ml Non Glass 2 Glucose Injection 5% 65.90 with special features Glucose (A) + Sodium Injection 5% (A) + 1000ml Non Glass 3 80.04 Chloride (B) 0.9% (B) with special features Glucose (A) + Sodium Injection 5% (A) + 500ml Non Glass 4 68.49 Chloride (B) 0.9% (B) with special features 100ml Non Glass 5 Sodium Chloride Injection 0.9% 33.68 with special features 250ml Non Glass 6 Sodium Chloride Injection 0.9% 49.74 with special features 500ml Non Glass 7 Sodium Chloride Injection 0.9% 70.43 with special features 1000ml Non Glass 8 Sodium Chloride Injection 0.9% 78.89 with special features TABLE ‘B’ Sl. No. Name of Manufacturer Product /Brand Name (1) (2) (3) 1 M/s. B.Braun Medical (I) Pvt. Ltd. Ecoflac Plus bottle with Eurohead 2 M/s. Amanta Healthcare Ltd. Steriport bottle 3 M/s. Aculife Healthcare Pvt. Ltd. Aculife bottle with Eurohead 4 M/s. Albert David Limited Albert David bottle with Eurohead 5 M/s. Denis Chem Limited Aquapulse with Eurohead 6 M/s. Claris Life Sciences Limited Claris bottle with Eurohead 7 M/s. Fresenius Kabi India Pvt. Limited Freeflex bags 8 M/s. Otsuka Pharmaceutical India Private Ltd. Unibag (previously known as Claris Otsuka Private Limited) 9 M/s. Aishwarya Lifesciences Lifusion Eurohead bottle 10 M/s. Baxter (India) Pvt. Ltd. Viaflex bags 11 M/s. Otsuka Pharmaceutical India Private Ltd. Eurohead bottle (previously known as Claris Otsuka Private Limited) 12 M/s. Fresenius Kabi India Pvt Limited Eurohead bottle Notes:— (a) The ceiling prices are applicable with effect from 01.04.2020 (ceiling prices are inclusive of Wholesale Price Index (WPI) @1.88468% for the year 2019 over 2018). (b) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise56 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] the existing M.R.P. of their formulations, on the basis of WPI @ 1.88468% for year 2019 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) Any other manufacturer claiming separate ceiling price for Non-Glass with special feature shall apply to NPPA for separate ceiling price approval with details and demonstrate, that such pack has all of the features as (i) self collapsibility and self-sealability (ii) not having air-vent; and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels alongwith documentation and demonstration. (f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation. (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/206/74/2020/F/ F. No. 8(74)/2020/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director ubZ fnYyh] 25 ekpZ] 2020 dk-vk-1216¼v½-&Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi&iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ksa dk iz;ksx djr s gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky;] ¼jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k½ ds vkns'k dk- vk- 960 ¼v½ fnukad 3 ekpZ] 2020 vkns'k ds vf/kØe.k eas tgk¡ rd , जिसमें अब तक यह पैक में ररंगर लैक्टेट इंिेक्िन से संबंजधत है, जिसमें जविेष सुजवधाएँ ह ैं िैसे (i) स्ट्व-संप्रेषणीयता और स्ट्व-सीलजबजलटी (ii) एयर-वेंट नहीं होना और (iii) जनमाचण/िलसेक/प्रवेि स्ट्तर के िौरान संिषू ण का कोई उपाय नहीं ह,ै uhps nh xbZ lkj.kh [k es a fofufnZ"V fuekZrk ds fo'ks”k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djr s gq, ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k dju s dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd ewY; lwpdkad ¼MCY;wihvkbZ½] 2019 ij vk/kkfjr la”kks/ku djrk gS] tSlk fd uhps dh lkj.kh ^d* ds LraHk ¼5½ es a fofufnZ"V gS] vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ eas dh xbZ Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LraHk ¼2½ eas dh xbZ rRLFkkuh izfof"V eas fofufnZ"V vulq wfpr fofufeZfr;ksa eas ls izR;sd dh oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i eas fu;r djrh gSA[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 57 lkj.kh d @ 1.88468% c<+kdj Ø- la- nokb;ka [kqjkd :i ,oa bdkbZ vf/kdre dher izcyrk ¼@ 1.88468% dh nj ls 01-04-2020 ls izHkkoh½ ¼#-½ (1) (2) (3) (4) (5) 1 ररंगर लैक्टेट इंिेक्िन 100 जमली प्रत्येक 100 जमलीलीटर पैक में जविेष जविेषताएं हैं 23.95 2 ररंगर लैक्टेट इंिेक्िन 250 जमली प्रत्येक 250 जमलीलीटर पैक में जविेष जविेषताएं हैं 40.84 3 ररंगर लैक्टेट इंिेक्िन 500 जमली प्रत्येक 500 जमलीलीटर पैक में जविेष जविेषताएं हैं 52.03 4 ररंगर लैक्टेट इंिेक्िन 1000 जमली प्रत्येक 1000 जमलीलीटर पैक में जविेष जविेषताएं हैं 91.46 lkj.kh ^[k^ dz-la- fuekZrkvksa dk uke (1) (2) 1 मैससच अल्बटच डेजवड जल. 2 मैससच एक्यूलाइफ हल्े थकेयर प्रा. जलजमटेड 3 मैससच बी। ब्रौन मेजडकल (इंजडया) प्रा. जलजमटेड 4 मैससच फ्रेसेजनयस काबी इंजडया प्रा. जलजमटेड 5 मैससच ओस्ट्तुका फामाचस्ट्यूटटकल्स इंजडया प्रा. जलजमटेड uksV% ¼d½ vf/kdre eYw ; fnukad 01-04-2020 ls ykxw gSa ¼vf/kdre eYw ;ks a eas 2018 dh vis{kk o"kZ 2019 ds fy, 1-88468% dh Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ dh nj “kkfey gS½A ¼[k½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLrq ,oa lsok dj] tk s ykxw gk]sa ;fn dksbZ gS½ ls vf/kd dher ij vuqlwfpr fofufeZfr;ks a ds mijksDr mRikn@czkaM dks csp jgs vuqlwfpr fofufeZfr;ks a ds fofuekZrk] mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher /ku oLrq ,oa lsok dj] tk s ykxw gks]a ;fn dksbZ gS] ls vf/kd lHkh ,slh fofufeZfr;ks a dh dher dk v/kkseq[kh iqujh{k.k djsxa sA ¼x½ lHkh ekStwnk fuekZrkvks a dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ks a ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 13¼2½ ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o"kZ 2019 ds fy, 1-88468% dh nj ls Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh fofufeZfr;ks a dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la“kksf/kr dj ldrs gSa ¼?k½ vxj fofuekZrkvks a u s mi;qZDr lkj.kh ds LraHk ¼5½ eas of.kZr vf/kdre dher ij ljdkj dk s okLro eas Hkqxrku fd;k gS ;k ;fn ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldr s gSA ¼M-½ कोई अन्य जवजनमाचता िो जविेष सुजवधाओं वाले पैकेिों में ररंगर लैक्टेट इंिेक्िन में िैसे (i) स्ट्व-संप्रेषणीयता और स्ट्व- सीलजबजलटी (ii) में एयर-वेंट नहीं होने और (iii) जनमाणच /िलसेक/प्रवेि के स्ट्तर के िौरान संिषू ण का कोई उपाय नहीं है, के जलए अलग अजधकतम मूल्य का िावा करता ह ैतो वह अलग अजधकतम मूल्य अनुमोिन के जलए एनपीपीए को आवेिन करेगा। ¼p½ fofuekZrk viuh fofufeZfr;ks a dh fdlh Hkh vU; fo'ks"k fo'ks"krkvks a dk nkok ;k vU; iSd vkdkj ds fy, fo'ks"k eYw ; fu/kkZj.k ds fy, ,uihih, eas vkosnu djsxkA ¼N½ vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 11 es a fn, x, izko/kkuks a ds rgr lEcfU/kr fuekZrkvks a dks mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ks a ds iSdks a ds fy, vf/kdre dher fu/kkZfjr djsAa fofuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V eas vf/klwpuk dh rkjh[k ls vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks ,d ewY; lwph tkjh djsxk rFkk mldh dkWih jkT; vkS"kf/k fu;a=dks a vkSj fofuekZrk forjd dk s tkjh djsxkA58 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼t½ vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds iSjk 24 ¼4½ ds vulq kj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i es a ,sl s ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke“kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`“; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf“kZr djsxkA ¼>½ mi;qZDr lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ks a ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvks a }kjk ,d ubZ vkS"kf/k ykap djrk gS rks mls igy s vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns“k] 2013 ds rgr lwph II es a fofufnZ"V QkeZ I ds ek/;e ls ,uihih, eas ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼.k½ mi;qZDr vuqlwfpr fofufeZfr;ks a ds mRiknu@vk;kr vkSj fcØh ds lEcU/k eas fuekZrkvks a dks vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 dh lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djuh gksxhA mi;qZDr vuqlwfpr fofufeZfr;ks a ds fofuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gks rks bldh lwpuk ls ,uihih, dks voxr djk;sxkA blds lEcU/k eas vxj vuqlwfpr fofufeZfr;ks a ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS] rks cUn dju s dh frfFk ls N% eghu s igy s lwph II ds QkWeZ IV eas Hkjdj ,uihih, dk s izLrqr djsxkA ¼V½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh eas n“kkZ;s vf/kdre ewY; vkSj uksV dk ikyu ugh a djrh gSa rks os vko“;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuks a ds v/khu C;kt lfgr vf/kizHkkfjr jkf“k dks tek dju s ds fy, mRrjnk;h gksxa sA ¼B½ bl vkn“s k eas mijksDr lkj.kh ds LraHk ¼2½ es a dh xbZ rRLFkkuh izfof"V es a fofufnZ"V ,slh fofufeZfr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vf/kdre ;k [kqnjk eYw ; fu/kkZfjr vkns“k] ;fn dksbZ gks] tk s bl vkns“k ls iwoZ tkjh gq, gSa] Lor% gh vf/kØe.k gks tk;sxa sA [dk-ala-@206@74@2020@,Q@Qk- la- 8¼74½@2020@Mhih@,uihih,-&fMoh&II] izlsuthr nkl] lgk;d funs“kd ORDER New Delhi, the 25th March, 2020 S.O. 1216(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O 960(E) dated 3rd March, 2020 in so far as it relates to ringer lactate injection in pack having special features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index (WPI) of 2019 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if any in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 1.88468% increase. Sl. Medicines Dosage form and Unit Ceiling price (wef No. Strength 01.04.2020 with WPI @ 1.88468%) (1) (2) (3) (4) (5) 1 Ringer lactate Injection100 ml Each 100 ml pack 23.95 having special features 2 Ringer lactate Injection 250 ml Each 250 ml pack 40.84 having special features[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 59 3 Ringer lactate Injection 500 ml Each 500 ml pack 52.03 having special features 4 Ringer lactate Injection 1000 ml Each 1000 ml pack 91.46 having special features TABLE ‘B’ Sl. Name of Manufacturer No. (1) (2) 1 M/s. Albert David Ltd. 2 M/s. Aculife Healthcare Pvt. Ltd. 3 M/s. B. Braun Medical (India) Pvt. Ltd. 4 M/s. Fresenius Kabi India Pvt. Ltd. 5 M/s. Ostuka Pharmaceuticals India Pvt. Ltd. Notes :— (a) The ceiling prices are applicable with effect from 01.04.2020 (ceiling prices are inclusive of Wholesale Price Index (WPI) @1.88468% for the year 2019 over 2018). (b) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 1.88468% for year 2019 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) Any other manufacturer claiming separate ceiling price for ringer lactate injection in pack having special features like (i) self collapsibility and self-sealability (ii) not having air-ventt and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels shall apply to NPPA for separate ceiling price approval. (f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.60 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/206/74/2020/F/F. No. 8(74)/2020/D.P./NPPA-Div.-II] PRASENJIT DAS, Assistant Director vkns'k ubZ fnYyh] 25 ekpZ] 2020 dk-vk- 1217¼v½-&jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] vkS"k/k foHkkx] jlk;u ,oa moZjd e=a ky; }kjk dksjksujh LVsVa ~l ds vf/kdre eYw ; fu/kkZj.k ds laca/k eas tkjh vf/klwpukvks a dk-vk- 639¼v½ fnukad 12-02-2018] 1464¼v½ fnukad 02-04-2018 vkSj 1488¼v½ fnukad 29-03-2019 tkjh eas ml lkj.kh ds LrHa k ¼4½ es a fofufnZ"V vf/kdre dher ds laca/k eas ;g fu.kZ; fy;k x;k gS fd o"kZ 2018 dh vis{kk o"kZ 2019 ds fy, 1-88468 izfr“kr dh nj ls Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ ij fopkj djus ds ckn ,rn~}kjk dksjksujh LVsaV~l ds of.kZr vf/kdre ewY;ksa, oLrq ,oa lsok dj] ;fn dkbs Z gS] dks NksM+dj, bl lkj.kh ds LraHk ¼4½ eas fofufnZ"V vf/kdre dher] LraHk ¼3½ eas of.kZr bdkbZ ds en~nsutj fnukad 01-04-2020 ls fuEu izdkj ls la“kksf/kr fd;k tkrk gS% lkj.kh vf/kdre ¼dksjksujh LVsaV~l½ bdkbZ dz-la- ewY; ¼Mhihlhvks] 2013 dh vuqlwph&I esa dz-la- 31½ ¼la[;k esa½ ¼#i;s esa½ ¼1½ ¼2½ ¼3½ ¼4½ 1 lkn s /kkrq LVsVa 1 8]417 vkS"k/k {kkyu LVasV ¼MhbZ,l½ ftlesa /kkfRod MhbZ,l vkSj tSo vo“kks"; 2 1 30]647 okfgdk <kapk ¼choh,l½@tSo voØe.kh; LVsVa lfEefyr gSaA uksV%- ¼d½ lHkh ekStwnk fuekZrkvks@a vk;krdks a dks dkjs ksujh LVsaV ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼4½ eas fofufnZ"V vf/kdre dher ¼oLrq ,oa lsok dj] ;fn dksbZ gS½ ls de gS] tgka dgh Hkh ykxw gks] vkS"k/k ¼eYw ; fu;a=.k½ vkn“s k] 2013 ds iSjkxzkQ 13¼2½ ds lkFk ifBr Mhihlhvks] 2013 ds iSjkxzkQ 16¼2½ ds vuqlkj o"kZ 2019 ds fy, 1-88468 izfr“kr dh nj ls Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½ ds vk/kkj ij viuh dkjs ksujh LVsVa dk ekStwnk vf/kdre [kqnjk ewY; ¼,evkjih½ dks la“kksf/kr dj ldrs gSaaaaA ¼[k½ vxj fuekZrkvks@a vk;krdks a u s mi;qZDr lkj.kh ds LraHk ¼4½ es a of.kZr vf/kdre dher ij ljdkj dks okLro eas Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dk s tksM+ ldr s gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkn“s k] 2013 ds 24¼4½ ds mica/kks a ds vuqlkj izR;sd QqVdj foØsrk vkSj forjd fofuekZrk }kjk fn, x, :i eas ,sl s ifjlj] tgka dkjksckj dks bl izdkj fd;k tk jgk gS fd mlls ijke“kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`“; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf“kZr djsxkA ¼?k½ fofuekZrk@vk;krd ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh eas n“kkZ;s vf/kdre eYw ; vkSj “krks± dk ikyu ugh a djrh gSa rks os vko“;d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuks a ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksxa sA [dk-ala-@206@74@2020@,Q@Qk- la- 8¼74½@2020@Mhih@,uihih,-&fMoh&II] vyksd jta u] lgk;d funs“kd ORDER New Delhi, the 25th March, 2020 S.O. 1217(E).—In continuation of the Notifications issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, S.O. 1464(E) dated 02.04.2018 and S.O. 1488(E) dated 29.03.2019 regarding the fixation of ceiling price of the Coronary Stents as specified in column No. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 1.88468 percent for the year 2019 over the year 2018, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column No. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2020, as under:[भाग II—खण् ड 3 (ii)] भारत का रािपत्र : असाधारण 61 TABLE Sl. Coronary Stents Unit Ceiling Price No. ( Sl. No. 31 in Schedule-I of the DPCO, 2013) (in Number) (in Rs.) (1) (2) (3) (4) 1 Bare Metal Stents 1 8,417 Drug Eluting Stents (DES) including metallic DES and 2 1 30,647 Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents Notes:- (a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 1.88468% for the year 2019 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013. (b) The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table. (c) As per Para 24(4) of DPCO 2013, every Retailer and Dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. [PN/206/74/2020/F/F. No. 8(74)/2020/D.P./NPPA-Div.-II] ALOK RANJAN, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers